Abstract is: Sexual dysfunction is difficulty experienced by an individual or partners during any stage of normal sexual activity, including physical pleasure, desire, preference, arousal, or orgasm. The World Health Organization defines sexual dysfunction as a "person's inability to participate in a sexual relationship as they would wish". This definition is broad and is subject to many interpretations. A diagnosis of sexual dysfunction under the DSM-5 requires a person to feel extreme distress and interpersonal strain for a minimum of six months (except for substance- or medication-induced sexual dysfunction). Sexual dysfunction can have a profound impact on an individual's perceived quality of sexual life. The term sexual disorder may not only refer to physical sexual dysfunction, but to paraphilias as well; this is sometimes termed disorder of sexual preference. A thorough sexual history and assessment of general health and other sexual problems (if any) are important when assessing sexual dysfunction, because it is usually correlated with other psychiatric issues, such as mood disorders, eating and anxiety disorders, and schizophrenia. Assessing performance anxiety, guilt, stress, and worry are integral to the optimal management of sexual dysfunction. Many of the sexual dysfunctions that are defined are based on the human sexual response cycle proposed by William H. Masters and Virginia E. Johnson, and modified by Helen Singer Kaplan.
| class of disease | Q112193867 |
| disease | Q12136 |
| psychosexual disorder | Q7256482 |
| sexual and gender disorder | Q18553616 |
| P2176 | drug or therapy used for treatment | tadalafil | Q424156 |
| P2293 | genetic association | PVALB | Q18030965 |
| MDGA2 | Q18052491 | ||
| ADAMTS19 | Q18052986 | ||
| P1995 | health specialty | psychiatry | Q7867 |
| P5008 | on focus list of Wikimedia project | WikiProject Medicine | Q4099686 |
| P910 | topic's main category | Category:Sexual dysfunctions | Q8733976 |
| Category:Sexual disorders | Q63000652 |
| Q110936352 | Vaginale Orgasmusunfähigkeit |
| Q55609245 | Death-grip syndrome |
| Q5958422 | Hyperorgasmia |
| Q778642 | Post-SSRI sexual dysfunction |
| Q21452236 | Sexuality after spinal cord injury |
| Q486058 | anaphrodisia |
| Q97366766 | dysorgasmia |
| Q184674 | erectile dysfunction |
| Q267907 | hypersexuality |
| Q303555 | hypoactive sexual desire disorder |
| Q10611388 | orgasmic dysfunction |
| Q176671 | persistent genital arousal disorder |
| Q66296097 | physiological sexual dysfunction |
| Q2275677 | sexual arousal disorder |
| Q22930959 | Q22930959 |
| Q122111923 | Der Arzt im Hause. Sexual-Katastrophen 3. Band |
| Q121924907 | Seelische und nervöse Störungen der Sexualität und ihre Behandlung: eine prinzipielle Untersuchung über Geschlecht, Angst und Illusion |
| Q122124490 | Seelische und nervöse Störungen der Sexualität und ihre Behandlung: eine prinzipielle Untersuchung über Geschlecht, Angst und Illusion |
| Q121954071 | Sexuologie pro zdravotníky |
| Q122010449 | Štěstí od pasu dolů: doktor Sex radí mužům i ženám |
| Q92589848 | "I did not know it was a medical condition": Predictors, severity and help seeking behaviors of women with female sexual dysfunction in the Volta region of Ghana |
| Q82777022 | "I'll look it up on the Web first": Barriers and overcoming barriers to consult for sexual dysfunction among young men |
| Q45246858 | "It is caused of the womans part or of the mans part": the role of gender in the diagnosis and treatment of sexual dysfunction in early modern England. |
| Q60641427 | 0510 CHANGE IN SEXUAL DYSFUNCTION ON SWITCHING TO ARIPIPRAZOLE |
| Q59679424 | 1074 DISCORDANCE IN CIRCULATING VON WILLEBRAND FACTOR AND SEXUAL DYSFUNCTION BETWEEN MEN AND WOMEN WHO ARE OVERWEIGHT/OBESE |
| Q114261849 | 415 SCIENTOMETRIC EVALUATION OF PUBLISHED ARTICLES ON FEMALE SEXUAL DYSFUNCTION |
| Q34017480 | 5-HT(1A) receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats |
| Q45207432 | 5-HT2A receptor -1438 G/A polymorphism and serotonergic antidepressant-induced sexual dysfunction in male patients with major depressive disorder: a prospective exploratory study |
| Q93720897 | : Sexual dysfunction in Asian couples |
| Q40436348 | A 10-year interval study to compare the prevalence and risk factors of female sexual dysfunction in Korea: the Korean internet sexuality survey (KISS) 2014. |
| Q34183759 | A Comparative Study of Sexual Dysfunction due to Typical and Atypical Antipsychotics in Remitted Bipolar-I Disorder. |
| Q67010143 | A Cyclic Pattern of Sexual Dysfunction in the Infertility Investigation |
| Q43664268 | A GP's view of sexual dysfunction and its treatment |
| Q99596932 | A Late COVID-19 Complication: Male Sexual Dysfunction |
| Q36142085 | A Longitudinal Study of Predictors of Sexual Dysfunction in Men on Active Surveillance for Prostate Cancer |
| Q37787663 | A Multidisciplinary Approach to Sexual Dysfunction in Medical Education |
| Q91953262 | A Paradigmatic Case of Postselective Serotonin Reuptake Inhibitors Sexual Dysfunction or Withdrawal After Discontinuation of Selective Serotonin Reuptake Inhibitors? |
| Q47587889 | A Population-Based Epidemiologic Study of Female Sexual Dysfunction Risk in Mainland China: Prevalence and Predictors |
| Q50241539 | A Prospective Study to Evaluate Sexual Dysfunction and Enlargement of Seminal Vesicles in Sexually Active Men Treated for Benign Prostatic Hyperplasia by Alpha Blockers. |
| Q37379326 | A Qualitative Study of the Relationship Between Methamphetamine Abuse and Sexual Dysfunction in Male Substance Abusers |
| Q91797404 | A Real-World Study on Antidepressant-Associated Sexual Dysfunction in 2144 Outpatients: The SALSEX I Study |
| Q86247885 | A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation (2005-03-31) |
| Q86247661 | A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation (2005-09-15) |
| Q59088423 | A Systematic Review of Research on Strategies for the Management of Antipsychotic-Induced Sexual Dysfunction |
| Q35688375 | A Trilogy Case Review Highlighting the Clinical and Pharmacologic Applications of Mirtazapine in Reducing Polypharmacy for Anxiety, Agitation, Insomnia, Depression, and Sexual Dysfunction |
| Q70455724 | A clinical guide to the diagnosis and treatment of heroin-related sexual dysfunction |
| Q40727723 | A clinical study of the effects of galvanic vaginal muscle stimulation in urinary stress incontinence and sexual dysfunction |
| Q43710284 | A comparative study of sexual dysfunction in schizophrenia patients taking aripiprazole versus risperidone. |
| Q33574421 | A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine |
| Q39292249 | A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women |
| Q43185627 | A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism |
| Q67794024 | A comparison of five-factor personality dimensions in males with sexual dysfunction and males with paraphilia |
| Q83308693 | A comparison of written materials vs. materials and counselling for women with sexual dysfunction and multiple sclerosis |
| Q28267932 | A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction |
| Q36451197 | A critical look at descriptive epidemiology of sexual dysfunction in Asia compared to the rest of the world - a call for evidence-based data |
| Q41428575 | A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management |
| Q44413442 | A descriptive study of the defining characteristics of nursing diagnosis: sexual dysfunction |
| Q40071356 | A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice |
| Q44860530 | A discordant monozygotic twin approach to testing environmental influences on sexual dysfunction in women. |
| Q46966328 | A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate |
| Q35543695 | A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women. |
| Q34830588 | A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction |
| Q35556718 | A framework for the present and future development of experimental models of female sexual dysfunction |
| Q28943500 | A genome-wide association study of female sexual dysfunction |
| Q37405142 | A literature review and case reports series on the use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction |
| Q38217916 | A literature review on the relationship between infertility and sexual dysfunction: does fun end with baby making? |
| Q34025151 | A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics |
| Q80377880 | A methodology study to validate a structured diagnostic method used to diagnose female sexual dysfunction and its subtypes in postmenopausal women |
| Q51797737 | A methodology to validate a structured diagnostic method used to diagnose female sexual dysfunction and its subtypes in postmenopausal women. |
| Q71228390 | A multidisciplinary approach to the evaluation and management of male sexual dysfunction |
| Q46512895 | A naturalistic prospective open study of the effects of adjunctive therapy of sexual dysfunction in chronic PTSD patients. |
| Q74505967 | A new non-pharmacological vacuum therapy for female sexual dysfunction |
| Q81306017 | A novel approach for predicting antidepressant-induced sexual dysfunction in rats |
| Q73610996 | A physiatrist's views regarding the report of the International Consensus Conference on Female Sexual Dysfunction: potential concerns regarding women with disabilities |
| Q38947105 | A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy |
| Q44859495 | A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. |
| Q30432842 | A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction |
| Q78440897 | A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction |
| Q33988612 | A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction |
| Q51832351 | A population survey of sexual activity, sexual dysfunction and associated help-seeking behavior in middle-aged and older adults in Germany. |
| Q71845008 | A possible physiological marker of female sexual dysfunction |
| Q91384813 | A practical approach to assessing and managing sexual dysfunction in multiple sclerosis |
| Q55297841 | A practical guide to female sexual dysfunction: An evidence-based review for physicians in Canada. |
| Q44309465 | A pragmatic approach to sexual dysfunction in diabetic men: psychosexual counselling |
| Q52253539 | A preliminary examination of the pornography experience of sex offenders, paraphiliacs, sexual dysfunction patients, and controls based on Meese Commission recommendations. |
| Q58114766 | A profile of women who seek counseling for sexual dysfunction |
| Q87686893 | A prospective study on association of prostatic calcifications with sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) |
| Q50892640 | A psychoeducational intervention for sexual dysfunction in women with gynecologic cancer. |
| Q36943850 | A review of the assessment of antidepressant-induced sexual dysfunction used in randomized, controlled clinical trials |
| Q53257161 | A self-report-based study of the incidence and associations of sexual dysfunction in survivors of intensive care treatment. |
| Q77812682 | A statement on the use of sildenafil in the management of sexual dysfunction in patients with cardiovascular disease. Heart and Stroke Foundation of Canada. Canadian Cardiovascular Society |
| Q44341971 | A study of assessment of sexual dysfunction in male subjects with opioid dependence |
| Q35211421 | A study of psychiatric morbidity in married males with sexual dysfunction |
| Q47978386 | A study of the main determinants of sexual dysfunction in women aged 15-45 years on chronic hemodialysis |
| Q71973691 | A system of group therapy for the treatment of marital and sexual dysfunction |
| Q93388939 | A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women |
| Q38180492 | A systematic review of sexual dysfunction measures for gay men: how do current measures measure up? |
| Q36567543 | A systematic review of the literature on female sexual dysfunction prevalence and predictors |
| Q33270841 | A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophrenia |
| Q64053278 | A web-based psycho-educational intervention (Fex-Can) targeting sexual dysfunction and fertility-related distress in young adults with cancer: study protocol of a randomized controlled trial |
| Q45844460 | AB028. New drugs for sexual dysfunction complementary medicine for sexual dysfunction in Australia. |
| Q46166052 | AB170. Molecular biology for genitourinary system diseases and sexual dysfunction clusterin produced by Sertoli cells inhibits heat stress-induced apoptosis in the rat testis. |
| Q46632335 | AB178. Molecular biology for genitourinary system diseases and sexual dysfunction icariside II prevents high-glucose-induced injury on human cavernous endothelial cells through Akt-eNOS signaling pathway. |
| Q45786072 | AB271. Sexual dysfunction in chronic prostatitis. |
| Q24655490 | ABC of urology. Subfertility and male sexual dysfunction |
| Q93730680 | ABSTRACTS FROM A SYMPOSIUM ON 'BLADDER AND SEXUAL DYSFUNCTION IN AGEING' |
| Q37855463 | ACOG Practice Bulletin No. 119: Female sexual dysfunction |
| Q22305441 | AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE EVALUATION AND TREATMENT OF MALE SEXUAL DYSFUNCTION: A COUPLE'S PROBLEM-2003 UPDATE |
| Q56997878 | ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction |
| Q72433888 | Absence of a therapeutic effect of zinc in the sexual dysfunction of haemodialysed patients |
| Q69657383 | Absence of sexual dysfunction does not mean that the couple does not need sexual counseling |
| Q70680186 | Absence of zinc testicular deficiency in the sexual dysfunction of experimentally induced uremic rats |
| Q94080098 | Abstracts from the current global literature: Finasteride and sexual dysfunction |
| Q52319881 | Abuse, cancer and sexual dysfunction in women: A potentially vicious cycle. |
| Q91663450 | Accuracy of the Defining Characteristics of the Sexual Dysfunction Nursing Diagnosis in Women with Breast Cancer |
| Q51239925 | Acknowledging female sexual dysfunction in women with cancer. |
| Q48303112 | Acromegaly is associated with higher frequency of female sexual dysfunction: experience of a single center. |
| Q73569854 | Acupuncture and hypnotic suggestions in the treatment of non-organic male sexual dysfunction |
| Q46595352 | Acute pregabalin reversal of citalopram-induced sexual dysfunction in generalized anxiety disorder |
| Q108778132 | Adaptation to Sexual Dysfunction in Patients with Chronic Renal Failure |
| Q108777806 | Adaptation to Sexual Dysfunction in Patients with Chronic Renal Failure in Indonesia |
| Q41702711 | Adding a sexual dysfunction domain to UPOINT system improves association with symptoms in women with interstitial cystitis and bladder pain syndrome. |
| Q51927054 | Adding insult to injury: the classification of dyspareunia as a sexual dysfunction in the DSM. |
| Q98387840 | Addressing Sexual Dysfunction After Childhood Sexual Abuse: A Clinical Approach from an Attachment Perspective |
| Q35007815 | Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention |
| Q40929520 | Addressing sexual dysfunction following radiation therapy for a gynecologic malignancy. |
| Q34234964 | Addressing sexual dysfunction in colorectal cancer survivorship care |
| Q64231876 | Addressing the Gaps in Post-Stroke Sexual Activity Rehabilitation: Patient Perspectives |
| Q83507355 | Adjunctive treatment with low-dosage pramipexole for risperidone-associated hyperprolactinemia and sexual dysfunction in a male patient with schizophrenia |
| Q40812576 | Adjuvant Rosa Damascena has a Small Effect on SSRI-induced Sexual Dysfunction in Female Patients Suffering from MDD. |
| Q51963478 | Adjuvant radiotherapy is associated with increased sexual dysfunction in male patients undergoing resection for rectal cancer: a predictive model. |
| Q45947581 | Adolescent TBI-induced hypopituitarism causes sexual dysfunction in adult male rats. |
| Q34465301 | Advances in pharmacotherapy for treating female sexual dysfunction |
| Q53221204 | Adverse impact of sexual dysfunction in chronic prostatitis/chronic pelvic pain syndrome. |
| Q37506771 | Aetiology, diagnostic algorithms and prognosis of female sexual dysfunction |
| Q73610908 | After reading the report of the International Consensus Conference on Female Sexual Dysfunction |
| Q51625359 | Age, gender, depression, and sexual dysfunction in Taiwan. |
| Q46244656 | Alleviation of both binge eating and sexual dysfunction with naltrexone |
| Q33822420 | Alpha-blocker use is associated with decreased risk of sexual dysfunction |
| Q35865091 | Alternative therapies for male and female sexual dysfunction |
| Q55064762 | Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. |
| Q58866023 | Ameliorative Effect of Fructo-Oligosaccharide Rich Extract of Orchis latifolia Linn. on Sexual Dysfunction in Hyperglycemic Male Rats |
| Q91643106 | Ameliorative effects of Lycium chinensis on male sexual dysfunction and testicular oxidative damage in streptozotocin-induced diabetic rats |
| Q71550842 | Amiodarone and sexual dysfunction |
| Q66912320 | Amputees and sexual dysfunction |
| Q37800587 | An Approach to Symptoms at the Interface of Medicine and Psychiatry: Pain, Insomnia, Weight Loss and Anorexia, Fatigue and Forgetfulness, and Sexual Dysfunction |
| Q99707952 | An Herbal Nanohybrid Formula of Epigallocatechin Gallate-Chitosan-Alginate Efficiently Restrict the Sexual Dysfunction Adverse Effect of β-Adrenergic Antagonist Drug: Propranolol |
| Q36590823 | An Internet survey of demographic and health factors associated with risk of sexual dysfunction in women who have sex with women |
| Q56700757 | An Old Problem with a New Cause-5 Alpha Reductase Inhibitors and Persistent Sexual Dysfunction |
| Q39861415 | An approach to the management of sexual dysfunction in the adolescent male |
| Q46812109 | An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder. |
| Q101211806 | An estimation of patients at potential risk for drug-induced sexual dysfunction using pharmacy dispensing data |
| Q37128707 | An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction |
| Q36973734 | An examination of the association of abuse (physical, sexual, or emotional) and female sexual dysfunction: results from the Boston Area Community Health Survey |
| Q53327582 | An external perspective on the report of the International Consensus Development Conference on Female Sexual Dysfunction: more work to be done. |
| Q48296610 | An integral view of the neuroendocrine aspects of male sexual dysfunction and aging |
| Q34754775 | An open trial of oral sildenafilin antidepressant-induced sexual dysfunction |
| Q46507541 | An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors |
| Q80203992 | An open-label study to evaluate switching from an SSRI or SNRI to tiagabine to alleviate antidepressant-induced sexual dysfunction in generalized anxiety disorder |
| Q56883154 | An overview and expert opinion on the use of alprostadil in the treatment of sexual dysfunction |
| Q35064935 | An unexpected association between urinary incontinence, depression and sexual dysfunction |
| Q38044019 | An update on the pharmacological management of female sexual dysfunction |
| Q44785126 | Analysis of mailed questionnaire for female sexual dysfunction after intra-pelvic surgery |
| Q34312937 | Anatomy and physiology of the clitoris, vestibular bulbs, and labia minora with a review of the female orgasm and the prevention of female sexual dysfunction |
| Q34566733 | Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: androgen and questionnaire results |
| Q47881407 | Androgens and Psychosocial Factors Related to Sexual Dysfunctions in Premenopausal Women∗: ∗2016 ISSM Female Sexual Dysfunction Prize |
| Q51478179 | Androgens and sexual dysfunction in naturally and surgically menopausal women. |
| Q43250308 | Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency |
| Q73433039 | Andrology, sexual dysfunction, infertility |
| Q35545746 | Animal models in urological disease and sexual dysfunction |
| Q38152536 | Animal models of female sexual dysfunction: basic considerations on drugs, arousal, motivation and behavior |
| Q50858739 | Anodyspareunia, the unacknowledged sexual dysfunction: a validation study of painful receptive anal intercourse and its psychosexual concomitants in homosexual men. |
| Q40147974 | Antidepressant drug therapy and sexual dysfunction in men: a review |
| Q31095337 | Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction |
| Q33766588 | Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting |
| Q34630601 | Antidepressant-associated sexual dysfunction: impact, effects, and treatment |
| Q34874381 | Antidepressant-induced sexual dysfunction |
| Q74468425 | Antidepressant-induced sexual dysfunction |
| Q90331938 | Antidepressant-induced sexual dysfunction |
| Q73719206 | Antidepressant-induced sexual dysfunction and Ginkgo Biloba |
| Q48010768 | Antidepressant-induced sexual dysfunction during treatment with fluoxetine, sertraline and trazodone; a randomized controlled trial |
| Q31387747 | Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. |
| Q73696610 | Antidepressant-induced sexual dysfunction in adolescence |
| Q38163261 | Antidepressant-induced sexual dysfunction in men. |
| Q69877438 | Antidepressant-induced sexual dysfunction in men: due to cholinergic blockade? |
| Q45123192 | Antidepressant-induced sexual dysfunction treated with vardenafil |
| Q33659909 | Antidepressant-induced sexual dysfunction: review, classification, and suggestions for treatment |
| Q30714090 | Antidepressant-related sexual dysfunction - perspectives from neuroimaging |
| Q73233513 | Antidepressants and sexual dysfunction |
| Q80049730 | Antidepressants and sexual dysfunction |
| Q92875926 | Antidepressants and sexual dysfunction: a history |
| Q30457744 | Antidepressants and sexual dysfunction: mechanisms and clinical implications |
| Q87148001 | Antidiabetic effect of α-mangostin and its protective role in sexual dysfunction of streptozotocin induced diabetic male rats |
| Q38602936 | Antihypertensive Drugs and Male Sexual Dysfunction: A Review of Adult Hypertension Guideline Recommendations |
| Q35122397 | Antihypertensive drug-associated sexual dysfunction: a prescription analysis-based study |
| Q70671943 | Antihypertensive drugs and sexual dysfunction |
| Q70647143 | Antihypertensive therapy and male sexual dysfunction |
| Q38009740 | Antihypertensive treatment and sexual dysfunction |
| Q37218074 | Antioxidant Potential and Ability of Phloroglucinol to Decrease Formation of Advanced Glycation End Products Increase Efficacy of Sildenafil in Diabetes-Induced Sexual Dysfunction of Rats. |
| Q40086735 | Antipsychotic drug therapy and sexual dysfunction in men. |
| Q61814995 | Antipsychotic-Induced Sexual Dysfunction and the Strength of the Evidence |
| Q36758151 | Antipsychotic-induced sexual dysfunction and its management |
| Q44535854 | Antipsychotic-induced sexual dysfunction and the strength of the evidence |
| Q44837947 | Antiretroviral therapy is associated with sexual dysfunction and with increased serum oestradiol levels in men. |
| Q70680723 | Aortoiliac operations and sexual dysfunction |
| Q97528523 | Application of Botulinum Neurotoxin in Male Sexual Dysfunction: Where Are We Now? |
| Q91566163 | Application of Sex Aids in Men With Sexual Dysfunction: A Review |
| Q91594698 | Approach to sexual dysfunction in women with cancer |
| Q44286277 | Arterial hypertension and female sexual dysfunction in postmenopausal women |
| Q38932023 | Asexuality: Sexual Orientation, Paraphilia, Sexual Dysfunction, or None of the Above? |
| Q45063190 | Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study |
| Q67865733 | Assailants' sexual dysfunction during rape reported by their victims |
| Q39874704 | Assailants' sexual dysfunction during rape: prevalence and relationship to genital trauma in female victims |
| Q37359884 | Assessing & managing female sexual dysfunction |
| Q89454125 | Assessing dutasteride-associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System |
| Q50774808 | Assessing female sexual dysfunction in epidemiological studies: why is it necessary to measure both low sexual function and sexually-related distress? |
| Q89540263 | Assessing finasteride-associated sexual dysfunction using the FAERS database |
| Q92304492 | Assessing sexual dysfunction in men with epilepsy: A need for specific tools! |
| Q37512995 | Assessing the clinical efficacy of sildenafil for the treatment of female sexual dysfunction |
| Q80254626 | Assessing the onset of antidepressant-induced sexual dysfunction using interactive voice response technology |
| Q39934210 | Assessing training in sexual dysfunction for genitourinary medicine registrars |
| Q37514221 | Assessment and Treatment of Psychiatric Distress, Sexual Dysfunction, Sleep Disturbances, and Pain in Multiple Sclerosis: A Survey of Members of the Consortium of Multiple Sclerosis Centers |
| Q47653061 | Assessment and management of sexual dysfunction in the context of depression |
| Q39984545 | Assessment of Sexual Dysfunction Symptoms in Female Drug Users: Standardized vs. Unstandardized Methods |
| Q34635780 | Assessment of female sexual dysfunction: review of validated methods |
| Q30463756 | Assessment of paroxetine-induced sexual dysfunction using the Changes in Sexual Functioning Questionnaire |
| Q55264783 | Assessment of sexual dysfunction and associated factors among patients with schizophrenia in Ethiopia, 2017. |
| Q47609081 | Assessment of sexual dysfunction and determination of its risk factors in the Republic of Korea. |
| Q51475908 | Assessment of sexual dysfunction and sexually related personal distress in patients who have undergone orthotopic liver transplantation for end-stage liver disease. |
| Q48972477 | Assessment of sexual dysfunction before and after surgery for lumbar disc herniation |
| Q88063268 | Assessment of sexual dysfunction in depressed patients and reporting attitudes in routine daily practice: Results of the postmarketing observational studies with moclobemide, a reversible MAO-A inhibitor |
| Q79342036 | Assessment of sexual dysfunction in male patients with Ankylosing Spondylitis |
| Q51686497 | Assessment of sexual dysfunction in patients with Parkinson's disease: a case-control study. |
| Q36409140 | Assessment of sexual dysfunction in patients with benign prostatic hyperplasia |
| Q90733702 | Assessment of sexual dysfunction in patients with inflammatory bowel disease |
| Q99604613 | Assessment of sexual dysfunction in patients with perianal Crohn's disease |
| Q46931080 | Assessment of sexually related personal distress accompanying premenopausal sexual dysfunction with an Arabic version of the Female Sexual Distress Scale |
| Q79815468 | Assessment of the relational factor in male patients consulting for sexual dysfunction: the concept of couple sexual dysfunction |
| Q64264641 | Association Between Alcohol Use and Female Sexual Dysfunction From the Data Registry on Experiences of Aging, Menopause, and Sexuality (DREAMS) |
| Q98282677 | Association Between Body Mass Index and Female Sexual Dysfunction: A Cross-sectional Study from the Data Registry on Experiences of Aging, Menopause, and Sexuality |
| Q39016013 | Association Between Infertility and Sexual Dysfunction in Men and Women. |
| Q58562863 | Association Between Multiple Sclerosis and Risk of Female Sexual Dysfunction: A Systematic Review and Meta-Analysis |
| Q98498272 | Association Between Overt Hyperthyroidism and Risk of Sexual Dysfunction in Both Sexes: A Systematic Review and Meta-Analysis |
| Q92525952 | Association between clitoral tissue perfusion and female sexual dysfunction in healthy women of reproductive age: a pilot study |
| Q91277767 | Association between comorbidities and female sexual dysfunction: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3) |
| Q91032525 | Association between epilepsy and risk of sexual dysfunction: A meta-analysis |
| Q37376104 | Association between fibromyalgia and sexual dysfunction in women |
| Q53136666 | Association between lower urinary tract symptoms and sexual dysfunction assessed using the core lower urinary tract symptom score and International Index of Erectile Function-5 questionnaires. |
| Q82721255 | Association between lower urinary tract symptoms and sexual dysfunction in Taiwanese men |
| Q48068200 | Association between mental health disorders and sexual dysfunction in patients suffering from rheumatic diseases |
| Q37070710 | Association between metabolic syndrome and sexual dysfunction among men with clinically diagnosed diabetes |
| Q91620834 | Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients |
| Q90552126 | Association between sexual dysfunction and avulsion of the levator ani muscle after instrumental vaginal delivery |
| Q90326149 | Association between sexuality knowledge and sexual dysfunction in hematopoietic stem cell transplantation patients and their partners |
| Q37586022 | Association between the hemodialysis adequacy and sexual dysfunction in chronic renal failure: a preliminary study |
| Q91994758 | Association between type 1 diabetes and female sexual dysfunction |
| Q91586663 | Association of Female Sexual Dysfunction and Fertility: a cross sectional study |
| Q47870749 | Association of anxiety, sleepiness, and sexual dysfunction with restless legs syndrome in hemodialysis patients |
| Q35124078 | Association of body weight and female sexual dysfunction: a case control study |
| Q47966052 | Association of brain-derived neurotrophic factor valine to methionine polymorphism with sexual dysfunction following selective serotonin reuptake inhibitor treatment in female patients with major depressive disorder |
| Q100431427 | Association of female genital mutilation and female sexual dysfunction: A systematic review and meta-analysis |
| Q46617454 | Association of lower urinary tract symptoms with sexual dysfunction: a cross-cultural study between Japanese and American men with localized prostate cancer |
| Q45754264 | Association of major depression with sexual dysfunction in men. |
| Q46149256 | Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry |
| Q112576500 | Associations Between Online Pornography Consumption and Sexual Dysfunction in Young Men: Multivariate Analysis Based on an International Web-Based Survey |
| Q38858318 | Associations of Body Mass Index and Physical Activity With Sexual Dysfunction in Breast Cancer Survivors |
| Q88223316 | Associations of Peritoneal Glucose Load With Male Sexual Dysfunction and Depression in Peritoneal Dialysis Patients |
| Q43418836 | Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study. |
| Q33554390 | Attention bias for sexual words in female sexual dysfunction |
| Q91867577 | Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice |
| Q45130847 | Attrition from an Internet-based treatment program for female sexual dysfunction: who is best treated with this approach? |
| Q34566727 | Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone |
| Q92616363 | Autologous Platelet-Released Growth Factor and Sexual Dysfunction Amendment: A Pilot Clinical Trial of Successful Improvement Sexual Dysfunction after Pelvic Irradiation |
| Q63352422 | Autonomic Dysfunction in Early Parkinson's Disease: Results from the United Kingdom Tracking Parkinson's Study |
| Q51070122 | Autonomic studies in hypertensive patient with unusual sexual dysfunction: response to reserpine. |
| Q80879891 | Avlimil taken for female sexual dysfunction |
| Q48651980 | Avoiding experiences: sexual dysfunction in women with a history of sexual abuse in childhood and adolescence |
| Q92264315 | BET 2: Is sexual dysfunction a recognised sign of cauda equina syndrome in the ED? |
| Q79137319 | Baclofen-induced sexual dysfunction |
| Q114600249 | Barriers to the management of sexual dysfunction among people with psychosis: analysis of qualitative data from the REMEDY trial |
| Q102155533 | Baseline patient reported outcomes data shows high prevalence of overactive bladder, sexual dysfunction, depression and anxiety in Canadian men with newly diagnosed localized prostate cancer |
| Q52496822 | Behavioral analysis of sexual dysfunction in Hansen's disease. |
| Q67665274 | Behaviour- and psychotherapy of functional sexual disorder in youth (author's transl) |
| Q46375324 | Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content. |
| Q73370882 | Benign prostatic hyperplasia and sexual dysfunction |
| Q94189573 | Benign prostatic hyperplasia and sexual dysfunction |
| Q46759869 | Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty |
| Q34738402 | Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction |
| Q79189431 | Bibliography. Current world literature. Andrology and sexual dysfunction |
| Q79406090 | Bibliography. Current world literature. Andrology, sexual dysfunction and infertility |
| Q80115206 | Bibliography. Current world literature. Andrology, sexual dysfunction and infertility |
| Q81254224 | Bibliography. Current world literature. Andrology, sexual dysfunction and infertility |
| Q82199496 | Bibliography. Current world literature. Andrology, sexual dysfunction and infertility |
| Q73433047 | Bibliography. Current world literature. Andrology, sexual dysfunction, infertility |
| Q73456743 | Bibliography. Current world literature. Andrology, sexual dysfunction, infertility |
| Q78660179 | Bibliography. Current world literature. Andrology, sexual dysfunction, infertility |
| Q24244831 | Bibliotherapy for sexual dysfunction |
| Q37998526 | Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis |
| Q96306531 | Biofeedback versus electrical stimulation for sexual dysfunction: a randomized clinical trial |
| Q44750155 | Biofeedback, electrical stimulation, pelvic floor muscle exercises, and vaginal cones: a combined rehabilitative approach for sexual dysfunction associated with urinary incontinence |
| Q36372389 | Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition |
| Q64976832 | Biopsychosocial Management of Female Sexual Dysfunction: A Pilot Study of Patient Perceptions From 2 Multi-Disciplinary Clinics. |
| Q43244192 | Bisphenol A exposure and sexual dysfunction in men: editorial commentary on the article 'Occupational exposure to bisphenol-A (BPA) and the risk of self-reported male sexual dysfunction' Li et al., 2009. |
| Q73442400 | Bladder and sexual dysfunction after mesorectal excision for rectal cancer |
| Q78553394 | Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer |
| Q53864691 | Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer (Br J Surg 2002; 89: 1551-1556). |
| Q71223670 | Bladder and sexual dysfunction in multiple sclerosis |
| Q45082721 | Bladder dysfunction and sexual dysfunction and their management in patients with MS disease |
| Q73701250 | Bladder, Bowel, and Sexual Dysfunction in Multiple Sclerosis |
| Q28201946 | Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies |
| Q71759661 | Bladder, bowel and sexual dysfunction in patients with multiple sclerosis--a cohort study |
| Q35209869 | Bladder, bowel, and sexual dysfunction in Parkinson's disease |
| Q67020020 | Blood plasma levels of testosterone in patients with psychogenic sexual dysfunction |
| Q34725501 | Body Image for Women: Conceptualization, Assessment, and a Test of its Importance to Sexual Dysfunction and Medical Illness |
| Q46075487 | Body image is a major determinant of sexual dysfunction in stable HIV-infected women. |
| Q51637392 | Body mass index, urinary incontinence, and female sexual dysfunction: how they affect female postmenopausal health. |
| Q46358900 | Bone mineral density and response to treatment in men younger than 50 years with testosterone deficiency and sexual dysfunction or infertility |
| Q36237257 | Botanical therapies in sexual dysfunction |
| Q93088236 | Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction |
| Q88286407 | Both men and women with functional gastrointestinal disorders suffer from a high incidence of sexual dysfunction |
| Q33931044 | Breast cancer treatment and sexual dysfunction: Moroccan women's perception |
| Q41427463 | Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction. |
| Q50240301 | Brysocarpus coccineus (Schum & Thonn) root reinstates sexual competence and testicular function in paroxetine-induced sexual dysfunction in male Wistar rats. |
| Q77995991 | Bulbocavernosus-reflex latencies and pudendal nerve SSEP compared to penile vascular testing in 669 patients with erectile failure and other sexual dysfunction |
| Q56038606 | Bupropion Treatment of Serotonin Reuptake Antidepressant-Associated Sexual Dysfunction |
| Q38219753 | Bupropion in the depression-related sexual dysfunction: a systematic review |
| Q34461089 | Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction |
| Q48307144 | Bupropion-related sexual dysfunction and possible management in a fresh patient with major depressive disorder |
| Q30439310 | Burden of phase-specific sexual dysfunction with SSRIs |
| Q59330835 | CANCER-RELATED FATIGUE, SEXUAL DYSFUNCTION, AND REDUCED LEAN BODY MASS IN AGING MEN WITH TESTOSTERONE DEFICIENCY |
| Q43976174 | CNS-targeted sexual dysfunction drug for men and women |
| Q72416717 | Cadmium-induced sexual dysfunction does not involve increased hepatic metabolism of testosterone nor increased circulating levels of corticosterone |
| Q97874711 | Can High Visceral Adiposity Index Be a Risk Factor for Sexual Dysfunction in Sexually Active Men? |
| Q39162361 | Can polyacrylic acid treat sexual dysfunction in women with breast cancer receiving tamoxifen? |
| Q39369510 | Can the UroLift prostatic implant device treat the symptoms of benign prostatic hypertrophy, avoid sexual dysfunction and reduce hospital TURP waiting times? A single centre, single surgeon experience and review of the literature |
| Q33875161 | Cancer and male sexual dysfunction |
| Q88579440 | Cardiometabolic Risk and Female Sexuality-Part I. Risk Factors and Potential Pathophysiological Underpinnings for Female Vasculogenic Sexual Dysfunction Syndromes |
| Q40677866 | Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes |
| Q38115833 | Cardiovascular changes resulting from sexual activity and sexual dysfunction after myocardial infarction: integrative review |
| Q66912316 | Cardiovascular patients and sexual dysfunction |
| Q33933321 | Cardiovascular rehabilitation, ballroom dancing and sexual dysfunction |
| Q44836365 | Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging |
| Q50532763 | Case management of the anemic patient. Epoetin alfa: focus on sexual dysfunction |
| Q36658543 | Categories of female sexual dysfunction |
| Q68253222 | Causes of sexual dysfunction |
| Q51212129 | Causes of sexual dysfunction: the role of anxiety and cognitive interference. |
| Q40633102 | Central nervous system based neurogenic female sexual dysfunction: current status and future trends |
| Q34585432 | Central nervous system-acting agents and the treatment of erectile and sexual dysfunction |
| Q36993652 | Centrally acting mechanisms for the treatment of male sexual dysfunction |
| Q36615031 | Cervical cancer survivors' and partners' experiences with sexual dysfunction and psychosexual support. |
| Q59415561 | Challenges in Designing Psychological Treatment Studies for Sexual Dysfunction |
| Q43735476 | Challenges in conducting multicenter clinical trials in female sexual dysfunction: baseline differences between study populations |
| Q38612844 | Change in Sexual Dysfunction Following Bariatric Surgery. |
| Q46727015 | Change in sexual dysfunction with aripiprazole: a switching or add-on study |
| Q77777467 | Characteristics of female patients with sexual dysfunction who also had a history of blunt perineal trauma |
| Q33267471 | Childhood sexual abuse and adult sexual dysfunction: response to commentary by Rind and Tromovitch (2007). |
| Q40925383 | Childhood sexual abuse as a predictor of adult female sexual dysfunction: a study of couples seeking sex therapy. |
| Q44165590 | Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without vardenafil on physiological sexual arousal in women with sexual dysfunction: a pilot study |
| Q39287904 | Chinese version of the Psychotropic-related Sexual Dysfunction Questionnaire (PRSexDQ -SALSEX): Validity and reliability for schizophrenic patients taking antipsychotics. |
| Q90280594 | Chronic Disease Burden, Sexual Frequency, and Sexual Dysfunction in Partnered Older Adults |
| Q37941361 | Chronic alcoholism and male sexual dysfunction |
| Q45334248 | Chronic fatigue and sexual dysfunction in female Gulf War veterans |
| Q44647304 | Circumcision, sexual dysfunction and the child's best interests: why the anatomical details matter |
| Q33551764 | Citalopram (antidepressant) administration causes sexual dysfunction in male mice through RF-amide related peptide in the dorsomedial hypothalamus |
| Q44216754 | Classification of Sexual Dysfunction for Management of Intracavernous Medication-Induced Erections |
| Q38930848 | Climacteric Symptoms and Sexual Dysfunction: Association between the Blatt-Kupperman Index and the Female Sexual Function Index |
| Q34667443 | Clinical Assessment of Tribulus terrestris Extract in the Treatment of Female Sexual Dysfunction |
| Q57468539 | Clinical Consultation Guide on Imaging in Male Infertility and Sexual dysfunction |
| Q104140412 | Clinical Pharmacokinetic Evaluation of Optimized Liquisolid Tablets as a Potential Therapy for Male Sexual Dysfunction |
| Q37643045 | Clinical Practice Guidelines for Management of Sexual Dysfunction |
| Q89146954 | Clinical Validation of the Nursing Diagnosis of Sexual Dysfunction in Pregnant Women |
| Q47423494 | Clinical and biopsychosocial determinants of sexual dysfunction in middle-aged and older Australian men. |
| Q34593179 | Clinical applications of centrally acting agents in male sexual dysfunction |
| Q113209855 | Clinical assessment of sildenafil in the treatment of neurogenic male sexual dysfunction: After the hype |
| Q49243791 | Clinical assessment of sildenafil in the treatment of neurogenic male sexual dysfunction: After the hype. |
| Q36372449 | Clinical biologic pathophysiologies of women's sexual dysfunction |
| Q34433316 | Clinical correlates of enlarged prostate size in subjects with sexual dysfunction |
| Q51822961 | Clinical evaluation and management strategy for sexual dysfunction in men and women. |
| Q38225768 | Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study |
| Q34201436 | Clinical follow-up of couples treated for sexual dysfunction |
| Q90209702 | Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram |
| Q38730995 | Clinical indicators of sexual dysfunction in pregnant women: integrative literature review. |
| Q96439283 | Clinical spectrum, diagnosis, and sexual dysfunction after repair of fracture penis: Is no news good news? |
| Q70094239 | Clinical study of sexual dysfunction after surgery of cancer of the rectum |
| Q77777513 | Clinical trial development in female sexual dysfunction |
| Q74733706 | Clinical trials in sexual dysfunction |
| Q86204967 | Clinico-demographic profile, sexual dysfunction and readiness to change in male alcohol dependence syndrome inpatients in a tertiary hospital |
| Q51802977 | Clitoral circulation in postmenopausal women with sexual dysfunction: a pilot randomized study with hormone therapy. |
| Q51531946 | Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients. |
| Q42549456 | Clonazepam-related sexual dysfunction in male veterans with PTSD. |
| Q28332651 | Clonidine (Catapres) and other drugs causing sexual dysfunction |
| Q51927324 | Co-occurrence of sexual dysfunction within young married couple dyads living in rural China: a population-based study. |
| Q35917862 | Co-relationship between sexual dysfunction and high-risk sexual behavior in patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence |
| Q51863486 | Cocaine and sexual dysfunction: the curse of mama coca. |
| Q42251180 | Cocaine- and alcohol-induced sexual dysfunction in patients with addictive disease |
| Q47240366 | Cognitive Attentional Syndrome and Metacognitive Beliefs in Male Sexual Dysfunction: An Exploratory Study. |
| Q62495937 | Cognitive and social aspects of sexual dysfunction: sexual scripts in sex therapy |
| Q64073586 | Cognitive function, depression, and anxiety in patients undergoing radical prostatectomy with and without adjuvant treatment |
| Q47569299 | Cognitive structures in women with sexual dysfunction: the role of early maladaptive schemas |
| Q68216065 | Collagen alterations in the corpus cavernosum of men with sexual dysfunction |
| Q61928763 | Combined Antihypertensive Therapy and Sexual Dysfunction: Terra Incognita |
| Q34121445 | Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects |
| Q84564557 | Comment for Summary of the recommendations of sexual dysfunction in women: R Basson, M Wierman, J van Lankveld, L Brotto. J Sex Med 2010;7:314-26 |
| Q86901865 | Comment on: Radiation Dose to the Penile Structures and Patient-Reported Sexual Dysfunction in Long-Term Prostate Cancer Survivors |
| Q42922410 | Comment on: Wing et al. Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD Study. Diabetes care 2013;36:2937-2944. |
| Q49692152 | Commentary on: Vaginal Laxity, Sexual Distress, and Sexual Dysfunction: A Cross-Sectional Study in a Plastic Surgery Practice. |
| Q45117863 | Commentary. Sexual dysfunction after conventional and endovascular AAA repair: results of the DREAM trial. |
| Q51539505 | Commentary: Female sexual dysfunction is a real but complex problem |
| Q50910662 | Comments on female sexual dysfunction with cervical cancer in Republic of Korea. |
| Q44276705 | Comments on the use of group therapy and written instruction in treatment of sexual dysfunction |
| Q36107691 | Common therapeutic strategies in the management of sexual dysfunction and cardiovascular disease. |
| Q48062490 | Comparative analysis of copper intrauterine device impact on female sexual dysfunction subtypes |
| Q50883431 | Comparative analysis of copper intrauterine device impact on female sexual dysfunction subtypes. |
| Q28257427 | Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women |
| Q56853910 | Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women |
| Q36458077 | Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia |
| Q64075516 | Comparing the Effects of Two Methods of Group Education and Peer Education on Sexual Dysfunction of Menopausal Women: A Randomized Controlled Trial |
| Q36429190 | Comparing the Efficacy of Bupropion and Amantadine on Sexual Dysfunction Induced by a Selective Serotonin Reuptake Inhibitor. |
| Q37058843 | Comparing the effects of treatment with sildenafil and cognitive-behavioral therapy on treatment of sexual dysfunction in women: a randomized controlled clinical trial |
| Q88310458 | Comparison of Correlated Comorbidities in Male and Female Sexual Dysfunction: Findings From the Third National Survey of Sexual Attitudes and Lifestyles (Natsal-3) |
| Q36203892 | Comparison of Sexual Dysfunction Using the Female Sexual Function Index following Surgical Treatments for Uterine Fibroids |
| Q35276390 | Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem |
| Q33572588 | Comparison of Sexual Dysfunction in Women with Migraine and Multiple Sclerosis (MS). |
| Q98953956 | Comparison of hormone profile and systemic inflammation in patients presenting with sexual dysfunction: Which is important? |
| Q37634789 | Comparison of sexual dysfunction between diabetic and non-diabetic women |
| Q43697592 | Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine |
| Q36906916 | Comparison of sexual dysfunction in women with infertility and without infertility referred to Al-Zahra Hospital in 2013-2014. |
| Q40679802 | Comparison of the Effects of Elaeagnus angustifolia Flower Capsule and Sildenafil Citrate Tablet on Anxiety Resulting From Sexual Dysfunction in Women Referring to the Selected Clinics of Shiraz University of Medical Sciences. |
| Q87605321 | Complementary and alternative medicine (CAM) for sexual dysfunction |
| Q69772926 | Complications following hypnosis in a psychotic patient with sexual dysfunction treated by a lay hypnotist |
| Q41740348 | Concordance of sexual dysfunction and dissatisfaction by self-report and those by partner's perception in young adult couples |
| Q36372367 | Confronting the challenges: epidemiological study of female sexual dysfunction and the menopause |
| Q90336264 | Consent Including Sexual Dysfunction and Pain with Sexual Activity after Inguinal Hernia Repair? |
| Q53639116 | Constitutive luteinizing hormone receptor signaling causes sexual dysfunction and Leydig cell adenomas in male mice. |
| Q90575578 | Consulting "Dr Google" for sexual dysfunction: a contemporary worldwide trend analysis |
| Q38128405 | Contemporary treatment of sexual dysfunction: reexamining the biopsychosocial model |
| Q42645653 | Contradictions in the medical encounter: female sexual dysfunction in primary care contacts |
| Q93062154 | Correction: "I did not know it was a medical condition": Predictors, severity and help seeking behaviors of women with female sexual dysfunction in the Volta region of Ghana |
| Q24633029 | Correlates of placebo response in the treatment of sexual dysfunction in women: a preliminary report |
| Q42600245 | Correlates of sexual dysfunction in men and women with multiple sclerosis |
| Q44557480 | Correlation of pelvic organ prolapse staging with lower urinary tract symptoms, sexual dysfunction, and quality of life |
| Q48374562 | Correlation of sexual dysfunction and brain magnetic resonance imaging in multiple sclerosis |
| Q104571252 | Correlation of sexual dysfunction with sex hormone and estrogen receptor gene polymorphism in Chinese Han women with epilepsy |
| Q36610030 | Correlations between female sex roles and attitudes toward male sexual dysfunction in thirty women |
| Q44596472 | Correlations between sexual dysfunction, depression, anxiety, and somatic symptoms among patients with major depressive disorder |
| Q93147292 | Corrigendum: Hypogonadism and Sexual Dysfunction in Testicular Tumor Survivors: A Systematic Review |
| Q52541444 | Cortical evoked potentials of the dorsal nerve of the clitoris and female sexual dysfunction in multiple sclerosis. |
| Q76313033 | Cost implications of sexual dysfunction: the female picture |
| Q34583440 | Counseling patients about sexual dysfunction |
| Q70808761 | Countertransference and transference in couple therapy: treating sexual dysfunction in older couples |
| Q47549007 | Couplepause: A New Paradigm in Treating Sexual Dysfunction During Menopause and Andropause |
| Q94370208 | Couples Consider Marriages Happy Despite Sexual Dysfunction: Study |
| Q48907987 | Couples referred to a sexual dysfunction clinic. Psychological and physical morbidity |
| Q73650576 | Creating a game for sexuality and aging: the Sexual Dysfunction Trivia game |
| Q73610915 | Critical overview of the new consensus-based definitions and classification of female sexual dysfunction |
| Q33852555 | Cross-sectional survey of sexual dysfunction and quality of life among older people in Indonesia. |
| Q60440055 | Cultural factors and sexual dysfunction in clinical practice |
| Q36372392 | Current perspectives on the clinical assessment and diagnosis of female sexual dysfunction and clinical studies of potential therapies: a statement of concern |
| Q77400135 | Current world literature. Andrology, sexual dysfunction, infertility |
| Q38991791 | Cycling-Related Sexual Dysfunction in Men and Women: A Review. |
| Q34733422 | Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. |
| Q83379853 | Defining characteristics, validated by specialists and manifested by patients: a study of the Sexual Dysfunction and Ineffective Sexuality Pattern diagnoses |
| Q74733744 | Definitions and classification of male sexual dysfunction |
| Q34287459 | Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision. |
| Q37730208 | Definitions/epidemiology/risk factors for sexual dysfunction |
| Q34296077 | Demographic and clinical correlates of sexual dysfunction among Nigerian male outpatients on conventional antipsychotic medications |
| Q41042677 | Depression and Sexual Dysfunction in Turkish Men Diagnosed With Infertility |
| Q47724791 | Depression and anxiety in men with sexual dysfunction: a retrospective study |
| Q34519600 | Depression and sexual dysfunction |
| Q34255703 | Depression and sexual dysfunction among HIV-positive and HIV-negative men who have sex with men: mediation by use of antidepressants and recreational stimulants |
| Q48239308 | Depression and sexual dysfunction complicating neurosarcoidosis |
| Q48224940 | Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need |
| Q48903644 | Depression as a prominent cause of sexual dysfunction in women with epilepsy |
| Q38087168 | Depression is correlated with the psychological and physical aspects of sexual dysfunction in men. |
| Q90115772 | Depression, Anxiety, Quality of Life and Sexual Dysfunction in Zabol Women with Infertility |
| Q104562056 | Depression, Sexual Dysfunction, and Medical Comorbidities in Young Adults Having Nicotine Dependence |
| Q48657469 | Depression, Testosterone concentration, sexual dysfunction and methadone use among men with hypogonadism and HIV Infection |
| Q34318607 | Depression, poor sleep, and sexual dysfunction in migraineurs women. |
| Q55429608 | Depression, sexual dysfunction and sexual quality of life in women with infertility. |
| Q45912333 | Depression, testosterone concentration, sexual dysfunction and methadone use among men with hypogonadism and HIV infection. |
| Q40904619 | Depressive symptoms, pain, and sexual dysfunction over the first year following vaginal or cesarean delivery: A prospective longitudinal study |
| Q38264198 | Designer drugs and sexual dysfunction |
| Q36934818 | Designing drugs for the treatment of female sexual dysfunction |
| Q36726509 | Detection rates of sexual dysfunction amongst patients with multiple sclerosis in an outpatient setting--can this be improved? |
| Q36450531 | Determinants of doctors' decisions to inquire about sexual dysfunction in Malaysian primary care settings |
| Q51572713 | Determinants of female sexual dysfunction in type 2 diabetes. |
| Q35054615 | Determinants of sexual dysfunction among clinically diagnosed diabetic patients |
| Q48339084 | Determinants of sexual dysfunction among middle-aged women |
| Q38653734 | Determinants of sexual dysfunction and interventions for patients with obstructive sleep apnoea: a systematic review |
| Q34816183 | Determinants of sexual dysfunction in women with multiple sclerosis |
| Q37559453 | Development of Booklet on Male Sexual Dysfunction, its Measures and Assessing its Impact on Knowledge of Patients with Urological Cancers |
| Q91234420 | Development of a Sexual Dysfunction Scale for Women With Inflammatory Bowel Disease |
| Q34623296 | Development of a sexual function questionnaire for clinical trials of female sexual dysfunction |
| Q68309745 | Developments in the treatment of sexual dysfunction |
| Q48664292 | Dextromethorphan-induced psychotoxic behaviors cause sexual dysfunction in male mice via stimulation of σ-1 receptors |
| Q38214434 | Diabetes and Quality of Life: Initial Approach to Depression, Physical Activity, and Sexual Dysfunction |
| Q53659026 | Diabetes and alcohol: Double jeopardy with regard to oxidative toxicity and sexual dysfunction in adult male Wistar rats. |
| Q36147458 | Diabetes and female sexual dysfunction: moving beyond "benign neglect". |
| Q37630425 | Diabetes and sexual dysfunction: current perspectives. |
| Q70660405 | Diabetes and sexual dysfunction: restoring normal ability |
| Q44031387 | Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men. |
| Q66948056 | Diabetes mellitus and sexual dysfunction |
| Q70829679 | Diabetes mellitus: the undiscussed side effect: sexual dysfunction |
| Q33593522 | Diabetes, sexual dysfunction and therapeutic exercise: a 20 year review |
| Q57456070 | Diabetic autonomic neuropathy resulting in sexual dysfunction |
| Q91754978 | Diabetic autonomic neuropathy resulting in sexual dysfunction |
| Q72922338 | Diabetic sexual dysfunction: a comparative study of 160 insulin treated diabetic men and women and an age-matched control group |
| Q38902582 | Diagnosing Sexual Dysfunction in Men and Women: Sexual History Taking and the Role of Symptom Scales and Questionnaires |
| Q40803038 | Diagnosing and treating female sexual dysfunction: a survey of the perspectives of obstetricians and gynaecologists. |
| Q43774166 | Diagnosis and treatment of sexual dysfunction in patients affected by chronic renal failure on hemodialysis. |
| Q40247504 | Diagnosis and treatment of sexual dysfunction in the male diabetic |
| Q92885220 | Diagnosis and treatment of urinary and sexual dysfunction in hereditary TTR amyloidosis |
| Q57486369 | Diagnostic evaluation of sexual dysfunction in the male partner in the setting of infertility: a committee opinion |
| Q95756911 | Diagnostic evaluation, classification, and treatment of men with sexual dysfunction |
| Q97087417 | Dialysis modality and sexual dysfunction in male patients |
| Q51420348 | Differences in prevalence of sexual dysfunction between primary and secondary infertile women. |
| Q98164495 | Different levels of estradiol are correlated with sexual dysfunction in adult men |
| Q44907503 | Difficulties in brief conjoint treatment of sexual dysfunction |
| Q79755747 | Dimensions of sexual dysfunction in Parkinson disease |
| Q41526087 | Directive therapy of sexual dysfunction |
| Q57897026 | Discopathy of the lumbar-sacral segment and its influence on sexual dysfunction |
| Q30980026 | Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humans |
| Q40246101 | Discussing Sexual Dysfunction with Chronic Kidney Disease Patients: Practice Patterns in the Office of the Nephrologist |
| Q56960560 | Disputing the myth of the sexual dysfunction of circumcised women: An interview with Fuambai S. Ahmadu by Richard A. Shweder |
| Q44558506 | Dissatisfaction with male sexual performance and female sexual dysfunction in women with type 1 diabetes |
| Q87423215 | Distinctive clinical features of Dhat syndrome with comorbid sexual dysfunction |
| Q35892185 | Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis |
| Q43951742 | Do gynecologists talk about sexual dysfunction with their patients? |
| Q81439997 | Do psychiatrists examine sexual dysfunction in schizophrenia patients? |
| Q73822779 | Does Avlimil work for sexual dysfunction in women? |
| Q89712399 | Does THA Affect Sexual Dysfunction in Female Patients With DDH? |
| Q35019610 | Does bicycle riding impact the development of lower urinary tract symptoms and sexual dysfunction in men? |
| Q61968479 | Does post-caesarean dyspareunia reflect sexual malfunction, pelvic floor and perineal dysfunction? |
| Q47707702 | Does sexual dysfunction correlate with deterioration of somatic sensory system in diabetic women? |
| Q34420461 | Does sexual dysfunction persist upon discontinuation of selective serotonin reuptake inhibitors? |
| Q95531236 | Dopamine partial agonism in antipsychotic-induced sexual dysfunction |
| Q35890354 | Dose-response relationship between cigarette smoking and female sexual dysfunction |
| Q38135025 | Drug addiction and sexual dysfunction |
| Q69784837 | Drug dependence and sexual dysfunction: a comparison of intravenous users of narcotics and oral users of amphetamines |
| Q71590880 | Drug holidays to counter sexual dysfunction |
| Q71338320 | Drug treatment of sexual dysfunction |
| Q40095352 | Drug-induced sexual dysfunction and infertility. |
| Q62267655 | Drug-induced sexual dysfunction and mental health patients' attitude to psychotropic medications |
| Q70796983 | Drug-induced sexual dysfunction in older men |
| Q99717403 | Drug-naïve Egyptian females with migraine are more prone to sexual dysfunction than those with tension-type headache: a cross-sectional comparative study |
| Q69421338 | Drugs causing sexual dysfunction and their alternatives: a reference tool |
| Q80195900 | Drugs for female sexual dysfunction |
| Q82851025 | Drugs for female sexual dysfunction |
| Q34446606 | Drugs in early clinical development for the treatment of female sexual dysfunction |
| Q69901930 | Drugs that cause sexual dysfunction |
| Q72446437 | Drugs that cause sexual dysfunction |
| Q72556576 | Drugs that cause sexual dysfunction |
| Q67883726 | Drugs that cause sexual dysfunction: an update |
| Q42861791 | Drug‐Induced Sexual Dysfunction in Rats |
| Q34544108 | Dysfunctional sexual beliefs as vulnerability factors to sexual dysfunction |
| Q36072837 | Dyspareunia Looks Sexy on First But How Much Pain Will It Take for It to Score? A Reply to My Critics Concerning the DSM Classification of Dyspareunia as a Sexual Dysfunction |
| Q41255123 | Dyspareunia and sexual dysfunction after vaginal delivery in Thai primiparous women with episiotomy. |
| Q45958496 | Dyspareunia and sexual dysfunction in women seeking fertility treatment. |
| Q81039287 | Dyspareunia is the only valid sexual dysfunction and certainly the only important one |
| Q51298260 | Dyspareunia: a symptom of female sexual dysfunction |
| Q38556096 | Dyspareunia: sexual dysfunction or pain syndrome? |
| Q68322802 | Dyspareunia; a symptom of sexual disorder in the female |
| Q85306369 | EAU updates evidence-based guidelines on male sexual dysfunction |
| Q50606669 | Early maladaptive schemas and sexual dysfunction in men. |
| Q47931408 | Effect of Adjunctive Aripiprazole on Sexual Dysfunction in Schizophrenia: A Preliminary Open-Label Study |
| Q37641348 | Effect of Attachment Styles to Parents on Sexual Dysfunction Domains of Married Women |
| Q43191355 | Effect of Chlorophytum Borivilianum Santapau and Fernandes on sexual dysfunction in hyperglycemic male rats. |
| Q58865777 | Effect of Curculigo orchioides on hyperglycemia-induced oligospermia and sexual dysfunction in male rats |
| Q95290004 | Effect of Depression and Antidepressants on Sexual Dysfunction in Men with Diabetes: A National Population-Based Cohort Study |
| Q40285855 | Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy |
| Q55091630 | Effect of Melissa officinalis (Lemon balm) on Sexual Dysfunction in Women: A Double- blind, Randomized, Placebo-controlled Study. |
| Q50057584 | Effect of Stevia rebaudiana Bertoni extract on sexual dysfunction in Streptozotocin-induced diabetic male rats |
| Q58617241 | Effect of Vitamin D Therapy on Sexual Function in Women with Sexual Dysfunction and Vitamin D Deficiency: a Randomized, Double-blind, Placebo-controlled Clinical Trial |
| Q30278767 | Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction |
| Q77653191 | Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients |
| Q36313107 | Effect of bupropion on sexual dysfunction |
| Q44682269 | Effect of bupropion on sexual dysfunction induced by fluoxetine: a case report of hypersexuality. |
| Q28377169 | Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors |
| Q69898048 | Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder |
| Q37257821 | Effect of colporrhaphy on the Sexual Dysfunction of women with pelvic organ prolapsed |
| Q43196464 | Effect of conventional and new therapies on climacteric symptoms and sexual dysfunction: a concern |
| Q51777872 | Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women. |
| Q37193515 | Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD study |
| Q46020995 | Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. |
| Q48015983 | Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial |
| Q36003883 | Effect of menses on standardized assessment of sexual dysfunction among women with uterine fibroids: a cohort study |
| Q92624809 | Effect of rescue fractional microablative CO2 laser on symptoms and sexual dysfunction in women affected by vulvar lichen sclerosus resistant to long-term use of topic corticosteroid: a prospective longitudinal study |
| Q59203750 | Effect of sildenafil citrate on women affected by sexual dysfunction referred to health clinics |
| Q88622034 | Effect of spinal anterior root stimulation and sacral deafferentation on bladder and sexual dysfunction in spinal cord injury |
| Q95934278 | Effect of tramadol dependence on male sexual dysfunction |
| Q70157124 | Effect of zinc therapy on sexual dysfunction in hemodialysis patients |
| Q58865994 | Effect ofAsparagus racemosuson sexual dysfunction in hyperglycemic male rats |
| Q67462185 | Effectiveness of psychological treatment of human sexual dysfunction |
| Q37579419 | Effectiveness of saikokaryukotsuboreito (herbal medicine) for antipsychotic-induced sexual dysfunction in male patients with schizophrenia: a description of two cases. |
| Q46211775 | Effects of Dracaena arborea (Dracaenaceae) on sexual dysfunction in 4 weeks hyperglycemic male rats |
| Q95593400 | Effects of Levonorgestrel Intrauterine System on Patients with Female Sexual Dysfunction |
| Q38670803 | Effects of Mindfulness-Based Therapies for Female Sexual Dysfunction: A Meta-Analytic Review |
| Q107213828 | Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions |
| Q47576340 | Effects of Renal Transplantation on Female Sexual Dysfunction: Comparative Study With Hemodialysis and a Control Group |
| Q54964781 | Effects of a food product (based on Daucus carota) and education based on traditional Persian medicine on female sexual dysfunction: a randomized clinical trial. |
| Q51340801 | Effects of antihypertensive therapy on female sexual dysfunction: clinically meaningful? |
| Q90187420 | Effects of demographic and obstetric variables with body image on sexual dysfunction in pregnancy: A cross-sectional and comparative study |
| Q84940067 | Effects of early pelvic-floor muscle exercise for sexual dysfunction in radical prostatectomy recipients |
| Q37179518 | Effects of expressive writing on sexual dysfunction, depression, and PTSD in women with a history of childhood sexual abuse: results from a randomized clinical trial |
| Q37012258 | Effects of mindfulness training on body awareness to sexual stimuli: implications for female sexual dysfunction |
| Q90088378 | Effects of saffron (Crocus sativus) on sexual dysfunction among men and women: A systematic review and meta-analysis |
| Q46797284 | Effects of testosterone gel followed by parenteral testosterone undecanoate on sexual dysfunction and on features of the metabolic syndrome |
| Q38372950 | Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome |
| Q91477877 | Effects of transcranial photobiomodulation with near-infrared light on sexual dysfunction |
| Q98393652 | Effects of vaginal administration of conjugated estrogens tablet on sexual function in postmenopausal women with sexual dysfunction: a double-blind, randomized, placebo-controlled trial |
| Q38877503 | Efficacy and Safety of Sildenafil in Men With Sexual Dysfunction and Spinal Cord Injury |
| Q91200513 | Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction |
| Q44035133 | Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson's disease. |
| Q34525812 | Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder |
| Q83448960 | Efficacy and safety of two polyherbal combinations: E-MA-H and E-MA-HP in male sexual dysfunction |
| Q37594796 | Efficacy of Cinnamomum cassia Blume. in age induced sexual dysfunction of rats |
| Q113268264 | Efficacy of Date Palm Pollen in the Male Sexual Dysfunction after Coronary Artery Bypass Graft: A Randomized, Double-Blind, Clinical Trial |
| Q48459322 | Efficacy of acupuncture treatment of sexual dysfunction secondary to antidepressants |
| Q30049015 | Efficacy of ellagic acid and sildenafil in diabetes-induced sexual dysfunction |
| Q38096318 | Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis |
| Q38054167 | Efficacy of psychosocial interventions in men and women with sexual dysfunctions--a systematic review of controlled clinical trials: part 1-the efficacy of psychosocial interventions for male sexual dysfunction |
| Q38054146 | Efficacy of psychosocial interventions in men and women with sexual dysfunctions--a systematic review of controlled clinical trials: part 2--the efficacy of psychosocial interventions for female sexual dysfunction |
| Q44758747 | Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis |
| Q71519775 | Efficacy of testosterone, trazodone and hypnotic suggestion in the treatment of non-organic male sexual dysfunction |
| Q37317353 | Efficacy trial of an Internet-based intervention for cancer-related female sexual dysfunction |
| Q69748971 | Electromyographical studies of the bulbo-cavernosus reflex in diabetic men with sexual dysfunction |
| Q83988172 | Electrophysiological assessment of sexual dysfunction in spinal cord injured patients |
| Q33682309 | Elevated free triiodothyronine may lead to female sexual dysfunction in Chinese urban women: A hospital-based survey |
| Q44041307 | Elevated sex hormone binding globulin levels may contribute to sexual dysfunction in men with chronic hepatitis C virus infection |
| Q35602681 | Emerging therapies for female sexual dysfunction |
| Q43781216 | Emotional blunting, sexual dysfunction and SSRIs |
| Q33537537 | Empirically validated treatment for sexual dysfunction |
| Q49907137 | Endocrine and psychological aspects of sexual dysfunction in Klinefelter patients. |
| Q36372496 | Endocrine aspects of sexual dysfunction in men. |
| Q67427474 | Endocrine basis for sexual dysfunction in men |
| Q73038509 | Endocrine changes and sexual dysfunction in kidney transplantation and hemodialysis: comparative study |
| Q67020300 | Endocrine changes in interoceptive sexual dysfunction and their dynamics during the treatment process |
| Q45097640 | Endocrine screening for sexual dysfunction using free testosterone determinations |
| Q28329278 | Endocrinological Changes in Patients with Sexual Dysfunction under Long-Term Neuroleptic Treatment |
| Q70509109 | Endocrinology of sexual dysfunction |
| Q83759089 | Endogenous hydrogen sulfide insufficiency as a predictor of sexual dysfunction in aging rats |
| Q47814228 | Endometriosis doubles the risk of sexual dysfunction: a cross-sectional study in a large amount of patients |
| Q48270030 | Endourological procedures and sexual dysfunction: a prospective multivariate analysis. |
| Q55364650 | Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases. |
| Q43920433 | Epidemiological characteristics of 250 women with sexual dysfunction who presented for initial evaluation |
| Q74508330 | Epidemiological characteristics of 250 women with sexual dysfunction who presented for initial evaluation |
| Q30444829 | Epidemiology and neurobiology of female sexual dysfunction |
| Q81468104 | Epidemiology and neurobiology of female sexual dysfunction |
| Q97092287 | Epidemiology of Male Sexual Dysfunction in Asian and European Regions: A Systematic Review |
| Q35681918 | Epidemiology of Sexual Dysfunction in Iran: A Systematic Review and Meta-analysis |
| Q71562578 | Epidemiology of current treatment for sexual dysfunction in spinal cord injured men in the USA model spinal cord injury centers |
| Q37501661 | Epidemiology of female sexual dysfunction |
| Q37502288 | Epidemiology of male sexual dysfunction |
| Q37084738 | Epidemiology of sexual dysfunction in Asia compared to the rest of the world |
| Q36548799 | Epidemiology of sexual dysfunction in the male population |
| Q90253230 | Epidemiology, diagnosis and management of sexual dysfunction in multiple sclerosis |
| Q34486044 | Epidemiology/risk factors of sexual dysfunction |
| Q36772776 | Essentials of female sexual dysfunction from a sex therapy perspective. |
| Q104567328 | Estimating the Prevalence of Sexual Dysfunction Using the New ICD-11 Guidelines |
| Q47215978 | Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. |
| Q42579933 | Ethical issues in the treatment of sexual dysfunction in HIV-seropositive patients |
| Q47180838 | Ethnic differences in sexual dysfunction among diabetic and nondiabetic males: the Oxford Sexual Dysfunction Study |
| Q35764292 | Ethnicity and neighbourhood deprivation determines the response rate in sexual dysfunction surveys |
| Q70895672 | Etiology and management of sexual dysfunction in elderly men |
| Q30456521 | Etiology of female sexual dysfunction |
| Q36226279 | Evaluating Sexual Nursing Care Intervention for Reducing Sexual Dysfunction in Indonesian Cervical Cancer Survivors |
| Q41610286 | Evaluating sexual dysfunction in women |
| Q53437731 | Evaluation and Management of Hypoactive Sexual Desire Disorder. |
| Q36893703 | Evaluation and treatment of sexual dysfunction in men with diabetes mellitus |
| Q35968184 | Evaluation and treatment of women with rectocele: focus on associated defecatory and sexual dysfunction |
| Q102063851 | Evaluation of Dermatological Life Quality Index, Sexual Dysfunction, and Other Psychiatric Diseases in Patients Diagnosed with Vitiligo with and without Genital Involvement |
| Q92907100 | Evaluation of Indicators of Female Sexual Dysfunction in Adult Entertainers |
| Q89099371 | Evaluation of Sexual Dysfunction in Females With Ankylosing Spondylitis |
| Q47840064 | Evaluation of Sexual Dysfunction in Men With Spinal Cord Injury Using the Male Sexual Quotient |
| Q91004871 | Evaluation of Sexual Dysfunction, Lower Urinary Tract Symptoms and Quality of Life in Men With Obstructive Sleep Apnea Syndrome and the Efficacy of Continuous Positive Airway Pressure Therapy |
| Q91723757 | Evaluation of factors affecting sexual dysfunction in female patients with diabetes mellitus |
| Q68427014 | Evaluation of first 406 patients in urology department based Center for Male Sexual Dysfunction |
| Q104141188 | Evaluation of genital self-image and sexual dysfunction in women with vulvar lichen planus or lichen sclerosus |
| Q68992940 | Evaluation of sexual dysfunction |
| Q92997251 | Evaluation of sexual dysfunction and female sexual dysfunction indicators in women with type 2 diabetes: a systematic review and meta-analysis |
| Q93272183 | Evaluation of sexual dysfunction and its associated risk factors in the male partners of the infertile couples using International Index of Erectile Function |
| Q92266728 | Evaluation of sexual dysfunction and quality of life in patients with severe mental illness: A cross-sectional study from a tertiary care center in Chhattisgarh |
| Q47629870 | Evaluation of sexual dysfunction in Parkinson's disease between two different regions of Turkey |
| Q38904472 | Evaluation of sexual dysfunction in female patients presenting with faecal incontinence or defecation disorder. |
| Q70660314 | Evaluation of sexual dysfunction in the female following rectal resection and intestinal stoma |
| Q68010897 | Evaluation of sexual dysfunction in women |
| Q48624867 | Evaluation of sexual dysfunction in women with rheumatoid arthritis: a controlled study |
| Q37703691 | Evaluation of sexual dysfunction in women with type 2 diabetes. |
| Q51723392 | Evaluation of sexual dysfunction prevalence in infertile couples. |
| Q92638632 | Evaluation of sexual dysfunction prevalence in infertile men with non-obstructive azoospermia |
| Q88990976 | Evaluation of sleep disorder and its effect on sexual dysfunction in patients with Fibromyalgia syndrome |
| Q88383424 | Evaluation of the association between sexual dysfunction and demyelinating plaque location and number in female multiple sclerosis patients |
| Q42579223 | Evaluation of the first 300 patients treated at an outpatient center for male sexual dysfunction |
| Q71252241 | Evaluation of the first 70 patients in the center for male sexual dysfunction of Beth Israel Medical Center |
| Q59809098 | Evaluation of the occurrence of sexual dysfunction and general quality of life in female patients with psoriasis |
| Q91985560 | Evidence that Relationship Quality, Social Support, and SSRI Use Do Not Account for the Shared Underlying Relationships among Symptoms of Depression, Anxiety, and Female Sexual Dysfunction |
| Q34510651 | Evidence-based practice for symptom management in adults with cancer: sexual dysfunction |
| Q104258857 | Examination of the effect of COVID-19 on sexual dysfunction in women |
| Q34286211 | Examining sexual dysfunction in non-muscle-invasive bladder cancer: results of cross-sectional mixed-methods research. |
| Q38150112 | Exercise therapy for sexual dysfunction after prostate cancer |
| Q68933042 | Exhibitionism--a criticism of only biologically oriented interpretations of this sexual disorder |
| Q57297181 | Exo-Clinical Trials of Nutritional Supplements for Sexual Dysfunction: Precedents, Principles, and Protocols |
| Q97519937 | Experience with ospemifene in patients with vulvar and vaginal atrophy and associated sexual dysfunction: case studies |
| Q97650285 | Experiences of a web-based psycho-educational intervention targeting sexual dysfunction and fertility distress in young adults with cancer-A self-determination theory perspective |
| Q44900087 | Experimental research on the regulating effects of ginseng with hairy antler on the sexual dysfunction rat model induced with adenine |
| Q57150304 | Expert opinion on existing and developing drugs to treat female sexual dysfunction |
| Q79769713 | Exploring cause and effect relationships in male sexual dysfunction |
| Q40127767 | Exploring gay couples' experience with sexual dysfunction after radical prostatectomy: a qualitative study |
| Q90275739 | Exploring the Role of Sexual Avoidance in Male Sexual Dysfunction |
| Q47991513 | Expressions of vaginal endothelial nitric oxide synthase and phosphodiesterase 5 in female sexual dysfunction: a pilot study |
| Q64059240 | Extracellular Vesicles From Human Urine-Derived Stem Cells Ameliorate Erectile Dysfunction in a Diabetic Rat Model by Delivering Proangiogenic MicroRNA |
| Q95786344 | FDA approves device for female sexual dysfunction |
| Q50977238 | FDA approves female sexual dysfunction drug. |
| Q37104229 | FEMALE SEXUAL DYSFUNCTION (FSD) IN WOMEN HEALTH CARE WORKERS. |
| Q91167512 | Factors Associated with Sexual Dysfunction in Individuals with Multiple Sclerosis: Implications for Assessment and Treatment |
| Q52044900 | Factors Associated with the Decision to Refer Patients with Anxiety Disorders or Sexual Dysfunction |
| Q68441010 | Factors associated with sexual dysfunction following transurethral resection of the prostate |
| Q33738261 | Factors associated with sexual dysfunction in Jordanian women and their sexual attitudes |
| Q36280442 | Factors associated with sexual dysfunction in Taiwanese females with rheumatoid arthritis. |
| Q33261422 | Factors associated with sexual dysfunction in men with HIV infection |
| Q40228176 | Factors associated with sexual dysfunction; a population based study in Iranian reproductive age women |
| Q48473439 | Factors contributing to psychoaffective differences among men with sexual dysfunction in response to a partnered sexual experience |
| Q69397517 | Factors in sexual dysfunction in diabetic female volunteer subjects |
| Q36204980 | Factors influencing fluoxetine-induced sexual dysfunction in female rats. |
| Q69494107 | Family environment: implications for sexual dysfunction and methaqualone dependence |
| Q45030299 | Fatigue, weakness, and sexual dysfunction after bariatic surgery - not an unusual case but an unusual cause |
| Q33633389 | Fear of Vaginal Penetration in the Absence of Pain as a Separate Category of Female Sexual Dysfunction: A Conceptual Overview |
| Q46262177 | Female Genital Dialogues: Female Genital Self-Image, Sexual Dysfunction, and Quality of Life in Patients With Vitiligo With and Without Genital Affection |
| Q30252426 | Female Sexual Dysfunction |
| Q91945630 | Female Sexual Dysfunction |
| Q64246925 | Female Sexual Dysfunction Among Greek Women With Multiple Sclerosis: Correlations With Organic and Psychological Factors |
| Q53405553 | Female Sexual Dysfunction Among Muslim Women: Increasing Awareness to Improve Overall Evaluation and Treatment. |
| Q104142977 | Female Sexual Dysfunction Among a Sample of Egyptian Patients with Asthma |
| Q36910517 | Female Sexual Dysfunction Among the Wives of Opioid-Dependent Males in Iran |
| Q64384975 | Female Sexual Dysfunction Issues: The Causes and Prevalence of Vestibulodynia: A Vulvar Pain Disorder |
| Q57345846 | Female Sexual Dysfunction and Premature Menopause with Focus on Women’s Wording |
| Q89566210 | Female Sexual Dysfunction and the Placebo Effect: A Meta-analysis |
| Q93266668 | Female Sexual Dysfunction and the Placebo Effect: A Meta-analysis |
| Q47770556 | Female Sexual Dysfunction in Presymptomatic Mutation Carriers and Patients with Huntington's Disease |
| Q35810065 | Female Sexual Dysfunction in Women with Non-Malignant Cervical Diseases: A Study from an Urban Chinese Sample |
| Q90639339 | Female Sexual Dysfunction in Women with Pelvic Pain |
| Q38793196 | Female Sexual Dysfunction in the Late Postpartum Period Among Women with Previous Gestational Diabetes Mellitus. |
| Q50198617 | Female Sexual Dysfunction: A Systematic Review of Outcomes Across Various Treatment Modalities |
| Q93041021 | Female Sexual Dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213 |
| Q93040994 | Female Sexual Dysfunction: ACOG Practice Bulletin Summary, NUMBER 213 |
| Q104562068 | Female Sexual Dysfunction: Indian Perspective and Role of Indian Gynecologists |
| Q38744650 | Female Sexual Dysfunction: Is It a Treatable Disease? |
| Q92898025 | Female Sexual Dysfunction: Natural and Complementary Treatments |
| Q96430215 | Female Sexual Dysfunction: Pharmacologic and Therapeutic Interventions |
| Q56019338 | Female hypoactive sexual disorder: Case studies of physiologic androgen replacement |
| Q33868218 | Female hypoactive sexual disorder: case studies of physiologic androgen replacement |
| Q43735489 | Female neurogenic sexual dysfunction secondary to clitoral neuropathy |
| Q73620005 | Female sexual dysfunction |
| Q74010917 | Female sexual dysfunction |
| Q74438197 | Female sexual dysfunction |
| Q74547147 | Female sexual dysfunction |
| Q75208872 | Female sexual dysfunction |
| Q77783982 | Female sexual dysfunction |
| Q78512751 | Female sexual dysfunction |
| Q66852963 | Female sexual dysfunction |
| Q66862970 | Female sexual dysfunction |
| Q81499923 | Female sexual dysfunction |
| Q81527564 | Female sexual dysfunction |
| Q81652698 | Female sexual dysfunction |
| Q84379028 | Female sexual dysfunction |
| Q93486030 | Female sexual dysfunction |
| Q30241630 | Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL). |
| Q51134848 | Female sexual dysfunction across the three pregnancy trimesters: an Egyptian study. |
| Q47637532 | Female sexual dysfunction after ileal pouch-anal anastomosis |
| Q51807848 | Female sexual dysfunction after pelvic surgery: is there a place for nerve-sparing surgery? |
| Q36286361 | Female sexual dysfunction after pelvic surgery: the impact of surgical modifications |
| Q80172853 | Female sexual dysfunction after radical cystectomy: a new outcome measure |
| Q38992780 | Female sexual dysfunction among Egyptian patients with chronic hepatitis C. |
| Q90455576 | Female sexual dysfunction among married women in the Gaza Strip: an internet-based survey |
| Q39615183 | Female sexual dysfunction among young and middle-aged women in Hong Kong: prevalence and risk factors |
| Q34660213 | Female sexual dysfunction and adolescents |
| Q43518676 | Female sexual dysfunction and antidepressant use. |
| Q34561155 | Female sexual dysfunction and diabetes: a systematic review and meta-analysis |
| Q51001661 | Female sexual dysfunction and epilepsy: It is time for the neurologist to act! |
| Q51449950 | Female sexual dysfunction and hormonal status in multiple sclerosis patients. |
| Q51519884 | Female sexual dysfunction and hormonal status in multiple sclerosis patients. |
| Q51753675 | Female sexual dysfunction and hormonal status in spinal cord injured (SCI) patients. |
| Q78071513 | Female sexual dysfunction and potential treatments |
| Q51718339 | Female sexual dysfunction and the central nervous system. |
| Q51727794 | Female sexual dysfunction and the central nervous system. |
| Q36106301 | Female sexual dysfunction and use of hormone therapy in postmenopausal women |
| Q44199073 | Female sexual dysfunction as adverse effect of pharmacological treatment |
| Q28370357 | Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention |
| Q91169755 | Female sexual dysfunction associated with idiopathic cerebellar ataxia: A case report |
| Q36366083 | Female sexual dysfunction following vaginal surgery: a review |
| Q35907299 | Female sexual dysfunction following vaginal surgery: myth or reality? |
| Q51340181 | Female sexual dysfunction in ESRD: an underappreciated epidemic? |
| Q51299684 | Female sexual dysfunction in Iran: study of prevalence and risk factors. |
| Q51449927 | Female sexual dysfunction in Iranian postmenopausal women: prevalence and correlation with hormonal profile. |
| Q38992348 | Female sexual dysfunction in Lower Egypt |
| Q45269754 | Female sexual dysfunction in a healthy Austrian cohort: prevalence and risk factors |
| Q81170726 | Female sexual dysfunction in a healthy austrian cohort: prevalence and risk factors |
| Q51825294 | Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors. |
| Q37666183 | Female sexual dysfunction in androgenetic alopecia: Case-control study |
| Q51778043 | Female sexual dysfunction in essential hypertension: a common problem being uncovered. |
| Q38694238 | Female sexual dysfunction in female genital mutilation |
| Q51739625 | Female sexual dysfunction in hypopituitarism. |
| Q50968705 | Female sexual dysfunction in multiple sclerosis: Results of a survey among Dutch urologists and patients. |
| Q51693473 | Female sexual dysfunction in obstetrics and gynecology. |
| Q51041301 | Female sexual dysfunction in patients treated with antidepressant-comparison between escitalopram and fluoxetine. |
| Q37630600 | Female sexual dysfunction in patients with endometriosis: Indian scenario |
| Q48350476 | Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms |
| Q48271743 | Female sexual dysfunction in patients with spinal cord injury: a study from Iran |
| Q36644699 | Female sexual dysfunction in patients with substance-related disorders |
| Q51608694 | Female sexual dysfunction in peritoneal dialysis and hemodialysis patients. |
| Q35053786 | Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials |
| Q50546215 | Female sexual dysfunction in psychiatry. |
| Q51329342 | Female sexual dysfunction in type 2 diabetes: a case control study. |
| Q51744134 | Female sexual dysfunction in urogenital prolapse surgery: colposacropexy vs. hysterocolposacropexy. |
| Q51598420 | Female sexual dysfunction in urological patients: findings from a major metropolitan area in the USA. |
| Q34666067 | Female sexual dysfunction in women with thyroid disorders |
| Q50992256 | Female sexual dysfunction is an artificial concept driven by commercial interests: AGAINST: FSD is a real and complex problem. |
| Q50992260 | Female sexual dysfunction is an artificial concept driven by commercial interests: FOR: FSD is a multimillion dollar business. |
| Q51346006 | Female sexual dysfunction is more than just a hormonal problem. |
| Q30245195 | Female sexual dysfunction post radical cystectomy and urinary diversion |
| Q30309607 | Female sexual dysfunction related to depression and antidepressant medications |
| Q33809790 | Female sexual dysfunction with combined oral contraceptive use. |
| Q44299447 | Female sexual dysfunction, sexual distress, and compatibility with partner |
| Q51778031 | Female sexual dysfunction, voiding symptoms and depression: common findings in partners of men with erectile dysfunction. |
| Q36216760 | Female sexual dysfunction: A comparative study in drug naive 1(st) episode of depression in a general hospital of South Asia |
| Q38835449 | Female sexual dysfunction: Assessment |
| Q38694389 | Female sexual dysfunction: a call to arms for collaboration to understand the sexological elephant |
| Q21563430 | Female sexual dysfunction: a case study of disease mongering and activist resistance |
| Q42688204 | Female sexual dysfunction: a focus on flibanserin |
| Q33314415 | Female sexual dysfunction: a new urogynaecological research field |
| Q37618950 | Female sexual dysfunction: a primary care perspective. |
| Q51537705 | Female sexual dysfunction: a reality not a myth |
| Q44785795 | Female sexual dysfunction: a systematic overview of classification, pathophysiology, diagnosis and treatment |
| Q51818313 | Female sexual dysfunction: a tale of two sides? |
| Q35166238 | Female sexual dysfunction: an update on physiopathology. |
| Q33834426 | Female sexual dysfunction: anatomy, physiology, evaluation and treatment options |
| Q82288132 | Female sexual dysfunction: are urogynecologists ready for it? |
| Q37512090 | Female sexual dysfunction: barriers to treatment. |
| Q36996855 | Female sexual dysfunction: classification, pathophysiology, and management |
| Q38095183 | Female sexual dysfunction: definition, classification, and debates |
| Q47634801 | Female sexual dysfunction: definitions and classifications |
| Q34873273 | Female sexual dysfunction: definitions, causes, and treatment |
| Q33975397 | Female sexual dysfunction: evaluation and treatment |
| Q43765667 | Female sexual dysfunction: facts and factors among gynecology outpatients |
| Q38311187 | Female sexual dysfunction: focus on low desire |
| Q75840438 | Female sexual dysfunction: focus on low desire |
| Q51022673 | Female sexual dysfunction: focus on low desire. |
| Q33727487 | Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options |
| Q73567006 | Female sexual dysfunction: industry creation or under-recognized problem? |
| Q37536193 | Female sexual dysfunction: knowledge development and practice implications |
| Q35166372 | Female sexual dysfunction: potential for pharmacotherapy |
| Q37573227 | Female sexual dysfunction: prevalence and risk factors |
| Q36434573 | Female sexual dysfunction: principles of diagnosis and therapy |
| Q51541585 | Female sexual dysfunction: reality or disease-mongering? |
| Q34993868 | Female sexual dysfunction: state of the art. |
| Q73003649 | Female sexual dysfunction: the BMJ fails to educate and fails to debate |
| Q36101796 | Female sexual dysfunction: the important points to remember. |
| Q34433634 | Female sexual dysfunction: therapeutic options and experimental challenges. |
| Q46105191 | Female sexual dysfunction: what Arab gynecologists think and know |
| Q37002525 | Female sexual dysfunction: what's new? |
| Q36581705 | Female sexual satisfaction and pharmaceutical intervention: a critical review of the drug intervention studies in female sexual dysfunction |
| Q74804636 | Female sexuality and sexual dysfunction |
| Q40307547 | Female sexuality and sexual dysfunction: are we stuck on the learning curve? |
| Q38823887 | Fertility and sexual dysfunction issues in adults with genitourinary congenital anomalies |
| Q91247168 | Finasteride 1 mg in alopecia: sexual dysfunction, suicidal ideation. Providing balanced information to male patients is key |
| Q113062764 | Finasteride for Androgenetic Alopecia Is Not Associated with Sexual Dysfunction: A Survey-Based, Single-Centre, Controlled Study |
| Q92141212 | Finasteride for androgenetic alopecia is not associated with sexual dysfunction: a survey-based, single-centre, controlled study |
| Q42964259 | Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder. |
| Q37085233 | Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction |
| Q70780767 | Fluoxetine and sexual dysfunction |
| Q72212964 | Fluoxetine and sexual dysfunction |
| Q93865705 | Fluoxetine and sexual dysfunction |
| Q28332909 | Fluoxetine-induced sexual dysfunction |
| Q28319504 | Fluoxetine-induced sexual dysfunction and an open trial of yohimbine |
| Q70695462 | Fluoxetine-induced sexual dysfunction and yohimbine |
| Q44044010 | Fluoxetine-induced sexual dysfunction reversed by loratadine |
| Q43516163 | Fluoxetine-induced sexual dysfunction reversed by trazodone |
| Q72579363 | Fluoxetine-induced sexual dysfunction: a dose-dependent effect? |
| Q77670627 | Fluoxetine-terfenadine and sexual dysfunction |
| Q84066628 | Foreword. Sexuality and sexual dysfunction |
| Q70753154 | Form and content in the conjoint treatment of sexual dysfunction: a controlled study |
| Q46699396 | Frequency and correlates of sexual dysfunction in women with diabetes mellitus. |
| Q64982634 | Frequency of Sexual Dysfunction in Patients Treated with Desvenlafaxine: A Prospective Naturalistic Study. |
| Q47618988 | Frequency of and Factors Associated With Sexual Dysfunction in Patients With Inflammatory Bowel Disease |
| Q33722587 | Frequency of sexual dysfunction and its causative factors among diabetic women in Turkey |
| Q44353613 | Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study |
| Q67344777 | Frequency of sexual dysfunction in "normal" couples |
| Q43612636 | Frequency of sexual dysfunction in a general gynecological clinic: an epidemiological approach |
| Q43137105 | Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics |
| Q43947063 | Frequency of sexual dysfunction in women with rheumatic diseases |
| Q43499657 | Frequency of sexual problems and sexual dysfunction in middle-aged Danish men. |
| Q34084735 | Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study |
| Q40613405 | Frequency, severity, and risk factors related to sexual dysfunction in Chinese women with T2D. |
| Q104796288 | From Promoting Healthy Sexual Functioning to Managing Biomedical Sexual Dysfunction: Health Professional Views of Youth Sexual Health |
| Q30488833 | Functional neuroanatomy in depressed patients with sexual dysfunction: blood oxygenation level dependent functional MR imaging |
| Q82365138 | Gabapentin and sexual dysfunction: an overlooked and underreported problem? |
| Q46807813 | Gabapentin and sexual dysfunction: report of two cases |
| Q83053684 | Gastrointestinal, urological, and sexual dysfunction in Parkinson's disease |
| Q48479193 | Gender difference in antidepressant-related sexual dysfunction in Taiwan |
| Q40344364 | Gender power and marital relationship as predictors of sexual dysfunction and sexual satisfaction among young married couples in rural China: a population-based study. |
| Q51183044 | General practitioners' procedures for sexual history taking and treating sexual dysfunction in primary care. |
| Q44597660 | Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients |
| Q92551443 | Genital Pain and Numbness and Female Sexual Dysfunction in Adult Bicyclists |
| Q36093835 | Genital duplex Doppler ultrasonography before and after sexual stimulation in women with sexual dysfunction: gray scale, volumetric, and hemodynamic findings |
| Q57150606 | Genito-Pelvic Pain Through a Dyadic Lens: Moving Toward an Interpersonal Emotion Regulation Model of Women's Sexual Dysfunction |
| Q28943420 | Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression |
| Q37732226 | Geriatric sexual dysfunction |
| Q52875205 | Geriatric sexual dysfunction: a case survey. |
| Q34747520 | Ginkgo biloba for antidepressant-induced sexual dysfunction |
| Q38088263 | Giving in to arousal or staying stuck in disgust? Disgust-based mechanisms in sex and sexual dysfunction |
| Q99204813 | Gold Thread Implantation for Female Sexual Dysfunction and Vaginal Laxity: A Preliminary Investigation |
| Q45025534 | Golombok Rust Inventory of Sexual Satisfaction for the presence of sexual dysfunction within a Ghanaian urological population |
| Q47869940 | Gonadal and Sexual Dysfunction in Childhood Cancer Survivors. |
| Q70384231 | Gonadal steroid and gonadotropin response to dexamethasone: a study in sexual dysfunction and normal controls |
| Q67883165 | Gracilis muscle transposition for sexual dysfunction after proctectomy |
| Q71094171 | Group treatment for female sexual dysfunction |
| Q51261239 | Group treatment of sexual dysfunction in gay men. |
| Q67385450 | Group treatment of sexual dysfunction in men without partners |
| Q37058005 | Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction : implications for sexual dysfunction |
| Q69933932 | Guidelines for assessment and treatment of sexual dysfunction |
| Q37665177 | Gynecologic factors in sexual dysfunction of the older woman |
| Q87268341 | Gynecomastia in subjects with sexual dysfunction |
| Q58862418 | HIV and sexual dysfunction |
| Q36632372 | HIV-associated female sexual dysfunction - clinical experience and literature review |
| Q43761789 | HMG-CoA reductase inhibitors and sexual dysfunction |
| Q88012690 | Health-Related Lifestyle Factors and Sexual Dysfunction: A Meta-Analysis of Population-Based Research |
| Q46598610 | Heart failure and sexual dysfunction |
| Q33413419 | Help-seeking behaviors for female sexual dysfunction: a cross sectional study from Iran |
| Q73921372 | Helping patients deal with sexual dysfunction following transplantation |
| Q34238200 | Helping the woman with sexual dysfunction |
| Q79362768 | Hemochromatosis and sexual dysfunction |
| Q77096026 | Heteroallelism at the het-c locus contributes to sexual dysfunction in outcrossed strains of Neurospora tetrasperma |
| Q44937002 | Heterosexual anal intercourse: increasing prevalence, and association with sexual dysfunction, bisexual behavior, and venereal disease history. |
| Q91260857 | High Burden of Sexual Dysfunction in Female Patients with Rheumatoid Arthritis: Results of a Cross-sectional Study |
| Q35217805 | High Prevalence of Sexual Dysfunction in a Vulvovaginal Specialty Clinic |
| Q34203935 | High frequency of sexual dysfunction in patients with male accessory gland infections |
| Q57422117 | High prevalence of male hypogonadism and sexual dysfunction in long-term clinically stable heart transplantation recipients |
| Q34425146 | High rate of sexual dysfunction following surgery for rectal cancer |
| Q84170470 | Higher prevalence of sexual dysfunction in colon and rectal cancer survivors compared with the normative population: a population-based study |
| Q47550481 | History of the Treatment of Female Sexual Dysfunction(s). |
| Q70674981 | Homosexuality, sexual dysfunction, and incest in male identical twins |
| Q93048715 | Hormonal Contraceptives, Female Sexual Dysfunction, and Managing Strategies: A Review |
| Q34108403 | Hormonal aspects of sexual dysfunction: the therapeutic use of exogenous androgens in men and women |
| Q51358423 | Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study. |
| Q34985476 | Hormonal factors in female sexual dysfunction |
| Q38761248 | Hormones and Female Sexual Dysfunction: Beyond Estrogens and Androgens--Findings from the Fourth International Consultation on Sexual Medicine |
| Q79702371 | Horseback riding: impact on sexual dysfunction and lower urinary tract symptoms in men and women |
| Q92493366 | Horsepower of Doctors' Cars Correlates with Cardiovascular Risk and Sedentary Lifestyle but Not with Sexual Dysfunction or Sexual Satisfaction |
| Q67872613 | How frequent is sexual dysfunction in hypertensive subjects and how is it treated? |
| Q58640962 | How the Prevalence Rates of Male Sexual Dysfunction Vary Using Different Criteria |
| Q37074425 | How to recognize late-onset hypogonadism in men with sexual dysfunction |
| Q59353305 | Human T-Lymphotropic Virus-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Associated With Sexual Dysfunction in Infected Women of Reproductive Age |
| Q68780374 | Human sexual malfunction: a consideration of "inner-mind" thought process |
| Q28371931 | Hyperprolactinemia and male sexual dysfunction |
| Q37823170 | Hypertension and sexual dysfunction: time to act. |
| Q57300798 | Hypertension as a risk factor for female sexual dysfunction: cross-sectional study |
| Q70648900 | Hypnosis in the treatment of sexual dysfunction |
| Q67313194 | Hypnotherapy in the treatment of sexual dysfunction |
| Q68996911 | Hypnotic metaphor and sexual dysfunction |
| Q36724452 | Hypoactive sexual dysfunction in a young woman |
| Q64247543 | Hypogonadism and Sexual Dysfunction in Testicular Tumor Survivors: A Systematic Review |
| Q69628765 | Hypogonadism and sexual dysfunction in hemochromatosis: the effects of cirrhosis and diabetes |
| Q44343269 | Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy |
| Q89804023 | Hysterectomy and sexual (dys)function: An analysis of sexual dysfunction after hysterectomy and a search for predictive factors |
| Q50930331 | Iatrogenic sexual dysfunction and the protective withholding of information: in whose best interest? |
| Q54514178 | Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogen. |
| Q91557314 | Identifying barriers to help-seeking for sexual dysfunction in multiple sclerosis |
| Q36576005 | Identifying sexual dysfunction |
| Q77227221 | Ileal J-pouch--anal anastomosis, sexual dysfunction, and fertility |
| Q72768207 | Imipramine and sexual dysfunction during the long-term treatment of recurrent depression |
| Q41069647 | Impact of Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlle |
| Q92046751 | Impact of Immune System Activation and Vascular Impairment on Male and Female Sexual Dysfunction |
| Q39439330 | Impact of bladder, bowel and sexual dysfunction on health status of people with thoracolumbar spinal cord injuries living in the community |
| Q51144623 | Impact of iron supplementation on sexual dysfunction of women with iron deficiency anemia in short term: a preliminary study. |
| Q90135094 | Impact of irregular marital cohabitation on quality of life and sexual dysfunction in infertile men from upper Egypt |
| Q34787761 | Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients |
| Q34484077 | Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction |
| Q43504320 | Impact of reported sexual dysfunction on outcome in patients with chronic heart failure |
| Q48066619 | Impaired Lipid Profile is a Risk Factor for the Development of Sexual Dysfunction in Women |
| Q51822472 | Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism. |
| Q73425871 | Improved outcome in fluvoxamine-treated patients with SSRI-induced sexual dysfunction |
| Q34061120 | Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. |
| Q42957263 | Improvement of hyperglycemia and sexual dysfunction in diabetic female rats by an artificial endocrine pancreas developed from mouse beta cells |
| Q45988893 | Improvement of selective serotonin reuptake inhibitor-induced sexual dysfunction without worsening of depressive symptom after switching to milnacipran. |
| Q97543933 | Improvement of the symptoms of lower urinary tract and sexual dysfunction with tadalafil and solifenacin after the treatment of benign prostatic hyperplasia with dutasteride |
| Q46601289 | Improvements in SSRI/SNRI-induced sexual dysfunction by switching to escitalopram |
| Q72647483 | In further pursuit of the perfect penis: the comprehensive urology center and the medicalization of male sexual dysfunction |
| Q88789902 | In localised prostate cancer, radical prostatectomy was associated with more sexual dysfunction and urinary incontinence than radiation or active surveillance |
| Q38765279 | Incidence and Prevalence of Sexual Dysfunction in Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015. |
| Q91319057 | Incidence and severity of sexual dysfunction among women with breast cancer: a meta-analysis based on female sexual function index |
| Q44199076 | Incidence and treatment of sexual dysfunction in heart disease |
| Q52686492 | Incidence of Sexual Dysfunction Among Patients with Hidradenitis Suppurativa: a population based retrospective analysis. |
| Q91312923 | Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal Malignancy |
| Q32067881 | Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction |
| Q48262503 | Incidence of sexual dysfunction in TBI patients during the early post-traumatic in-patient rehabilitation phase |
| Q28373147 | Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy |
| Q93646397 | Incidence of sexual dysfunction in male patients treated surgically for rectal malignancy |
| Q34436833 | Incidence of sexual dysfunction in men after cardiac surgery in Afshar hospital, Yazd |
| Q44983313 | Incidence of sexual dysfunction in patients with obesity and overweight |
| Q77419830 | Incidence of sexual dysfunction in surgically menopausal women |
| Q34116960 | Incidence of sexual dysfunction: a prospective survey in Ghanaian females |
| Q101041819 | Increased Rate of Sexual Dysfunction by Increased Severity of Nasal Obstruction in Patients With Chronic Rhinosinusitis |
| Q43624939 | Increased risk of sexual dysfunction in male patients with psoriasis: a nationwide population-based follow-up study |
| Q40010891 | Increased sexual dysfunction in men with storage and voiding lower urinary tract symptoms |
| Q49791495 | Increased visceral adiposity index associated with sexual dysfunction in men. |
| Q28341979 | Indomethacin-associated sexual dysfunction |
| Q48075619 | Infertility, Sexual Dysfunction, and Depression: Recommendations for Future Studies |
| Q93370047 | Inflammatory Bowel Diseases Were Associated With Risk of Sexual Dysfunction in Both Sexes: A Meta-analysis |
| Q33562013 | Inflammatory bowel disease and sexual dysfunction |
| Q71511472 | Influence of 1,25 dihydroxycholecalciferol on sexual dysfunction and related endocrine parameters in patiens on maintenance hemodialysis |
| Q71836144 | Influence of transurethral resection on sexual dysfunction in patients with prostate cancer |
| Q114670133 | Insights into the role of pERK1/2 signaling in post-cerebral ischemia reperfusion sexual dysfunction in rats |
| Q90791215 | Insomnia and sexual dysfunction associated with severe worsening of the quality of life in sexually active hysterectomized women |
| Q64149337 | Instituting impairment: Extended cognition and the construction of Female Sexual Dysfunction |
| Q37824739 | Instruments to measure sexual dysfunction in community and psychiatric populations |
| Q51172136 | Insufficient assessment of sexual dysfunction: a problem in gynecological practice. |
| Q36195167 | Integrating medication, realistic expectations, and therapeutic interventions in the treatment of male sexual dysfunction |
| Q30455811 | Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 1. For women with incomplete loss of desire or sexual receptivity |
| Q30456597 | Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 2. For women with loss of subjective sexual arousal |
| Q69730474 | Intercorrelations among general arousability, emerging and current sexual desire, and severity of sexual dysfunction in women |
| Q67017147 | Interdisciplinary treatment of male sexual dysfunction in a military health care setting |
| Q26741933 | Internet-Based Interventions for Women’s Sexual Dysfunction |
| Q51185177 | Interruption in the maintenance of compulsive sexual disorder: two case studies. |
| Q100310355 | Interventions for Sexual Dysfunction Following Stroke |
| Q24195102 | Interventions for sexual dysfunction following stroke |
| Q94477233 | Interventions for sexual dysfunction following stroke |
| Q24242883 | Interventions for sexual dysfunction following treatments for cancer |
| Q24246178 | Interventions for sexual dysfunction following treatments for cancer |
| Q24186175 | Interventions for sexual dysfunction following treatments for cancer in women |
| Q24186905 | Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD) |
| Q24187576 | Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD) |
| Q24250222 | Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy |
| Q24235471 | Interventions for treating sexual dysfunction in patients with chronic kidney disease |
| Q24240619 | Interventions for treating sexual dysfunction in patients with chronic kidney disease |
| Q37357628 | Intrauterine device migration to the urinary bladder causing sexual dysfunction: a case report |
| Q102064291 | Introducing sexual dysfunction in mental care |
| Q83826878 | Introduction to the 2008 IUGA Sexual Dysfunction in Women Roundtable |
| Q81453049 | Introduction: centrally acting agents in male sexual dysfunction |
| Q64054993 | Investigating the basis of sexual dysfunction during late-onset hypogonadism |
| Q60912971 | Investigation of prostate resected weight on postoperative sexual dysfunction following transurethral resection of prostate surgery: a population-based study |
| Q26340993 | Investigation of reports of sexual dysfunction among male chemical workers manufacturing stilbene derivatives |
| Q100695933 | Investigation of the relationship between the pelvic floor and sexual dysfunction in women with Sjögren's syndrome |
| Q98163910 | Is Low Inferior Mesenteric Artery Ligation Worthwhile to Prevent Urinary and Sexual Dysfunction After Total Mesorectal Excision for Rectal Cancer? |
| Q97528764 | Is Sexual Dysfunction in Young Adult Survivors to the L'Aquila Earthquake Related to Post-traumatic Stress Disorder? A Gender Perspective |
| Q97642255 | Is There an Association Between Contraception and Sexual Dysfunction in Women? A Systematic Review and Meta-analysis Based on Female Sexual Function Index |
| Q91996404 | Is There an Association Between Schizophrenia and Sexual Dysfunction in Both Sexes? A Systematic Review and Meta-Analysis |
| Q46488441 | Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome? Signs "UPOINT" to yes. |
| Q34286249 | Is female sexual dysfunction related to personality and coping? An exploratory study |
| Q42788044 | Is sexual dysfunction following radical surgery for cancer of the rectum and sigmoid colon a justifiable complication? |
| Q74765253 | Is sexual dysfunction in hypertensive women uncommon or understudied? |
| Q46475550 | Is sexual dysfunction in women with obstructive sleep apnea-hypopnea syndrome associated with the severity of the disease? A pilot study |
| Q51656665 | Is the Menopause Rating Scale accurate for diagnosing sexual dysfunction among climacteric women? |
| Q51736579 | Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women? |
| Q38867698 | Is the use of plants in Jordanian folk medicine for the treatment of male sexual dysfunction scientifically based? Review of in vitro and in vivo human and animal studies. |
| Q74733813 | Issues and priorities in the development of drug treatments for female sexual dysfunction |
| Q51907455 | Issues for DSM-V: sexual dysfunction, disorder, or variation along normal distribution: toward rethinking DSM criteria of sexual dysfunctions. |
| Q68292165 | Issues in the use of psychophysiology to assess female sexual dysfunction |
| Q51829293 | Issues of intimacy and sexual dysfunction following major head and neck cancer treatment. |
| Q80233312 | JAMA patient page. Male sexual dysfunction |
| Q74449033 | JAMA patient page: sexual dysfunction |
| Q42695203 | Kyo-Green improves sexual dysfunction in men and women. |
| Q77357143 | L4-5 disk lesion resulting in back pain with bowel, bladder and sexual dysfunction without paraparesis |
| Q48078143 | Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women. |
| Q30310780 | Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder |
| Q87159459 | Lack of sexual privacy affects psychological and marital domains of male sexual dysfunction |
| Q42369982 | Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review |
| Q35545741 | Late-stage clinical development in lower urogenital targets: sexual dysfunction |
| Q90730429 | Leaf-Methanolic Extract of Pseudopanax arboreus (Araliaceae) (L. F. Phillipson) Reverses Amitriptyline-Induced Sexual Dysfunction in Male Rats |
| Q24170469 | Les lanternes rouges: the race for information about cycling-related female sexual dysfunction |
| Q28363305 | Letter: Sexual dysfunction due to methyldopa |
| Q36406665 | Life after prostate cancer treatment: a mixed methods study of the experiences of men with sexual dysfunction and their partners |
| Q100573143 | Lifestyle modifications alone or combined with hormonal contraceptives improve sexual dysfunction in women with polycystic ovary syndrome |
| Q35540272 | Linguistic changes in expressive writing predict psychological outcomes in women with history of childhood sexual abuse and adult sexual dysfunction |
| Q35073873 | Linguistic validation of the Sexual Inhibition and Sexual Excitation Scales (SIS/SES) translated into five South Asian languages: Oxford Sexual Dysfunction Study (OSDS) |
| Q38049347 | Listening to placebo in clinical trials for female sexual dysfunction |
| Q38331438 | Lithium and sexual dysfunction: an under-researched area |
| Q113388431 | Long covid: Hair loss and sexual dysfunction are among wider symptoms, study finds |
| Q91072410 | Long-Term Follow-Up of Sexual Dysfunction in Women Following Allogeneic Hematopoietic Stem Cell Transplantation |
| Q41539955 | Long-term anorectal, urinary and sexual dysfunction causing distress after radiotherapy for anal cancer: a Danish multicentre cross-sectional questionnaire study. |
| Q43360464 | Long-term outcome after colorectal cancer resection. Patients' self-reported quality of life, sexual dysfunction and surgeons' awareness of patients' needs. |
| Q35618696 | Long-term side effects of SSRIs: sexual dysfunction and weight gain. |
| Q42915290 | Loveʼs labors lost: Sexual dysfunction in an adolescent male |
| Q43533282 | Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study (EMAS). |
| Q44673081 | Low risk of sexual dysfunction after transection and nontransection urethroplasty for bulbar urethral stricture |
| Q81377046 | Low testosterone not associated with female sexual dysfunction |
| Q38226026 | Lower urinary tract and sexual dysfunction in neurological patients |
| Q44271375 | Lower urinary tract symptoms (LUTS) and sexual dysfunction (SD): new targets for new combination therapies? |
| Q81479558 | Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries |
| Q53295449 | Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). |
| Q57540297 | Lower urinary tract symptoms and sexual dysfunction in community-dwelling men |
| Q64061854 | Lower urinary tract symptoms and sexual dysfunction in men with multiple sclerosis |
| Q37097048 | Lower urinary tract symptoms and sexual dysfunction: a common approach |
| Q79837105 | Lower urinary tract symptoms and sexual dysfunction: additional evidence of an association |
| Q48685240 | Lower urinary tract symptoms and sexual dysfunction: an audit of sexual symptoms among patients attending a nurse-led prostate clinic |
| Q36409135 | Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology |
| Q81761714 | Lumbar burst fracture associated with bowel, bladder, and sexual dysfunction: case study |
| Q90804040 | MANAGEMENT OF ENDOCRINE DISEASE: Female sexual dysfunction for the endocrinologist |
| Q64912827 | MON-216 Sexual Dysfunction and Eating and Sleeping Disorders in Women with PCOS: A Systematic Review and Meta-Analysis. |
| Q92203089 | Male Sexual Dysfunction Among Egyptian Patients with Chronic Hepatitis C Virus Infection Before and After Direct-Acting Antiviral Drugs |
| Q99212043 | Male Sexual Dysfunction after Pelvic Surgery for Colorectal Cancer |
| Q37714464 | Male Sexual Dysfunction and Chronic Kidney Disease |
| Q50054865 | Male Sexual Dysfunction and Hypogonadism Guidelines for the Aging Male. |
| Q70254627 | Male Sexual Dysfunction as Related to Alcohol Consumption: A Pilot Study |
| Q36626592 | Male Sexual Dysfunction, Leptin, Pituitary and Gonadal Hormones in Nigerian Males with Metabolic Syndrome and Type 2 Diabetes Mellitus |
| Q97078354 | Male and Female Sexual Dysfunction in Pediatric Cancer Survivors |
| Q39016006 | Male and Female Sexual Dysfunction in a Rapidly Changing Cultural Environment: Addressing Gender Equality versus Equivalence in the Bedroom |
| Q92165271 | Male and female sexual dysfunction in diabetic subjects: Focus on new antihyperglycemic drugs |
| Q34495259 | Male gonadal function in coeliac disease: 1. Sexual dysfunction, infertility, and semen quality |
| Q37779626 | Male sexual dysfunction |
| Q44104550 | Male sexual dysfunction |
| Q72062061 | Male sexual dysfunction |
| Q81111082 | Male sexual dysfunction |
| Q85957843 | Male sexual dysfunction |
| Q44961278 | Male sexual dysfunction after pelvic fracture |
| Q84078619 | Male sexual dysfunction after rectal cancer surgery |
| Q39494631 | Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212. |
| Q69441011 | Male sexual dysfunction after stroke |
| Q38176192 | Male sexual dysfunction and HIV--a clinical perspective. |
| Q38275464 | Male sexual dysfunction and ankylosing spondylitis: a systematic review and metaanalysis. |
| Q55618047 | Male sexual dysfunction and cimetidine |
| Q64970415 | Male sexual dysfunction and cimetidine. |
| Q70922227 | Male sexual dysfunction and diabetes mellitus. Multidisciplinary approach to diagnosis and management |
| Q37074577 | Male sexual dysfunction and infertility associated with neurological disorders. |
| Q40086050 | Male sexual dysfunction and psychoactive drug use: review of a common relationship |
| Q46377274 | Male sexual dysfunction and quality of life in schizophrenia. |
| Q44016963 | Male sexual dysfunction associated with antiretroviral therapy |
| Q71153716 | Male sexual dysfunction associated with coronary heart disease |
| Q69642706 | Male sexual dysfunction due to cimetidine |
| Q28326476 | Male sexual dysfunction during treatment with cimetidine |
| Q66912719 | Male sexual dysfunction during treatment with cimetidine |
| Q37085395 | Male sexual dysfunction in Asia. |
| Q46750809 | Male sexual dysfunction in Ireland: prevalence and associated sociodemographic characteristics |
| Q30453565 | Male sexual dysfunction in mice bearing targeted mutant alleles of the PEA3 ets gene |
| Q90060132 | Male sexual dysfunction in obesity: The role of sex hormones and small fibre neuropathy |
| Q40977292 | Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients |
| Q73143739 | Male sexual dysfunction in renal transplant recipients: comparison to men awaiting transplant |
| Q34015282 | Male sexual dysfunction in unconsummated marriage: long-term outcome in 417 patients. |
| Q91858717 | Male sexual dysfunction: A review of literature on its pathological mechanisms, potential risk factors, and herbal drug intervention |
| Q33568819 | Male sexual dysfunction: diagnosis and treatment from a sexological and interdisciplinary perspective |
| Q39753290 | Male sexual dysfunction: evaluation and treatment. |
| Q47726512 | Male sexuality and psychological trauma: soldiers and sexual disorder in World War I and Weimar Germany |
| Q37776834 | Male sexuality. 1. Medical causes of male sexual dysfunction |
| Q90574508 | Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach |
| Q90596999 | Management Strategies in Opioid Abuse and Sexual Dysfunction: A Review of Opioid-Induced Androgen Deficiency |
| Q90492101 | Management of Antipsychotic-Related Sexual Dysfunction: Systematic Review |
| Q91306013 | Management of Urologic and Sexual Dysfunction in Parkinson Disease |
| Q33693819 | Management of and counseling for psychotropic drug-induced sexual dysfunction |
| Q38261833 | Management of antidepressant-induced sexual dysfunction |
| Q95535497 | Management of drug induced sexual dysfunction in male rats by ethyl acetate fraction of onion |
| Q36879627 | Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies |
| Q98784275 | Management of male sexual dysfunction after cancer treatment |
| Q35071261 | Management of sexual dysfunction after prostate brachytherapy. |
| Q24197558 | Management of sexual dysfunction due to antipsychotic drug therapy |
| Q24246362 | Management of sexual dysfunction due to antipsychotic drug therapy |
| Q26863071 | Management of sexual dysfunction due to central nervous system disorders: a systematic review |
| Q38079282 | Management of sexual dysfunction due to vulvar lichen sclerosus in postmenopausal women. |
| Q35588404 | Management of sexual dysfunction in Parkinson's disease |
| Q59411060 | Management of sexual dysfunction in breast cancer survivors: a systematic review |
| Q59411104 | Management of sexual dysfunction in breast cancer survivors: a systematic review editorial---looking back to move ahead |
| Q52076090 | Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel. |
| Q33971218 | Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel |
| Q44611132 | Management of sexual dysfunction in patients with coronary heart disease |
| Q44092791 | Management of sexual dysfunction in patients with varying degree of cardiac risk: recommendations of the Princeton Consensus Panel |
| Q36274927 | Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. |
| Q37947414 | Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review |
| Q37129139 | Management strategies for SSRI-induced sexual dysfunction |
| Q38003720 | Management strategies in SSRI-associated sexual dysfunction in women at midlife. |
| Q91604533 | Managing Women with Sexual Dysfunction: Difficulties Experienced by Malaysian Family Physicians |
| Q38145668 | Managing female sexual dysfunction |
| Q36180319 | Managing treatment-emergent sexual dysfunction associated with serotonergic antidepressants: before and after sildenafil |
| Q34338909 | Manufacturing desire: the commodification of female sexual dysfunction |
| Q39620366 | Marital Sexual Dysfunction: Female Dysfunctions |
| Q54330341 | Marital conflict and sexual dysfunction in alcoholic and non-alcoholic couples. |
| Q67926795 | Marital problems and sexual dysfunction: how are they related? |
| Q43521809 | Marital sexual dysfunction: ejaculation disturbances |
| Q79324329 | Mayo Clinic office visit. Female sexual dysfunction |
| Q90677874 | Meanings of Sexuality: Views from Malay Women with Sexual Dysfunction |
| Q51546570 | Measuring Women’s Satisfaction with Treatment for Sexual Dysfunction: Development and Initial Validation of the Women’s Inventory of Treatment Satisfaction (WITS-9) |
| Q33961966 | Mechanisms and treatments of SSRI-induced sexual dysfunction |
| Q93214891 | Medical Treatment of Peyronie's Disease With Collagenase Clostridium Histolyticum |
| Q81599692 | Medical student views on teaching about sexual dysfunction |
| Q35204840 | Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life |
| Q73921385 | Medication-induced sexual dysfunction in transplant recipients |
| Q37781093 | Medicinal plants as alternative treatments for female sexual dysfunction: utopian vision or possible treatment in climacteric women? |
| Q44880075 | Meeting sexual dysfunction again for the first time |
| Q28307256 | Melanocortins in the treatment of male and female sexual dysfunction |
| Q43428778 | Men living with HIV and experiencing sexual dysfunction: an analysis of treatment options |
| Q79544788 | Men treated for prostate cancer did not consider urinary, bowel, or sexual dysfunction as problems of health |
| Q97678139 | Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease |
| Q37126321 | Men's experience with sexual dysfunction post-rectal cancer treatment: a qualitative study |
| Q37970483 | Men's health: sexual dysfunction, physical, and psychological health--is there a link? |
| Q92706501 | Meta-analytic Evidence for Neural Dysactivity Underlying Sexual Dysfunction |
| Q37928407 | Metabolic syndrome and sexual dysfunction |
| Q88391991 | Metabolic syndrome and sexual dysfunction |
| Q89380151 | Methodological differences as an explanation for the divergent results of studies on sexual dysfunction related to the use of vortioxetine |
| Q40734960 | Methodological problems in the evaluation of drug induced sexual dysfunction for oral contraceptives. |
| Q88193279 | Methotrexate-associated Sexual Dysfunction: Two Case Reports |
| Q46564136 | Methylmercury Exposure Induces Sexual Dysfunction in Male and Female Drosophila Melanogaster |
| Q45975883 | Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial. |
| Q73446786 | Mianserin, a 5-HT2a/2c and alpha 2 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors |
| Q88444421 | Microbiota potential for the treatment of sexual dysfunction |
| Q40387161 | Middle-aged female sexual dysfunction and multimorbidity: a population-based study |
| Q69617693 | Mild androgen insensitivity presenting with sexual dysfunction |
| Q92996286 | Minimizing Sexual Dysfunction in BPH Surgery |
| Q34812007 | Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: a retropective investigation |
| Q34750586 | Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. |
| Q43910941 | Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial |
| Q48037738 | Missed Opportunities in the Patient-Focused Drug Development Public Meeting and Scientific Workshop on Female Sexual Dysfunction Held at the FDA, October 2014. |
| Q53155220 | More education in the diagnosis and management of sexual dysfunction is needed. |
| Q71846617 | More on drug-induced sexual dysfunction |
| Q47891730 | More than just bad sex: sexual dysfunction and distress in patients with endometriosis |
| Q102152977 | Multi-polar RF and PEMF for Treatment of Vulvovaginal Atrophy |
| Q93592366 | Multiaxial classification of male sexual dysfunction |
| Q37650040 | Multidisciplinary Management of Sexual Dysfunction, Perineal Pain, and Elimination Dysfunction in a Woman with Multiple Sclerosis |
| Q37037517 | Multiple sclerosis and sexual dysfunction |
| Q47737563 | Multiple sclerosis and sexual dysfunction: A need for further education and interdisciplinary care |
| Q51983105 | Multiple sclerosis patients with and without sexual dysfunction: are there any differences? |
| Q72028078 | Multiple sclerosis. Sexual dysfunction and its response to medications |
| Q69492563 | Multivariate assessment of sexual dysfunction |
| Q53327579 | Musings on the report of the International Consensus Development Conference on Female Sexual Dysfunction: definitions and classifications. |
| Q80604130 | NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction |
| Q36706519 | Narrative literature review: sexual dysfunction in the patient on hemodialysis. |
| Q71818914 | Nefazodone-breakthrough therapy for depressive disorders with sexual dysfunction |
| Q43803726 | Nerve-sparing approach reduces sexual dysfunction in patients undergoing laparoscopic radical hysterectomy. |
| Q91790434 | Network Pharmacology of Yougui Pill Combined with Buzhong Yiqi Decoction for the Treatment of Sexual Dysfunction |
| Q36755395 | Network position and sexual dysfunction: implications of partner betweenness for men. |
| Q30503382 | Neural correlates of antidepressant-related sexual dysfunction: a placebo-controlled fMRI study on healthy males under subchronic paroxetine and bupropion |
| Q39554476 | Neuroanatomic Correlates of Female Sexual Dysfunction in Multiple Sclerosis |
| Q37667861 | Neuroanatomy and neurophysiology related to sexual dysfunction in male neurogenic patients with lesions to the spinal cord or peripheral nerves. |
| Q92265599 | Neurogenic Sexual Dysfunction Treatment: A Systematic Review |
| Q34660725 | Neurogenic bladder, neurogenic bowel, and sexual dysfunction in people with spinal cord injury |
| Q34471719 | Neurogenic female sexual dysfunction: a review |
| Q79343469 | Neurogenic vesical and sexual dysfunction attendant on trauma to the spinal cord. Observations on management |
| Q34562311 | Neuroleptics and sexual dysfunction in man. Neuroendocrine aspects |
| Q62868805 | Neurologist-induced sexual dysfunction: Enzyme-inducing antiepileptic drugs |
| Q82946398 | Neurology of bladder, bowel and sexual dysfunction |
| Q48627239 | Neurophysiological evaluation of sexual dysfunction in familial amyloidotic polyneuropathy--Portuguese type |
| Q77738289 | Neurophysiological evaluation of sexual dysfunction in patients operated for colorectal cancer |
| Q39537807 | Neurophysiology of male sexual dysfunction in neurologic disorders |
| Q80295650 | New Findings in Prostate Cancer, Benign Prostatic Hyperplasia, and Sexual Dysfunction: Highlights from the XVIII Congress of the European Association of Urology, March 12-15, 2003, Madrid, Spain |
| Q73611002 | New classification on female sexual dysfunction: some reflections on the consensus report |
| Q73610970 | New diagnostic categories for female sexual dysfunction: does the falling tree make a sound if no one is there to hear it? |
| Q33921115 | New directions in the treatment of antidepressant-induced sexual dysfunction |
| Q79199865 | New progress on diagnosis and treatment of female sexual dysfunction |
| Q57389803 | No Effect of Oral Testosterone Treatment on Sexual Dysfunction in Alcoholic Cirrhotic Men |
| Q45002987 | No association between hormonal abnormality and sexual dysfunction in Japanese schizophrenia patients treated with antipsychotics |
| Q40707085 | No difference in sexual dysfunction after transabdominal preperitoneal (TAPP) approach for inguinal hernia with fibrin sealant or tacks for mesh fixation. |
| Q61826918 | No evidence of association between native tissue vault suspension and risk of pelvic pain or sexual dysfunction |
| Q34632315 | No evidence of depression, anxiety, and sexual dysfunction following penile fracture |
| Q41561648 | Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal women |
| Q90338624 | Non-pharmacological interventions for treating sexual dysfunction in postpartum women: a systematic review protocol |
| Q92535542 | Nonalcoholic Fatty Liver Disease, Male Sexual Dysfunction, and Infertility: Common Links, Common Problems |
| Q36234630 | Noninvasive management of lower urinary tract symptoms and sexual dysfunction associated with benign prostatic hyperplasia in the primary care setting |
| Q91855566 | Nontransecting Techniques Reduce Sexual Dysfunction after Anastomotic Bulbar Urethroplasty: Results of a Multi-Institutional Comparative Analysis |
| Q36253085 | Normal aging and the evaluation of sexual dysfunction |
| Q35544237 | Novel agents for sexual dysfunction |
| Q34104594 | Novel approaches to female sexual dysfunction |
| Q71959352 | Nursing care of the chronic renal failure patient with sexual dysfunction |
| Q51211642 | Nursing diagnosis: potential sexual dysfunction after myocardial infarction. |
| Q91683919 | Nursing interventions for sexual dysfunction: An integrative review for the psychiatric nurse |
| Q49672477 | Obesity and Sexual Dysfunction: Making the Connection |
| Q46485457 | Obesity and sexual dysfunction in younger Danish men. |
| Q37133986 | Obesity and sexual dysfunction, male and female |
| Q90329434 | Obesity, mental health, and sexual dysfunction: A critical review |
| Q37879909 | Obesity, the metabolic syndrome, and sexual dysfunction in men. |
| Q37058211 | Obstetrics and gynaecology residents' self-rated knowledge, motivation, skill, and practice patterns in counselling for contraception, STI prevention, sexual dysfunction, and intimate partner violence and sexual coercion |
| Q23911450 | Occupational exposure to bisphenol-A (BPA) and the risk of self-reported male sexual dysfunction |
| Q36993647 | Office evaluation of male sexual dysfunction |
| Q67323345 | Office recognition and management of sexual dysfunction |
| Q70648435 | Office treatment of male sexual dysfunction |
| Q53211098 | Omissions in Urology Residency Training Regarding Sexual Dysfunction Subsequent to Prostate Cancer Treatment: Identifying a Need. |
| Q86843254 | On the Relationship of Male Sexual Dysfunction and Ankylosing Spondylitis |
| Q51030903 | On the etiology of sexual dysfunction |
| Q40308300 | On the pathogenesis of sexual dysfunction of the uraemic male. |
| Q34423133 | One hundred and twenty cases of enduring sexual dysfunction following treatment |
| Q34569400 | Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction |
| Q35508699 | Opioid analgesics suppress male gonadal function but opioid use in males and females does not correlate with symptoms of sexual dysfunction |
| Q47398797 | Opioids Increase Sexual Dysfunction in Patients With Non-Cancer Pain. |
| Q40469763 | Organic causes of female sexual dysfunction |
| Q35678874 | Osteopathic approach to sexual dysfunction: holistic care to improve patient satisfaction and prevent mortality and morbidity. |
| Q36109827 | Outcome measurement in female sexual dysfunction clinical trials: review and recommendations. |
| Q48222333 | Overactive bladder and its effects on sexual dysfunction among women |
| Q45823059 | P-133Assessment of sexual dysfunction in rectal cancer survivors. |
| Q37254054 | P-glycoprotein (PGP) polymorphisms and sexual dysfunction in female patients with depression and SSRI-associated sexual side effects |
| Q60460433 | P.2.f.022 Psychiatric disorder and sexual dysfunction: a pilot study |
| Q60460444 | P.8.b.003 Light therapy as a treatment for sexual dysfunction |
| Q71368968 | PCP and sexual dysfunction |
| Q73132023 | PIs may cause sexual dysfunction |
| Q38408496 | PTSD and Sexual Dysfunction in Men and Women |
| Q34503164 | Pain related sexual dysfunction after inguinal herniorrhaphy |
| Q95278732 | Panic Disorder Correlates With the Risk for Sexual Dysfunction |
| Q91656983 | Parkinson's Disease Is Associated with Risk of Sexual Dysfunction in Men but Not in Women: A Systematic Review and Meta-Analysis |
| Q71216169 | Participants' reactions to components of a rapid-treatment workshop for sexual dysfunction |
| Q50703737 | Partner's Perspective on Long-term Sexual Dysfunction After Prostate Cancer Treatment. |
| Q83826888 | Pathophysiology of sexual dysfunction as related to pelvic floor disorders |
| Q55515092 | Patient perceived changes in sexual dysfunction after initiation of natalizumab for multiple sclerosis. |
| Q90678213 | Pelvic Floor and Sexual Dysfunction After Vaginal Birth With Episiotomy in Vietnamese Women |
| Q96178901 | Pelvic Floor and Sexual Dysfunction in Women With Sjogren's Syndrome |
| Q61450136 | Pelvic floor disorders associated with higher-level sexual dysfunction in the Kersa district, Ethiopia |
| Q34603464 | Pelvic floor involvement in male and female sexual dysfunction and the role of pelvic floor rehabilitation in treatment: a literature review |
| Q42669651 | Pelvic floor muscle strength of women consulting at the gynecology outpatient clinics and its correlation with sexual dysfunction: A cross-sectional study |
| Q37943783 | Pelvic floor muscle training in treatment of female stress urinary incontinence, pelvic organ prolapse and sexual dysfunction |
| Q50958661 | Pelvic organ prolapse contributes to sexual dysfunction: a cross-sectional study. |
| Q42621140 | Pelvic ring injury is associated with sexual dysfunction in women |
| Q34666879 | Penile anesthesia in Post SSRI Sexual Dysfunction (PSSD) responds to low-power laser irradiation: a case study and hypothesis about the role of transient receptor potential (TRP) ion channels |
| Q78844258 | Penile lipomas, cause of sexual dysfunction |
| Q72124555 | Penile prostheses for the management of the neuropathic bladder and sexual dysfunction in spinal cord injury patients: long term follow up |
| Q98182203 | Perceived cognitive impairment is associated with sexual dysfunction in people with multiple sclerosis: A 2.5-year follow-up study of a large international cohort |
| Q44155090 | Perceived prevalence and definitions of sexual dysfunction as predictors of sexual function and satisfaction |
| Q72616573 | Perceived sexual dysfunction amongst patients with inflammatory bowel disease |
| Q40027230 | Perceptions of female sexual health and sexual dysfunction in a cohort of urban professional women in Abuja, Nigeria |
| Q50990197 | Perfectionism, marital satisfaction, and contributing factors to sexual dysfunction in men with erectile disorder and their spouses. |
| Q44981822 | Pergolide mesylate can improve sexual dysfunction in patients with Parkinson's disease: the results of an open, prospective, 6-month follow-up. |
| Q79467720 | Perioperative radiation for rectal cancer and sexual dysfunction after TME: cause and effect? |
| Q56016542 | Persistence of Sexual Dysfunction Side Effects after Discontinuation of Antidepressant Medications: Emerging Evidence |
| Q40777322 | Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study |
| Q38405165 | Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss |
| Q38130915 | Persistent genital arousal and restless genitalia: sexual dysfunction or subtype of vulvodynia? |
| Q28263497 | Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors |
| Q34677278 | Persistent sexual dysfunction after early exposure to SSRIs: Systematic review of animal studies |
| Q83690100 | Persistent sexual dysfunction and 5 alpha reductase inhibitors |
| Q34457965 | Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring? |
| Q44330426 | Persistent sexual dysfunction impairs quality of life after cardiac transplantation. |
| Q46185720 | Persistent sexual dysfunction in genitourinary medicine clinic attendees induced by selective serotonin reuptake inhibitors |
| Q57282063 | Personality Traits of Postmenopausal Women with Sexual Dysfunction |
| Q46434147 | Personality and birth order in monozygotic twins adopted apart: a test of Sulloway's theory; Research Reviews: twin births and cancer risk in mothers, male sexual dysfunction, twin study of ultimatum game behavior; Human Interest: 'The Land of Twins |
| Q70582475 | Personality correlates of college students reporting sexual dysfunction |
| Q44952769 | Personality traits and psychopathology on male sexual dysfunction: an empirical study |
| Q40318948 | Peyronie's disease: a difficult sexual dysfunction problem. |
| Q37618221 | Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications. |
| Q36279178 | Pharmacogenetics of glutamate system genes and SSRI-associated sexual dysfunction |
| Q26773724 | Pharmacologic and surgical therapies for sexual dysfunction in male cancer survivors |
| Q68040384 | Pharmacologic erection with intracavernosal injection for men with sexual dysfunction following irradiation: a preliminary report |
| Q57575699 | Pharmacologic management of female sexual dysfunction |
| Q35069543 | Pharmacologic management of sexual dysfunction: benefits and limitations |
| Q38168070 | Pharmacologic therapy for female sexual dysfunction |
| Q34551495 | Pharmacologic treatment strategies for sexual dysfunction in patients with epilepsy and depression. |
| Q37079096 | Pharmacological therapy for female sexual dysfunction: has progress been made? |
| Q96645723 | Pharmacological treatment of female sexual dysfunction: a critical analysis of the placebo and nocebo effects |
| Q44199084 | Pharmacological treatment of sexual dysfunction in women |
| Q35779189 | Pharmacotherapy for sexual dysfunction in women |
| Q37519719 | Pharmacotherapy for women's sexual dysfunction |
| Q28375888 | Phenelzine-induced sexual dysfunction treated with sildenafil |
| Q72552308 | Phenothiazines and sexual dysfunction |
| Q35199122 | Phosphodiesterase 5 inhibitors in male sexual dysfunction |
| Q36296249 | Phosphodiesterase inhibitors in female sexual dysfunction |
| Q89499237 | Physical etiology of sexual dysfunction in obstetric fistula patients: A prospective study |
| Q44982532 | Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications |
| Q50108098 | Physicians' response to sexual dysfunction presented by a younger vs. An older adult |
| Q48799039 | Physiologic studies of male sexual dysfunction in multiple sclerosis |
| Q74687855 | Physiological mechanisms of sexual dysfunction side effects associated with antidepressant medication |
| Q78110876 | Pills and potency: blood pressure drugs and sexual dysfunction |
| Q42602461 | Pilot study of sexual dysfunction following abdominal aortic aneurysm surgery |
| Q35749060 | Pilot study of sexual dysfunction in patients with psoriasis: influence of biologic therapy. |
| Q55039715 | Plasma Oxytocin Level and Sexual Dysfunction in Depressed Women Treated by Either Fluoxetine or Citalopram: a Pilot Clinical Trial. |
| Q67336656 | Plasma testosterone in male patients with sexual dysfunction |
| Q92535553 | Platelet-Rich Plasma Therapy for Male Sexual Dysfunction: Myth or Reality? |
| Q89045006 | Polyvictimization and the Associations Between Poor Self-Perceived Health, Dissatisfaction With Life, and Sexual Dysfunction Among Women in Estonia |
| Q38407480 | Poor Sleep Quality Predicts Hypogonadal Symptoms and Sexual Dysfunction in Male Nonstandard Shift Workers. |
| Q97561155 | Positive role of cognitive-behavioral therapy on sexual dysfunction and behavioral problems in prostate cancer-treated patients |
| Q39853401 | Possible Sexual Dysfunction Associated With Bupropion for Smoking Cessation: A Case Report |
| Q35525750 | Possible benefits of robot-assisted rectal cancer surgery regarding urological and sexual dysfunction: a systematic review and meta-analysis. |
| Q36372475 | Possible correlation between type 1 diabetes mellitus and female sexual dysfunction: case report and literature review |
| Q37873452 | Possible role of Chlamydia and virus infections in the development of sexual dysfunction |
| Q89925578 | Post-SSRI sexual dysfunction |
| Q43878826 | Post-stroke sexual dysfunction at a young age: time to act! |
| Q46922474 | Post-stroke sexual dysfunction: an overlooked and under-addressed problem |
| Q69641040 | Post-traumatic stress syndrome and sexual dysfunction |
| Q88426364 | Poster 374 Sexual Dysfunction After Sacroiliac Joint Radiofrequency Denervation: A Case Report |
| Q45043623 | Poster 425 Male Sexual Dysfunction in Patients with Chronic Pain |
| Q43477807 | Postmenopausal female sexual dysfunction: at a crossroads |
| Q91981503 | Postpartum Female Sexual Function: Risk Factors for Postpartum Sexual Dysfunction |
| Q73062755 | Poststroke sexual dysfunction and quality of life |
| Q48160122 | Postural instability, the absence of sexual intercourse in the past month, and loss of libido are predictors of sexual dysfunction in Parkinson's disease |
| Q36626775 | Potential future options in the pharmacotherapy of female sexual dysfunction |
| Q46576545 | Potential testosterone therapy for hypogonadal sexual dysfunction in women |
| Q36372394 | Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women |
| Q67277508 | Practical psychiatry in medicine. Part 8. Sexual dysfunction |
| Q81663502 | Practice patterns of physician members of the American Urogynecologic Society regarding female sexual dysfunction: results of a national survey |
| Q95761965 | Practice patterns of physician members of the American Urogynecologic Society regarding female sexual dysfunction: results of a national survey |
| Q68273324 | Pre- and postdexamethasone cortisol and prolactin levels in sexual dysfunction and normal controls |
| Q31159118 | Preclinical effects of melanocortins in male sexual dysfunction |
| Q93023285 | Predictive Factors of Male Sexual Dysfunction After Traumatic Spinal Cord Injury |
| Q57913595 | Predictors of Body Image Related Sexual Dysfunction in Men and Women with Multiple Sclerosis |
| Q92756738 | Predictors of Sexual Dysfunction in Veterans with Post-Traumatic Stress Disorder |
| Q55411147 | Predictors of female sexual dysfunction: a systematic review and qualitative analysis through gender inequality paradigms. |
| Q48125017 | Predictors of sexual dysfunction incidence and remission in men. |
| Q98943457 | Preliminary Investigation of Cancer Patients with Sexual Dysfunction |
| Q56972717 | Premature ejaculation during vaginal intercourse is not a male sexual dysfunction |
| Q36580691 | Premature ejaculation: on defining and quantifying a common male sexual dysfunction |
| Q88009035 | Premature ovarian failure is a major risk factor for cancer-related sexual dysfunction |
| Q79172580 | Premature to early ejaculation: a sampling of manuscripts regarding the most common male sexual dysfunction published in the IJIR: The Journal of Sexual Medicine |
| Q37037710 | Premenopausal women with sexual dysfunction: the need for a bladder function history |
| Q49075478 | Prenatal and neonatal exposure to cimetidine results in gonadal and sexual dysfunction in adult males |
| Q98298595 | Preparing patients for sexual dysfunction after radiation for anorectal cancers: a systematic review |
| Q112798976 | Prevalence and Associated Factors of Female Sexual Dysfunction Among Sexually Active Students of the University of Buea |
| Q48064578 | Prevalence and Correlates of Sexual Dysfunction in Men and Women With Type 2 Diabetes |
| Q33776836 | Prevalence and Factors Associated with Female Sexual Dysfunction in Beijing, China |
| Q101475064 | Prevalence and Predictive Factors of Female Sexual Dysfunction in a Sample of Saudi Women |
| Q37289852 | Prevalence and Predictive Factors of Sexual Dysfunction in Iranian Women: Univariate and Multivariate Logistic Regression Analyses |
| Q92275552 | Prevalence and Predictors of Female Sexual Dysfunction in Migraine |
| Q90212094 | Prevalence and Psychopathological Determinants of Sexual Dysfunction and Related Distress in Women With and Without Multiple Sclerosis |
| Q50856736 | Prevalence and associated factors of female sexual dysfunction in women with endometriosis. |
| Q47401942 | Prevalence and associated factors of sexual dysfunction in cervical cancer patients |
| Q90911302 | Prevalence and associated risk factors of female sexual dysfunction among Jordanian women |
| Q51148878 | Prevalence and associating factors of sexual dysfunction in women who use intrauterine device (IUD) for contraception. |
| Q39054585 | Prevalence and characteristics of female sexual dysfunction in a sample of women from Upper Egypt |
| Q44298136 | Prevalence and clinical features of sexual dysfunction in male with epilepsy: the first southern Italy hospital-based study. |
| Q37234399 | Prevalence and correlates of female sexual dysfunction among Turkish pregnant women |
| Q37783815 | Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies |
| Q34686667 | Prevalence and correlates of sexual dysfunction among women with bladder pain syndrome/interstitial cystitis |
| Q43554242 | Prevalence and correlates of sexual dysfunction among young adult married women in rural China: a population-based study |
| Q55040538 | Prevalence and correlates of sexual dysfunction in male patients with alcohol dependence syndrome: A cross-sectional study. |
| Q37456947 | Prevalence and degree of sexual dysfunction in a sample of women seeking bariatric surgery |
| Q38823387 | Prevalence and differences between type 1 and type 2 diabetes mellitus regarding female sexual dysfunction: a cross-sectional Egyptian study |
| Q39006632 | Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe |
| Q46070373 | Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey |
| Q46532630 | Prevalence and impact of disability and sexual dysfunction on Health-Related Quality of Life of Nigerian stroke survivors |
| Q36366024 | Prevalence and pattern of sexual dysfunction in married females receiving antidepressants: An exploratory study |
| Q91367734 | Prevalence and possible predictors of sexual dysfunction and self-reported needs related to the sexual life of advanced cancer patients |
| Q27015951 | Prevalence and predictors of female sexual dysfunction: a protocol for a systematic review |
| Q45115399 | Prevalence and predictors of sexual dysfunction 12 months after major trauma: a national study |
| Q77302671 | Prevalence and predictors of sexual dysfunction in long-term survivors of marrow transplantation |
| Q78841101 | Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes |
| Q79257352 | Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes |
| Q51902064 | Prevalence and predictors of sexual dysfunction in psychiatric inpatients. |
| Q48844371 | Prevalence and psychological impact of antidepressant-associated sexual dysfunction: a study from North India |
| Q39092273 | Prevalence and risk factors for female sexual dysfunction among Egyptian women |
| Q43517570 | Prevalence and risk factors for female sexual dysfunction in Turkish women. |
| Q51630371 | Prevalence and risk factors for female sexual dysfunction in women attending a medical clinic in south India. |
| Q92110746 | Prevalence and risk factors for sexual dysfunction in reproductive-aged married women: A cross-sectional epidemiological study |
| Q45030850 | Prevalence and risk factors of female sexual dysfunction among healthcare personnel in Malaysia |
| Q45132799 | Prevalence and risk factors of sexual dysfunction among younger married men in a rural area in China |
| Q90011836 | Prevalence and risk factors of sexual dysfunction in healthy women in Turkey |
| Q34108370 | Prevalence and risk factors of sexual dysfunction in men and women |
| Q40951188 | Prevalence and risk factors of sexual dysfunction in postpartum Australian women |
| Q48408536 | Prevalence and risk factors of the female sexual dysfunction in a sample of infertile Iranian women. |
| Q43785857 | Prevalence and sociocultural predictors of sexual dysfunction among Chinese men who have sex with men in Hong Kong |
| Q30240844 | Prevalence of Female Sexual Dysfunction Among Premenopausal Women: A Systematic Review and Meta-Analysis of Observational Studies |
| Q38985842 | Prevalence of Physiologic Sexual Dysfunction Is High Following Treatment for Rectal Cancer: But Is It the Only Thing That Matters? |
| Q36485544 | Prevalence of Sexual Concerns and Sexual Dysfunction among Sexually Active and Inactive Men and Women with Screen-Detected Type 2 Diabetes |
| Q47600394 | Prevalence of Sexual Dysfunction among Expectant Women. |
| Q57020216 | Prevalence of Sexual Dysfunction among Infertile Women in Iran: A Systematic Review and Meta-analysis |
| Q39743314 | Prevalence of Sexual Dysfunction and Associated Risk Factors in Middle-Aged and Elderly Korean Men in Primary Care |
| Q40275364 | Prevalence of Sexual Dysfunction and Associations with Psychiatric Disorders Among Women Aged 50 and Older |
| Q90177132 | Prevalence of Sexual Dysfunction in Women with Multiple Sclerosis: a Systematic Review and Meta-Analysis |
| Q91241928 | Prevalence of and factors associated with female sexual dysfunction among women using hormonal and non-hormonal contraception at the AGA Khan University Hospital Nairobi |
| Q34251394 | Prevalence of and recent developments in female sexual dysfunction |
| Q40753157 | Prevalence of and risk factors for sexual dysfunction in young Chinese women according to the Female Sexual Function Index: an internet-based survey |
| Q92946254 | Prevalence of antidepressant-induced sexual dysfunction among psychiatric outpatients attending a tertiary care hospital |
| Q97590476 | Prevalence of antidepressant-induced sexual dysfunction among psychiatric outpatients attending a tertiary care hospital |
| Q37540028 | Prevalence of female sexual dysfunction among Indian fertile females |
| Q58616717 | Prevalence of female sexual dysfunction among women attending college presenting for gynecological care at a university student health center |
| Q38863769 | Prevalence of female sexual dysfunction during pregnancy among Egyptian women |
| Q38971689 | Prevalence of female sexual dysfunction in Brazil: A systematic review |
| Q91283910 | Prevalence of female sexual dysfunction in allied health workers: a cross-sectional pilot study in a tertiary hospital in Singapore |
| Q53298273 | Prevalence of female sexual dysfunction in gynecologic and urogynecologic patients according to the international consensus classification. |
| Q40186167 | Prevalence of female sexual dysfunction in urban chinese women based on cutoff scores of the Chinese version of the female sexual function index: a preliminary study |
| Q44531217 | Prevalence of female sexual dysfunction symptoms and its relationship to quality of life: a Japanese female cohort study |
| Q53270016 | Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. |
| Q85168045 | Prevalence of male sexual dysfunction among Ghanaian populace: myth or reality? |
| Q40347194 | Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy. |
| Q44690820 | Prevalence of sexual dysfunction among climacteric women |
| Q51065360 | Prevalence of sexual dysfunction among female patients followed in a Brasília Cohort of early rheumatoid arthritis. |
| Q46142034 | Prevalence of sexual dysfunction among females in a university community in Enugu, Nigeria |
| Q30309316 | Prevalence of sexual dysfunction among newer antidepressants. |
| Q51397480 | Prevalence of sexual dysfunction among postmenopausal women with and without metabolic syndrome. |
| Q97589134 | Prevalence of sexual dysfunction among prenatal women attending the Greater Accra Regional Hospital, Ghana |
| Q46252193 | Prevalence of sexual dysfunction and impact of contraception in female German medical students |
| Q37147530 | Prevalence of sexual dysfunction and its associated factors in women aged 40-65 years with 11 years or more of formal education: a population-based household survey |
| Q92091273 | Prevalence of sexual dysfunction and related factors among diabetes mellitus patients in Southwest Ethiopia |
| Q40648603 | Prevalence of sexual dysfunction and urinary incontinence and associated risk factors in Turkish women. |
| Q51603055 | Prevalence of sexual dysfunction during pregnancy. |
| Q53291939 | Prevalence of sexual dysfunction in Chinese men with chronic prostatitis. |
| Q73708258 | Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapy |
| Q44255735 | Prevalence of sexual dysfunction in climacteric women. Influence of menopause and hormone replace therapy |
| Q43906681 | Prevalence of sexual dysfunction in female outpatients and personnel at a Colombian hospital: correlation with hormonal profile |
| Q73398408 | Prevalence of sexual dysfunction in heterosexual patients attending a central London genitourinary medicine clinic |
| Q47287560 | Prevalence of sexual dysfunction in infertile versus fertile couples |
| Q72301444 | Prevalence of sexual dysfunction in male cancer patients treated with rectal excision and coloanal anastomosis |
| Q34048317 | Prevalence of sexual dysfunction in male subjects with alcohol dependence. |
| Q51900538 | Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome. |
| Q37038158 | Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis |
| Q104755868 | Prevalence of sexual dysfunction in men with multiple sclerosis: a systematic review and meta-analysis |
| Q35528436 | Prevalence of sexual dysfunction in new heterosexual attenders at a central London genitourinary medicine clinic in 1998. |
| Q43604027 | Prevalence of sexual dysfunction in old and middle-aged males in Pingliang area |
| Q43893938 | Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation. |
| Q92763040 | Prevalence of sexual dysfunction in pregnancy |
| Q46161636 | Prevalence of sexual dysfunction in primigravidae in Rio Branco, Acre State, Brazil |
| Q41012761 | Prevalence of sexual dysfunction in saudi women with Type 2 diabetes: Is it affected by age, glycemic control or obesity? |
| Q62011246 | Prevalence of sexual dysfunction in three psychiatric outpatient settings: A drug misuse service, an alcohol misuse service and a general adult psychiatry clinic |
| Q44793333 | Prevalence of sexual dysfunction in women seeking services at family planning centers in Tehran |
| Q64092343 | Prevalence of sexual dysfunction in women with systemic lupus erythematosus and its related factors |
| Q72622229 | Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynecological clinic |
| Q80296878 | Prevalence of sexual dysfunction, efficacy of therapy |
| Q92388019 | Prevalence, dimensions, and predictor factors of sexual dysfunction in women of Iran Multiple Sclerosis Society: a cross-sectional study |
| Q51556929 | Prevalence, risk factors, and predictors of female sexual dysfunction in a primary care setting: a survey finding. |
| Q87774148 | Primary Prevention of Sexual Dysfunction With Mediterranean Diet in Type 2 Diabetes: The MÈDITA Randomized Trial |
| Q89702234 | Principles of Marital Therapies and Behavior Therapy of Sexual Dysfunction |
| Q54564026 | Print media advertisements on sexual dysfunction: Turning readers into patients? |
| Q33598850 | Problems assessing nonserious adverse drug reactions: antidepressant drug therapy and sexual dysfunction |
| Q98784953 | Problems in defining sexual dysfunction in prostate cancer patients |
| Q36364326 | Progress in female sexual dysfunction |
| Q75194574 | Progress in sexual dysfunction |
| Q61446259 | Prolactin and Thyroid Stimulating Hormone (TSH) Levels and Sexual Dysfunction in Patients with Schizophrenia Treated with Conventional Antipsychotic Medication: A Cross-Sectional Study |
| Q42133672 | Prolactin and sexual dysfunction in women |
| Q46605204 | Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone |
| Q36996581 | Proposed revisions for the nursing diagnoses sexual dysfunction and ineffective sexuality patterns |
| Q64060510 | Prospective Study on Sexual Dysfunction in Male Chinese Liver Transplant Recipients |
| Q47669555 | Prospective study of sexual dysfunction after proctectomy for rectal cancer. |
| Q45847855 | Prospective study of sexual dysfunction in men with rectal cancer: feasibility and results of nerve sparing surgery |
| Q84092369 | Prostate, baldness drugs linked to sexual dysfunction |
| Q35070009 | Prostatic disease and sexual dysfunction |
| Q96439444 | Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part II on Urological Management) |
| Q96344676 | Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part III on Psychosexual Therapy and the Masculine Self-Esteem) |
| Q93164729 | Prostatic irradiation-induced sexual dysfunction: a review and multidisciplinary guide to management in the radical radiotherapy era (Part I defining the organ at risk for sexual toxicities) |
| Q56953140 | Protease inhibitors, sexual dysfunction and Viagra |
| Q91795188 | Protective effect of ethanolic extract of Hygrophila auriculata seeds in cyproterone acetate-induced sexual dysfunction in male albino rats |
| Q38631603 | Protective effects of Lycium barbarum polysaccharide on male sexual dysfunction and fertility impairments by activating hypothalamic pituitary gonadal axis in streptozotocin-induced type-1 diabetic male mice |
| Q50908657 | Provoked Vestibulodynia: Does Pain Intensity Correlate With Sexual Dysfunction and Dissatisfaction? |
| Q60045789 | Psoriasis and sexual dysfunction: links, risks, and management challenges |
| Q33854893 | Psychiatric Comorbidity, Sexual Dysfunction, and Quality of Life in Patients Undergoing Hemodialysis: A Case-Control Study |
| Q70476014 | Psychiatric aspects of sexual dysfunction in women |
| Q51974085 | Psychiatric comorbidity in heterosexual couples with sexual dysfunction assessed with the composite international diagnostic interview. |
| Q34477611 | Psychiatric disorders and sexual dysfunction |
| Q108172387 | Psycho-behavioural factors associated with medication adherence among male outpatients with hypertension in a Ghanaian hospital |
| Q66965626 | Psychodynamics in sexual dysfunction |
| Q98292680 | Psychoeducational Group Therapy for sexual function and marital satisfaction in Iranian couples with sexual dysfunction disorder |
| Q47836161 | Psychologic and sexual dysfunction in primary and secondary infertile male patients |
| Q33521446 | Psychologic disorder and sexual dysfunction in elders |
| Q34868332 | Psychologic treatments for female sexual dysfunction: are they effective and do we need them? |
| Q92706256 | Psychological Impacts of Male Sexual Dysfunction in Pelvic Cancer Survivorship |
| Q71717005 | Psychological and hormonal factors in the treatment of female sexual dysfunction |
| Q93263011 | Psychological burden prediction based on demographic variables among infertile men with sexual dysfunction |
| Q30611540 | Psychological correlates of sexual dysfunction in female rectal and anal cancer survivors: analysis of baseline intervention data. |
| Q37881311 | Psychological factors associated with male sexual dysfunction: screening and treatment for the urologist |
| Q47789969 | Psychological impact and sexual dysfunction in men with and without spinal cord injury. |
| Q67559672 | Psychometric characteristics of individuals with sexual dysfunction and their partners |
| Q72989685 | Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish work group for the study of psychotropic-related sexual dysfunctions |
| Q46656051 | Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders |
| Q70147030 | Psychopathology associated with sexual dysfunction |
| Q67816468 | Psychophysiologic and psychopathologic aspects associated with sexual dysfunction |
| Q93182786 | Psychosexual Correlates of Unwanted Sexual Experiences in Women Consulting for Female Sexual Dysfunction According to Their Timing Across the Life Span |
| Q45949341 | Psychosocial Impairment as a Possible Cause of Sexual Dysfunction among Young Men with Mild Androgenetic Alopecia: A Cross-sectional Crowdsourcing Web-based Study. |
| Q55254687 | Psychosocial interventions for sexual dysfunction in addictive disorders. |
| Q48357610 | Psychosocial pathways to sexual dysfunction among female inmates |
| Q35041808 | Psychosocial profile of male patients presenting with sexual dysfunction in a psychiatric outpatient department in Mumbai, India |
| Q51012099 | Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors. |
| Q37426042 | Psychotherapeutic interventions for female sexual dysfunction |
| Q34728034 | Psychotherapeutic interventions for treating female sexual dysfunction |
| Q41565368 | Psychotherapy for female sexual dysfunction: a review |
| Q33722771 | Psychotherapy for male sexual dysfunction: a review |
| Q73817282 | Psychotherapy of sexual dysfunction |
| Q67993178 | Psychotropic drugs and sexual dysfunction |
| Q37711569 | Psychotropics and sexual dysfunction |
| Q37129475 | Psychotropics and sexual dysfunction: the evidence and treatments |
| Q92473045 | Pycnogenol supplementation as an adjunct treatment for antidepressant-induced sexual dysfunction |
| Q92519676 | Quality of Life and Female Sexual Dysfunction in Croatian Women with Stress-, Urgency- and Mixed Urinary Incontinence: Results of a Cross-Sectional Study |
| Q36380476 | Quality of life among women with sexual dysfunction undergoing hemodialysis: a cross-sectional observational study |
| Q96615884 | Quality of life and sexual dysfunction in gynaecological cancer patients: a psychosomatic approach |
| Q53574399 | Quality of life assessment in sexual dysfunction trials. |
| Q48101127 | Quality of life, depression, and sexual dysfunction in spouses of female patients with fibromyalgia |
| Q37910308 | Questionnaires for assessment of female sexual dysfunction: a review and proposal for a standardized screener |
| Q38741581 | Racial Disparities in Sexual Dysfunction Outcomes After Prostate Cancer Treatment: Myth or Reality? |
| Q35556232 | Racial differences in sexual dysfunction among postdeployed Iraq and Afghanistan veterans. |
| Q41126537 | Radiation Dose to the Penile Structures and Patient-Reported Sexual Dysfunction in Long-Term Prostate Cancer Survivors |
| Q99204809 | Randomized Controlled Trial Protocol for Evaluating the Effect of Group Education on Postmenopausal Sexual Dysfunction |
| Q64326037 | Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Bupropion as Treatment for Methadone-Emergent Sexual Dysfunction in Men |
| Q39150270 | Rapid Inpatient Treatment of Severe Female Sexual Dysfunction |
| Q86179355 | Re: A prospective study on association of prostatic calcifications with sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) |
| Q91087029 | Re: Association between Comorbidities and Female Sexual Dysfunction: Findings from the Third National Survey of Sexual Attitudes and Lifestyles (Natsal-3) |
| Q97676566 | Re: Association between Sexual Dysfunction and Avulsion of the Levator Ani Muscle after Instrumental Vaginal Delivery |
| Q53110709 | Re: Association between lower urinary tract symptoms and sexual dysfunction assessed using the core lower urinary tract symptom score and International Index of Erectile Function-5 questionnaires. |
| Q82587233 | Re: Behavior and symptom change among women treated with placebo for sexual dysfunction |
| Q44051552 | Re: Classification of sexual dysfunction for management of intracavernous medication-induced erections |
| Q70075794 | Re: Evaluation of the first 70 patients in the Center for Male Sexual Dysfunction of Beth Israel Medical Center |
| Q47549050 | Re: Female Sexual Dysfunction (FSD): Prevalence and Impact on Quality of Life (QoL). |
| Q80548116 | Re: Hypoactive sexual dysfunction in a young woman |
| Q42759580 | Re: Male sexual dysfunction: diagnosis and treatment from a sexological and interdisciplinary perspective. Absence of desire |
| Q42759584 | Re: Male sexual dysfunction: diagnosis and treatment from a sexological and interdisciplinary perspective. Association with sleep apnea |
| Q42759576 | Re: Male sexual dysfunction: diagnosis and treatment from a sexological and interdisciplinary perspective. Sexual culture |
| Q42759574 | Re: Male sexual dysfunction: diagnosis and treatment from a sexological and interdisciplinary perspective. Sexuality undergoing changes |
| Q88331477 | Re: Non-Alcoholic Fatty Liver Disease as a Risk Factor for Female Sexual Dysfunction in Premenopausal Women |
| Q48060133 | Re: Ozkan et al: Depression and Sexual Dysfunction in Turkish Men Diagnosed With Infertility (Urology 2015;85:1389-1393). |
| Q47770297 | Re: Pastuszak et al.: Poor Sleep Quality Predicts Hypogonadal Symptoms and Sexual Dysfunction in Male Nonstandard Shift Workers: Methodological Issues to Avoid Prediction Fallacy (Urology 2017;102:121-125). |
| Q49963572 | Re: Prevalence of Sexual Dysfunction in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Meta-Analysis |
| Q47978529 | Re: Prevalence of and Risk Factors for Sexual Dysfunction in Young Chinese Women According to the Female Sexual Function Index: An Internet-Based Survey |
| Q51377778 | Re: Recent and Lifelong sexual dysfunction in a female UK population sample: prevalence and risk factors. |
| Q54171419 | Re: Semen Quality Impairment is Associated with Sexual Dysfunction According to its Severity. |
| Q54734151 | Re: Sexual Dysfunction among Females Receiving Psychotropic Medication: A Hospital-Based Cross-Sectional Study. |
| Q91818359 | Re: Sexual Dysfunction and Quality of Life in Chronic Heroin-Dependent Individuals on Methadone Maintenance Treatment |
| Q91818400 | Re: Sexual Dysfunction in Men with Prediabetes |
| Q88331455 | Re: Sexual Dysfunction is Associated with Suicidal Ideation in Female Service Members and Veterans |
| Q87332192 | Re: Sexual dysfunction among reproductive-aged Chinese married women in Hong Kong: prevalence, risk factors, and associated consequences |
| Q56965644 | Re: Simões Paço J, Jorge Pereira B.: New Therapeutic Perspectives in Premature Ejaculation (Urology 2016; 88:87-92). A Rebuttal: Premature Ejaculation is Not a Male Sexual Dysfunction |
| Q88423964 | Re: Testosterone Therapy for Sexual Dysfunction in Men with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| Q90389974 | Re: The Risk of Sexual Dysfunction and Effectiveness of Treatment of Benign Prostatic Hyperplasia with Severe Lower Urinary Tract Dysfunction with Combination of Dutasteride and Solifenacin |
| Q87147194 | Re: The evolution of self-reported urinary and sexual dysfunction over the last two decades: implications for comparative effectiveness research |
| Q95403920 | Re: Transcutaneous Electrical Nerve Stimulation to Improve Female Sexual Dysfunction Symptoms: |
| Q88056969 | Re: What Kind of Sexual Dysfunction is Most Common among Overweight and Obese Women in Reproductive Age? |
| Q86346716 | Re: Women's expectations and experiences of hormone treatment for sexual dysfunction |
| Q48127064 | Re: low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study (EMAS). |
| Q48545963 | Re: persistent sexual dysfunction impairs quality of life after cardiac transplantation |
| Q43457022 | Re: prevalence and risk factors for female sexual dysfunction in Turkish women |
| Q46044821 | Re: quality of life among women with sexual dysfunction undergoing hemodialysis: a cross-sectional observational study |
| Q44413167 | Re: sexual dysfunction among Chinese married men aged 30-60 years: a population-based study in Hong Kong |
| Q79823659 | Re: sexual dysfunction in women with hyperprolactinemia: a pilot study report |
| Q51388161 | Re: the impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument. |
| Q86179358 | Rebuttal: A prospective study on association of prostatic calcifications with sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) |
| Q34108396 | Recent advances in female sexual dysfunction |
| Q43832473 | Recent and lifelong sexual dysfunction in a female UK population sample: prevalence and risk factors |
| Q34108378 | Recent developments in male sexual dysfunction |
| Q73610941 | Receptivity and personal distress: considerations for redefining female sexual dysfunction |
| Q38527705 | Recognising female sexual dysfunction as an essential aspect of effective diabetes care |
| Q30306925 | Recognition and assessment of sexual dysfunction associated with depression |
| Q35958929 | Recognition of sexual dysfunction in medical practice |
| Q33231534 | Recommendations for the management of premature ejaculation: BASHH Special Interest Group for Sexual Dysfunction |
| Q33231535 | Recommendations for the management of retarded ejaculation: BASHH Special Interest Group for Sexual Dysfunction |
| Q34484132 | Recommendations for the management of vaginismus: BASHH Special Interest Group for Sexual Dysfunction |
| Q30359853 | Reduced melanocortin production causes sexual dysfunction in male mice with POMC neuronal insulin and leptin insensitivity. |
| Q48570352 | Reduced sensitivity of penile mechanoreceptors in aging rats with sexual dysfunction |
| Q37735342 | Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY. |
| Q36619321 | Reduced treatment-emergent sexual dysfunction as a potential target in the development of new antidepressants |
| Q32112747 | Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. |
| Q70559327 | Referral of impotent patients to a sexual dysfunction clinic |
| Q37542111 | Refusing to Treat Sexual Dysfunction in Sex Offenders |
| Q77777447 | Regulatory and drug development issues related to female sexual dysfunction |
| Q40692310 | Regulatory and scientific issues in studies to evaluate sexual dysfunction in antidepressant drug trials |
| Q77501419 | Rehabilitation of intimacy and sexual dysfunction in couples with multiple sclerosis |
| Q79362761 | Relation of sex steroid hormones to genital tissue structure and arousal: a sampling of manuscripts discussing endocrinologic sexual dysfunction |
| Q73907829 | Relation of sexual dysfunction to hormone levels, diseases and drugs used in andrological patients |
| Q44178585 | Relationship between CYP 2D6 metabolic status and sexual dysfunction in paroxetine treatment |
| Q39683042 | Relationship between General Health Indices and Sexual Dysfunction in Women Experiencing Spousal Abuse. |
| Q90376598 | Relationship between Hypogonadal Symptoms, Sexual Dysfunction and Chronic Prostatitis in Middle-Aged Men by Self-Reported Questionnaires, even without Biochemical Testosterone Deficiency |
| Q44874312 | Relationship between SSRI-induced sexual dysfunction and central serotonergic activity based on the loudness dependence of auditory evoked potentials |
| Q34984090 | Relationship between Serum Testosterone and Cardiovascular Disease Risk Determined Using the Framingham Risk Score in Male Patients with Sexual Dysfunction |
| Q41099497 | Relationship between female pelvic floor dysfunction and sexual dysfunction: an observational study |
| Q44442599 | Relationship between menopausal symptoms and sexual dysfunction among married Turkish women in 40-65 age group |
| Q47924383 | Relationship between pelvic floor muscle strength and sexual dysfunction in postmenopausal women: a cross-sectional study. |
| Q51823997 | Relationship between sexual dysfunction and psychiatric status in premenopausal women with fibromyalgia. |
| Q45805792 | Relationship between sexual dysfunction and psychological burden in men with infertility: a large observational study in China |
| Q71701471 | Relationship factors in the treatment of sexual dysfunction |
| Q63616150 | Relationship of episiotomy to perineal trauma and morbidity, sexual dysfunction, and pelvic floor relaxation |
| Q35917622 | Relationship of sexual dysfunction and its associated factors in women with genital and breast cancers. |
| Q44537803 | Relationship of sexual dysfunction to epilepsy laterality and reproductive hormone levels in women |
| Q93021544 | Relationships between body image, sexual dysfunction, and health-related quality of life among middle-aged women: A cross-sectional study |
| Q41659474 | Relationships of Sexual Dysfunction with Depression and Acceptance of Illness in Women and Men with Type 2 Diabetes Mellitus. |
| Q28374418 | Relief of SSRI-induced sexual dysfunction with mirtazapine treatment |
| Q39405960 | Relief of serotonin selective reuptake inhibitor induced sexual dysfunction with low-dose mianserin in patients with traumatic brain injury |
| Q51252747 | Remission of female sexual dysfunction in morbidly obese female patients with the Scopinaro procedure. |
| Q48729743 | Renal provider perceptions and practice patterns regarding the management of pain, sexual dysfunction, and depression in hemodialysis patients. |
| Q92239015 | Reply to Comment on "Inflammatory Bowel Diseases Were Associated With Risk of Sexual Dysfunction in Both Sexes: A Meta-analysis" by Li Y and Liu X |
| Q34180078 | Report of the International Consensus Development Conference on Female Sexual Dysfunction: a view from down under |
| Q33845358 | Report of the international consensus development conference on female sexual dysfunction: definitions and classifications |
| Q58306016 | Reported Sexual Dysfunction in Obstructive Sleep Apnea Patients |
| Q33225770 | Reproductive and sexual dysfunction in men with epilepsy |
| Q51350628 | Resident training in female sexual dysfunction: a comparison of urology and obstetrics and gynecology programs. |
| Q91300221 | Resolution of Female Sexual Dysfunction (FSD) Among the Obese Multiethnic Malaysian Women Now a Reality with Bariatric Surgery: a Prospective Pilot Study in Malaysia |
| Q42545865 | Resolution of fluoxetine-induced sexual dysfunction with the 5-HT3 antagonist granisetron. |
| Q46554644 | Resolution of sexual dysfunction during acute treatment of major depression with milnacipran |
| Q46735457 | Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine |
| Q62746649 | Response and Rebuttal to Editorial Comment on “Radiation Dose to the Penile Structures and Patient-Reported Sexual Dysfunction in Long-Term Prostate Cancer Survivors” |
| Q42922460 | Response to Comment on: Wing et al. Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD Study. Diabetes care 2013;36:2937-2944. |
| Q92213288 | Response to: Assessing sexual dysfunction in men with epilepsy: A need for specific tools! |
| Q92307628 | Retracted: Sexual Dysfunction in Women with Diabetic Kidney |
| Q87032959 | Retraction statement: The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study |
| Q51341521 | Retrograde ejaculation and sexual dysfunction in men with diabetes mellitus: a prospective, controlled study. |
| Q39562630 | Reversal by bethanechol of sexual dysfunction caused by anticholinergic antidepressants |
| Q34659646 | Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study. |
| Q44683359 | Reversal of fluoxetine-induced sexual dysfunction by switching to escitalopram |
| Q26752977 | Review of Naturopathy of Medical Mushroom, Ophiocordyceps Sinensis, in Sexual Dysfunction |
| Q83826891 | Review of current status of female sexual dysfunction evaluation in urogynecology |
| Q37611352 | Review of drug treatment for female sexual dysfunction |
| Q78743902 | Review: Beta-blockers increase fatigue and sexual dysfunction but not depression after myocardial infarction |
| Q59186998 | Review: beta blockers increase fatigue and sexual dysfunction but not depression after myocardial infarction |
| Q59187003 | Review: beta blockers increase fatigue and sexual dysfunction but not depression after myocardial infarction * In response |
| Q35038081 | Review: beta-blockers increase fatigue and sexual dysfunction but not depression after myocardial infarction. |
| Q88954604 | Rheumatoid Arthritis and Risk of Sexual Dysfunction: A Systematic Review and Metaanalysis |
| Q38765282 | Risk Factors for Sexual Dysfunction Among Women and Men: A Consensus Statement From the Fourth International Consultation on Sexual Medicine 2015. |
| Q92751632 | Risk Factors of Sexual Dysfunction in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study |
| Q39151286 | Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis |
| Q79679489 | Risk factors associated with sexual dysfunction after transurethral resection of the prostate |
| Q40917068 | Risk factors associated with sexual dysfunction in Brazilian postmenopausal women |
| Q51706596 | Risk factors for female sexual dysfunction in the general population: exploring factors associated with low sexual function and sexual distress. |
| Q51662584 | Risk factors for sexual dysfunction after rectal cancer treatment. |
| Q90311342 | Risk factors for sexual dysfunction in BRCA mutation carriers after risk-reducing salpingo-oophorectomy |
| Q101053469 | Risk factors for sexual dysfunction in Romanian women with type 1 diabetes mellitus and chronic autoimmune thyroiditis: a comparative cross-sectional study |
| Q101213374 | Risk factors for sexual dysfunction in pregnant women during the COVID-19 pandemic |
| Q54337489 | Risk factors of sexual dysfunction after transurethral resection of the prostate (TURP): a 12 months follow-up. |
| Q47869703 | Risk of Erectile Dysfunction After Traumatic Brain Injury: A Nationwide Population-Based Cohort study in Taiwan. |
| Q92013650 | Risk of female sexual dysfunction following concussion in women of reproductive age |
| Q39271933 | Risk of sexual dysfunction in a randomly selected nonclinical sample of the Swedish population |
| Q98504582 | Risk of sexual dysfunction with progestin-based contraceptives in women of child-bearing age |
| Q36631024 | Risk stratification using gated stress myocardial perfusion imaging: comparison between patients with and without sexual dysfunction |
| Q46533535 | Risperidone-induced sexual dysfunction in a prepubertal child - a case report |
| Q104618299 | Rohypnol-induced sexual dysfunction is via suppression of hypothalamic-pituitary-testicular axis: An experimental study in rats |
| Q44193331 | Role of androgen in the elderly. Male sexual dysfunction and androgen |
| Q45075009 | Role of sildenafil in female sexual dysfunction |
| Q44348993 | Rosa Damascena oil improved methadone-related sexual dysfunction in females with opioid use disorder under methadone maintenance therapy - results from a double-blind, randomized, and placebo-controlled trial |
| Q35174211 | Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial |
| Q53756171 | SA1. Sexual Dysfunction and Lipid Abnormalities in First-Episode Psychosis. |
| Q61882739 | SAT0075 Prevalence of Sexual Dysfunction Among Moroccan Women with Rheumatoid Arthritis: Case-Control Study |
| Q52136336 | SEXUAL DISORDER IN POSTTRAUMATIC AND POSTCONCUSSIONAL STATES |
| Q47549396 | SEXUAL DYSFUNCTION AND INCIDENCE OFDEPRESSION IN MULTIPLE SCLEROSIS PATIENTS. |
| Q52135658 | SEXUAL DYSFUNCTION ASSOCIATED WITH THIORIDAZINE HYDROCHLORIDE. |
| Q34566722 | SSRI sexual dysfunction: a female perspective |
| Q56621920 | SSRI-Associated Sexual Dysfunction |
| Q33999156 | SSRI-associated sexual dysfunction |
| Q50650302 | SSRI-induced sexual dysfunction treated with sildenafil. |
| Q34742856 | SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. |
| Q72786477 | SSRIs to treat sexual dysfunction |
| Q34145492 | Sacral neuromodulation stimulation for IC/PBS, chronic pelvic pain, and sexual dysfunction |
| Q37538025 | Saddle-horn injury of the pelvis. The injury, its outcomes, and associated male sexual dysfunction |
| Q73235167 | Safety of sildenafil for antidepressant-related sexual dysfunction |
| Q44075006 | Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study |
| Q48102831 | Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study. |
| Q37924984 | Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction |
| Q39425082 | Screening for Sexual Dysfunction by Medical Students. |
| Q70642343 | Screening for sexual dysfunction |
| Q95531044 | Screening of sexual dysfunction in Saudi women before and after the age of 40 years |
| Q36192428 | Second generation antipsychotics improve sexual dysfunction in schizophrenia: a randomised controlled trial |
| Q94525692 | Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives |
| Q35069534 | Selective phosphodiesterase type-5 inhibitor treatment of serotonergic reuptake inhibitor antidepressant-associated sexual dysfunction: a review of diagnosis, treatment, and relevance |
| Q51740824 | Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670. |
| Q46154884 | Selective serotonin reuptake inhibitor is more likely to induce sexual dysfunction than mirtazapine in treating depression |
| Q35867932 | Selective serotonin reuptake inhibitor-induced sexual dysfunction in adolescents: a review |
| Q55067868 | Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. |
| Q34296663 | Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday |
| Q44536104 | Selegiline in the treatment of sexual dysfunction in schizophrenic patients maintained on neuroleptics: a pilot study. |
| Q74057978 | Self Reported Sexual Dysfunction in Men and Women Treated With Bisoprolol, Hydrochlorothiazide, Enalapril, Amlodipine, Placebo, or Bisoprolol/Hydrochlorothiazide |
| Q56336759 | Self-Reported Sexual Dysfunction Is Frequent Among HIV-Infected Persons and Is Associated with Suboptimal Adherence to Antiretrovirals |
| Q91238912 | Self-reported sexual dysfunction in patients with rectal cancer |
| Q47665048 | Semen quality impairment is associated with sexual dysfunction according to its severity. |
| Q73017840 | Sensate focus and its role in treating sexual dysfunction |
| Q56910278 | Serotonergic targets in the treatment of antidepressant induced sexual dysfunction: a pilot study of granisetron and sumatriptan |
| Q39057533 | Serotonin Selective Reuptake Inhibitors (SSRIs) and Female Sexual Dysfunction (FSD): Hypothesis on Its association and options of treatment |
| Q34065140 | Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients |
| Q44785609 | Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years with no complaints of sexual dysfunction. |
| Q44770307 | Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction. |
| Q47144902 | Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics. |
| Q34073926 | Severe sexual dysfunction in women with the irritable bowel syndrome: comparison with inflammatory bowel disease and duodenal ulceration |
| Q92970699 | Severity of urinary incontinence is associated with prevalence of sexual dysfunction |
| Q82523113 | Sex and the heart - the correlation between sexual dysfunction and cardiovascular disease. Proceedings of a meeting. April 23, 2005. Galveston, Texas, USA |
| Q34601196 | Sex and the oncology patient: discussing sexual dysfunction helps the patient optimize quality of life. |
| Q34216425 | Sex hormone levels and sexual dysfunction in men after coronary artery bypass graft. |
| Q37408345 | Sex steroid hormones in diabetes-induced sexual dysfunction: focus on the female gender |
| Q37361480 | Sex therapy for female sexual dysfunction |
| Q58881774 | Sexual Abuse in Childhood and Sexual Dysfunction in Adulthood: An Australian Population-Based Study |
| Q52675152 | Sexual Activity, Sexual Dysfunction, and Sexual Life Quality Among Psychiatric Hospital Inpatients With Schizophrenia. |
| Q88660655 | Sexual Counseling in Women With Primary Infertility and Sexual Dysfunction: Use of the BETTER Model |
| Q64333040 | Sexual Desire in Opiate-Dependent Men Receiving Methadone-Assisted Treatment |
| Q47756771 | Sexual Dysfunction After Abdominal Aortic Aneurysm Surgical Repair: Current Knowledge and Future Directions |
| Q56893577 | Sexual Dysfunction After Conventional and Endovascular AAA Repair:Results of the DREAM Trial |
| Q47559181 | Sexual Dysfunction After Good-Grade Aneurysmal Subarachnoid Hemorrhage |
| Q30240280 | Sexual Dysfunction After Urethroplasty |
| Q87975800 | Sexual Dysfunction Among Patients With Schizophrenia in Southwest Nigeria |
| Q100426561 | Sexual Dysfunction Among Young Adults in Sweden-A Population-Based Observational Study |
| Q48519334 | Sexual Dysfunction Among Young Men: Overview of Dietary Components Associated With Erectile Dysfunction. |
| Q40093104 | Sexual Dysfunction Due to Antihypertensive Agents |
| Q30276147 | Sexual Dysfunction Due to Psychotropic Medications |
| Q39774051 | Sexual Dysfunction Following Surgical Therapy for Aorto-Iliac Disease |
| Q100945497 | Sexual Dysfunction Following Traumatic Pelvic Fracture |
| Q47748498 | Sexual Dysfunction In Epilepsy And The Role Of Anti-Epileptic Drugs |
| Q55710183 | Sexual Dysfunction Is Associated with Depression and Anxiety in Patients with Predialytic Chronic Kidney Disease. |
| Q90097387 | Sexual Dysfunction Is a More Common Problem in Young Women with Type 1 Diabetes than in Healthy Women |
| Q51112248 | Sexual Dysfunction Management and Expectations Assessment in Multiple Sclerosis-Female (SEA-MS-F): creation and validation of a specific questionnaire. |
| Q40193608 | Sexual Dysfunction Problems in Female College Students: Sexual Victimization, Substance Use, and Personality Factors |
| Q59282454 | Sexual Dysfunction Questionnaire for General Practitioners |
| Q104618111 | Sexual Dysfunction Reduction in Female Patients with Chronic Kidney Disease Undergoing Continuous Ambulatory Peritoneal Dialysis |
| Q35841676 | Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs |
| Q92082598 | Sexual Dysfunction Secondary to Lumbar Stiffness in Adult Spinal Deformity Patients before and after Long-Segment Spinal Fusion |
| Q91261005 | Sexual Dysfunction Seems to Trigger Depression in Female Multiple Sclerosis Patients |
| Q38828170 | Sexual Dysfunction among Chinese Nurses: Prevalence and Predictors |
| Q37315844 | Sexual Dysfunction among Females Receiving Psychotropic Medication: A Hospital-based Cross-sectional Study |
| Q61809266 | Sexual Dysfunction among Men in Rural Tamil Nadu: Nature, Prevalence, Clinical Features, and Explanatory Models |
| Q100437840 | Sexual Dysfunction and Associated Anxiety and Depression in Female Hemodialysis Patients: A Cross-Sectional Study at Karachi Institute of Kidney Diseases |
| Q57750746 | Sexual Dysfunction and Cardiac Risk (the Second Princeton Consensus Conference) |
| Q57750785 | Sexual Dysfunction and Cardiac Risk (the Second Princeton Consensus Conference) |
| Q82142894 | Sexual Dysfunction and Cardiac Risk. Proceedings of the 2nd Princeton Consensus Conference, June 11-12, 2004, Princeton, New Jersey, USA |
| Q57826436 | Sexual Dysfunction and Childhood Trauma In Female Patients With Fibromyalgia |
| Q35776724 | Sexual Dysfunction and Depression in Individuals with Multiple Sclerosis: Is there a Link? |
| Q90236046 | Sexual Dysfunction and Depression in Patients with Multiple Sclerosis in Croatia |
| Q88922765 | Sexual Dysfunction and Depression in Pregnancy |
| Q98568392 | Sexual Dysfunction and Distress Among Childhood Sexual Abuse Survivors: The Role of Post-Traumatic Stress Disorder |
| Q35795641 | Sexual Dysfunction and Help Seeking Behaviors in Newly Married Men in Sari City: a Descriptive |
| Q88344120 | Sexual Dysfunction and Hypogonadism in Men With Diabetes |
| Q39419618 | Sexual Dysfunction and Intimacy for Ostomates |
| Q90088093 | Sexual Dysfunction and Mood Stabilizers in Long-Term Stable Patients With Bipolar Disorder |
| Q64121919 | Sexual Dysfunction and Quality of Life in Chronic Heroin-Dependent Individuals on Methadone Maintenance Treatment |
| Q93126004 | Sexual Dysfunction and Reproductive Concerns in Young Men Diagnosed With Testicular Cancer: An Observational Study |
| Q57813930 | Sexual Dysfunction and Satisfaction in Japanese Couples During Pregnancy and Postpartum |
| Q90212087 | Sexual Dysfunction and Satisfaction in Kidney Transplant Patients |
| Q93368083 | Sexual Dysfunction and Sex Hormone Abnormalities in Patients With Cirrhosis: Review of Pathogenesis and Management |
| Q39044241 | Sexual Dysfunction and Sexual Behaviors in a Sample of Brazilian Male Substance Misusers |
| Q64321802 | Sexual Dysfunction and its Associated Factors After Delivery: Longitudinal Study in Iranian Women |
| Q33653021 | Sexual Dysfunction and the Primary Care Physician. |
| Q35380548 | Sexual Dysfunction before and after Cardiac Rehabilitation |
| Q41199726 | Sexual Dysfunction following Therapy for Cancer of the Prostate, Testis, and Penis |
| Q94543922 | Sexual Dysfunction in Adolescent and Young Adult Survivors of Childhood Cancer: Presentation, Risk Factors, and Evaluation of an Underdiagnosed Late Effect: A Narrative Review |
| Q38773944 | Sexual Dysfunction in Breast Cancer Survivors: Cross-Cultural Adaptation of the Sexual Activity Questionnaire for Use in Portugal. |
| Q92068105 | Sexual Dysfunction in Breast Cancer Survivors: Is it Surgical Modality or Adjuvant Therapy? |
| Q85048234 | Sexual Dysfunction in CKD |
| Q48019908 | Sexual Dysfunction in Cancer Patients and Survivors #293. |
| Q89896874 | Sexual Dysfunction in Carcinoma Cervix: Assessment in Post Treated Cases by LENTSOMA Scale |
| Q95358379 | Sexual Dysfunction in Diabetes |
| Q70564530 | Sexual Dysfunction in Diabetic Females |
| Q69754909 | Sexual Dysfunction in Diabetic Men |
| Q90243789 | Sexual Dysfunction in Drug-Naïve or Drug-Free Male Patients with Psychosis: Prevalence and Risk Factors |
| Q99410977 | Sexual Dysfunction in Early-Onset Parkinson's Disease: A Cross-Sectional, Multicenter Study |
| Q48339477 | Sexual Dysfunction in Female Patients With Neurodermatitis |
| Q38671404 | Sexual Dysfunction in Females after Cancer Treatment: an Unresolved Issue |
| Q58896760 | Sexual Dysfunction in First-Episode Schizophrenia Patients |
| Q35906924 | Sexual Dysfunction in Heroin Dependents: A Comparison between Methadone and Buprenorphine Maintenance Treatment |
| Q49788390 | Sexual Dysfunction in Interstitial Cystitis. |
| Q58641082 | Sexual Dysfunction in Intimate Heterosexual Relationships |
| Q50090511 | Sexual Dysfunction in Lesbian Women: A Systematic Review of the Literature |
| Q91577946 | Sexual Dysfunction in Male Canadian Armed Forces Members and Veterans Seeking Mental Health Treatment |
| Q47765553 | Sexual Dysfunction in Male Patients With Behçet's Disease |
| Q87984852 | Sexual Dysfunction in Married Women With Urinary Incontinence |
| Q41106158 | Sexual Dysfunction in Men Receiving Methadone Maintenance Treatment: Clinical History and Psychobiological Correlates |
| Q47648928 | Sexual Dysfunction in Men With Inflammatory Bowel Disease: A New IBD-Specific Scale |
| Q92245433 | Sexual Dysfunction in Men with Prediabetes |
| Q92350462 | Sexual Dysfunction in Menopausal Women |
| Q46936818 | Sexual Dysfunction in Neurological Disorders: Diagnosis, Management and Rehabilitation |
| Q97518545 | Sexual Dysfunction in Parkinson Disease: A Multicenter Italian Cross-sectional Study on a Still Overlooked Problem |
| Q59416819 | Sexual Dysfunction in Parkinson's Disease |
| Q96055883 | Sexual Dysfunction in Partner of Patients With Ankylosing Spondylitis |
| Q57471142 | Sexual Dysfunction in Patients With Inflammatory Bowel Disease |
| Q95509793 | Sexual Dysfunction in Patients with Antidepressant-treated Anxiety or Depressive Disorders: a Pragmatic Multivariable Longitudinal Study |
| Q33631194 | Sexual Dysfunction in Patients with Diabetes Mellitus: The Role of a "Central" Neuropathy |
| Q67833967 | Sexual Dysfunction in Patients with Hypothalamo-Pituitary Disorders |
| Q35784232 | Sexual Dysfunction in Patients with Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis |
| Q39374306 | Sexual Dysfunction in Patients with Polycystic Ovary Syndrome in Malaysia |
| Q90997198 | Sexual Dysfunction in Postpartum Turkish Women: It's Relationship with Depression and Some Risk Factors |
| Q53761754 | Sexual Dysfunction in Premenopausal Women Treated for Breast Cancer - Implications for their Clinical Care. |
| Q47590409 | Sexual Dysfunction in Premenopausal Women With Obstructive Sleep Apnea |
| Q47579206 | Sexual Dysfunction in Primary Care: An Exploratory Descriptive Analysis of Medical Record Diagnoses. |
| Q100500713 | Sexual Dysfunction in Puerto Rican Women with Inflammatory Bowel Disease |
| Q92161957 | Sexual Dysfunction in Survivorship; the Impact of Menopause and Endocrine Therapy |
| Q28554489 | Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors |
| Q49601600 | Sexual Dysfunction in Unmedicated Patients with Schizophrenia and in Healthy Controls |
| Q50133225 | Sexual Dysfunction in Urethral Reconstruction: A Review of the Literature |
| Q64078414 | Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease |
| Q36626599 | Sexual Dysfunction in Women Undergoing Fertility Treatment in Iran: Prevalence and Associated Risk Factors |
| Q104485917 | Sexual Dysfunction in Women With Kidney Disease |
| Q47906379 | Sexual Dysfunction in Women With Migraine and Overweight/Obesity: Relative Frequency and Association With Migraine Severity |
| Q92125239 | Sexual Dysfunction in Women With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis |
| Q93048082 | Sexual Dysfunction in Women with Depression: A Hospital-Based Cross-sectional Comparative Study |
| Q92835376 | Sexual Dysfunction in Women with Hypertension: a Systematic Review and Meta-analysis |
| Q40636350 | Sexual Dysfunction in Women: A Practical Approach. |
| Q38869211 | Sexual Dysfunction in Young Adult Survivors of Childhood Cancer |
| Q96680721 | Sexual Dysfunction in Young Women with Type 1 Diabetes |
| Q47571985 | Sexual Dysfunction in a Patient Taking Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C: A Case Report |
| Q40355399 | Sexual Dysfunction in the Male |
| Q40841334 | Sexual Dysfunction to the Rescue |
| Q37612905 | Sexual Dysfunction, Depression and Quality of Life in Patients With HIV Infection |
| Q39944108 | Sexual Dysfunction, Depression, and Anxiety Among Patients of an Inner-City Menopause Clinic |
| Q45867949 | Sexual Dysfunction: A Neuro-Medical Approach |
| Q50185775 | Sexual Dysfunction: Behavioral, Medical, and Surgical Treatment |
| Q90789300 | Sexual Dysfunction: Prevalence and Prognosis in Patients Operated for Degenerative Lumbar Spondylolisthesis |
| Q62489325 | Sexual Function Before and After Vesicovaginal Fistula Repair |
| Q38934448 | Sexual activity and sexual dysfunction of women in the perinatal period: a longitudinal study |
| Q51828647 | Sexual activity, sexual dysfunction and associated help-seeking behaviours in middle-aged and older adults in Spain: a population survey. |
| Q72521351 | Sexual behavior in the Japanese males. 3. Sexual dysfunction following radical surgery for cancer of the rectum and colon |
| Q70555820 | Sexual behavior in the Japanese males. 4. Sexual dysfunction following simple prostatectomy |
| Q70458959 | Sexual behavior in the Japanese males. 5. Sexual dysfunction following priapism |
| Q38977572 | Sexual counselling for treating or preventing sexual dysfunction in women living with female genital mutilation: A systematic review |
| Q58641578 | Sexual desire, general arousability, and sexual dysfunction |
| Q78724889 | Sexual disorder after implantation of high dose of follicular hormone in a young man |
| Q37608087 | Sexual disorder improvement: a target or a way in treatment of fibromyalgia. A case report and brief review |
| Q42340343 | Sexual disorder in 'mepacrine psychoses'. |
| Q41421928 | Sexual disorder in hemodialysis patients |
| Q44758128 | Sexual distress, sexual dysfunction and relationship quality in women with systemic sclerosis: correlation with clinical variables |
| Q28301050 | Sexual dysfunction (Kṛcchra Vyavāya) in obesity (Sthaulya): Validation by an observational study |
| Q58029420 | Sexual dysfunction after a first trimester induced abortion in a Chinese population |
| Q67735372 | Sexual dysfunction after abdominoperineal resection |
| Q67013739 | Sexual dysfunction after aorto-iliac surgery. With special reference to the importance of the hypogastric plexus |
| Q103828028 | Sexual dysfunction after cervical cancer treatment |
| Q70987293 | Sexual dysfunction after colectomy |
| Q80159819 | Sexual dysfunction after colostomy |
| Q38072839 | Sexual dysfunction after colpectomy and vaginal reconstruction with a vertical rectus abdominis myocutaneous flap |
| Q53260633 | Sexual dysfunction after curative radical resection of rectal cancer in men: the role of extended systematic lymph-node dissection. |
| Q26853466 | Sexual dysfunction after cystectomy and urinary diversion |
| Q53175426 | Sexual dysfunction after elective endovascular or hand-assisted laparoscopic abdominal aneurysm repair. |
| Q92780857 | Sexual dysfunction after elective laparoscopic or endovascular abdominal aortic aneurysm repair in men |
| Q69606793 | Sexual dysfunction after excision of the rectum |
| Q28316634 | Sexual dysfunction after gemfibrozil |
| Q46120644 | Sexual dysfunction after hematopoietic stem cell transplantation |
| Q40307093 | Sexual dysfunction after inguinal hernia repair with the Onstep versus Lichtenstein technique: A randomized clinical trial |
| Q48966622 | Sexual dysfunction after liver transplantation. |
| Q70771734 | Sexual dysfunction after low anterior resection for midrectal cancer |
| Q37148119 | Sexual dysfunction after menopause: assessment and treatment. |
| Q36179314 | Sexual dysfunction after pelvic surgery |
| Q46540158 | Sexual dysfunction after premenopausal stage I and II breast cancer: do androgens play a role? |
| Q69016667 | Sexual dysfunction after prostatectomy |
| Q80297447 | Sexual dysfunction after radical prostatectomy |
| Q36310552 | Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distress |
| Q53062406 | Sexual dysfunction after radical prostatectomy: treatment failure or treatment delay? |
| Q78024627 | Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation |
| Q72003117 | Sexual dysfunction after rectal operations |
| Q51770482 | Sexual dysfunction after rectal surgery: a retrospective study of men without disease recurrence. |
| Q73740067 | Sexual dysfunction after renal replacement therapy |
| Q53142639 | Sexual dysfunction after simultaneous pancreas-kidney transplantation. |
| Q40834955 | Sexual dysfunction after spinal cord injury. |
| Q70571307 | Sexual dysfunction after spinal cord or cauda equina lesions |
| Q89888408 | Sexual dysfunction after stroke-A biopsychosocial perspective |
| Q81530585 | Sexual dysfunction after stroke: a need for more study |
| Q77890325 | Sexual dysfunction after surgery for rectal cancer |
| Q54437554 | Sexual dysfunction after therapy for cervical carcinoma |
| Q49243827 | Sexual dysfunction after traumatic brain injury. |
| Q69822267 | Sexual dysfunction after treatment for genitourinary cancers |
| Q35052018 | Sexual dysfunction after treatment for gynaecologic and breast malignancies |
| Q34466650 | Sexual dysfunction after treatment for testicular cancer: a systematic review |
| Q71205667 | Sexual dysfunction after treatment of cervical cancer |
| Q83067565 | Sexual dysfunction after trocar-guided transvaginal mesh repair of pelvic organ prolapse |
| Q41744724 | Sexual dysfunction after uterine artery embolization |
| Q44996089 | Sexual dysfunction among 78 Moroccan male hemodialysis patients: clinical and endocrine study |
| Q39473967 | Sexual dysfunction among Chinese married men aged 30-60 years: a population-based study in Hong Kong |
| Q34243141 | Sexual dysfunction among Ghanaian men presenting with various medical conditions |
| Q38201099 | Sexual dysfunction among HIV patients: three case reports and review of literature |
| Q60466948 | Sexual dysfunction among HIV-positive gay males |
| Q82800219 | Sexual dysfunction among Jordanian men with diabetes |
| Q88443484 | Sexual dysfunction among Nigerian women with epilepsy |
| Q87152219 | Sexual dysfunction among Sri Lankan adults: effect of diabetes mellitus |
| Q46916019 | Sexual dysfunction among diabetics and its impact on the SQoL of their partners |
| Q34453958 | Sexual dysfunction among female patients of reproductive age in a hospital setting in Nigeria |
| Q50645347 | Sexual dysfunction among infertile Nigerian women. |
| Q39776600 | Sexual dysfunction among male patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence |
| Q44377781 | Sexual dysfunction among male veterans returning from Iraq and Afghanistan: prevalence and correlates. |
| Q33834874 | Sexual dysfunction among married couples living in Kumasi metropolis, Ghana |
| Q43852523 | Sexual dysfunction among men in secondary care in southern India: Nature, prevalence, clinical features and explanatory models |
| Q46294658 | Sexual dysfunction among middle aged women |
| Q70392837 | Sexual dysfunction among middle aged women |
| Q36895566 | Sexual dysfunction among middle aged women in the community |
| Q37374996 | Sexual dysfunction among older adults: prevalence and risk factors from a nationally representative U.S. probability sample of men and women 57-85 years of age. |
| Q44697023 | Sexual dysfunction among patients treated with antidepressants--a Hungarian retrospective study. |
| Q42214917 | Sexual dysfunction among patients with arthritis |
| Q40767376 | Sexual dysfunction among patients with psychiatric disorders |
| Q43706031 | Sexual dysfunction among postmenopausal women |
| Q41732370 | Sexual dysfunction among reproductive-aged Chinese married women in Hong Kong: prevalence, risk factors, and associated consequences |
| Q43755145 | Sexual dysfunction among secondary school teachers in Ilorin, Nigeria |
| Q50594773 | Sexual dysfunction among subjects with hypertension in a Nigerian teaching hospital. |
| Q74044970 | Sexual dysfunction among type II diabetic men: a controlled study |
| Q39948273 | Sexual dysfunction among women of low‐income status in an urban setting |
| Q40434555 | Sexual dysfunction among women with Schizophrenia-A cross sectional study from India |
| Q37199077 | Sexual dysfunction among women with diabetes mellitus in a diabetic center in Amol |
| Q64082732 | Sexual dysfunction among women with systemic lupus erythematosus: might it reflect cardiovascular disease burden? |
| Q51344084 | Sexual dysfunction among young married women in southern India. |
| Q36198284 | Sexual dysfunction among youth: an overlooked sexual health concern |
| Q67599706 | Sexual dysfunction amongst women with Crohn's disease: a hidden problem |
| Q52096274 | Sexual dysfunction and COPD: problems and management. |
| Q92723043 | Sexual dysfunction and Fertility Problems in Men with Inflammatory Bowel Disease |
| Q56942599 | Sexual dysfunction and HAART |
| Q56935900 | Sexual dysfunction and HAART--is there a connection? |
| Q56946811 | Sexual dysfunction and HIV infection |
| Q45404865 | Sexual dysfunction and Parkinson's disease: a need for further understanding |
| Q73037099 | Sexual dysfunction and antidepressants |
| Q91360513 | Sexual dysfunction and antidepressants: a review with emphasis on treatment |
| Q34530080 | Sexual dysfunction and antipsychotic treatment |
| Q51953032 | Sexual dysfunction and antipsychotics. |
| Q59252633 | Sexual dysfunction and anxiety in HIV-1-infected males in Eastern Sicily |
| Q40851717 | Sexual dysfunction and anxiety levels of type 2 male diabetics |
| Q37637373 | Sexual dysfunction and aromatase inhibitor use in survivors of breast cancer |
| Q90960674 | Sexual dysfunction and associated factors among patients with epilepsy at Amanuel Mental Specialty Hospital, Addis Ababa - Ethiopia |
| Q89236217 | Sexual dysfunction and associated factors in Chinese Han women with epilepsy |
| Q44252905 | Sexual dysfunction and associated psychitric disorders |
| Q51728037 | Sexual dysfunction and associated risk factors in women with end-stage renal disease. |
| Q42396662 | Sexual dysfunction and brain tumors: why address it? |
| Q36194182 | Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). |
| Q81637400 | Sexual dysfunction and cardiac risk (the second Princeton Concensus Conference) |
| Q73488978 | Sexual dysfunction and cardiovascular disease: a transatlantic consensus |
| Q36357698 | Sexual dysfunction and cardiovascular disease: integrative concepts and strategies |
| Q47859267 | Sexual dysfunction and central obesity in patients with first episode psychosis |
| Q36523569 | Sexual dysfunction and chronic illness: the role of flexibility in coping |
| Q70308723 | Sexual dysfunction and chronic obstructive pulmonary disease |
| Q81397620 | Sexual dysfunction and chronic pain: the role of psychological variables and impact on quality of life |
| Q42267364 | Sexual dysfunction and clomipramine |
| Q80977445 | Sexual dysfunction and coronary artery disease: what applies to the gander may apply to the goose |
| Q34251408 | Sexual dysfunction and depression |
| Q41165693 | Sexual dysfunction and depression among Turkish women with infertile husbands: the invisible part of the iceberg |
| Q48432055 | Sexual dysfunction and depression in premenopausal women with mucocutaneous Behçet's disease |
| Q34707312 | Sexual dysfunction and depression: etiology, prevalence, and treatment |
| Q35782658 | Sexual dysfunction and diabetes |
| Q69757482 | Sexual dysfunction and disorder patterns of husbands of working and nonworking women |
| Q52263422 | Sexual dysfunction and disorder patterns of working and nonworking wives. |
| Q39014560 | Sexual dysfunction and dissatisfaction in chronic hepatitis C patients |
| Q90699155 | Sexual dysfunction and distress in premenopausal women with migraine: association with depression, anxiety and migraine-related disability |
| Q51270211 | Sexual dysfunction and distress--development of a Polish version of the female sexual distress scale-revised. |
| Q41437597 | Sexual dysfunction and dual psychiatric diagnoses |
| Q39629711 | Sexual dysfunction and electroejaculation in men with spinal cord injury: review |
| Q95480226 | Sexual dysfunction and epilepsy: the reasons beyond medications |
| Q98215679 | Sexual dysfunction and fertility-related distress in young adults with cancer over 5 years following diagnosis: study protocol of the Fex-Can Cohort study |
| Q43541357 | Sexual dysfunction and fluvoxamine therapy |
| Q99557371 | Sexual dysfunction and health condition in Chinese doctor: prevalence and risk factors |
| Q46098990 | Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone |
| Q51375267 | Sexual dysfunction and hyperprolactinemia in Japanese schizophrenic patients taking antipsychotics. |
| Q39726164 | Sexual dysfunction and hyperprolactinemia in male psychotic inpatients: a cross-sectional study |
| Q91705204 | Sexual dysfunction and hyperprolactinemia in schizophrenia before and after six weeks of D2/3 receptor blockade - An exploratory study |
| Q70820050 | Sexual dysfunction and hysteria |
| Q34604454 | Sexual dysfunction and infertility as late effects of cancer treatment |
| Q59798045 | Sexual dysfunction and infertility in the male spina bifida patient |
| Q70731364 | Sexual dysfunction and interpersonal stress: the significance of the presenting complaint in seeking and engaging help |
| Q40303285 | Sexual dysfunction and its determinants among women infected with HIV. |
| Q47821145 | Sexual dysfunction and its determinants in Malaysian women with rheumatoid arthritis. |
| Q37192319 | Sexual dysfunction and its determinants in Moroccan women with rheumatoid arthritis. |
| Q100379197 | Sexual dysfunction and its determinants in women with rheumatoid arthritis |
| Q40101154 | Sexual dysfunction and its impact on quality of life in Chinese patients with schizophrenia treated in primary care |
| Q46878230 | Sexual dysfunction and its relation to heart disease |
| Q67327508 | Sexual dysfunction and its treatment |
| Q36144545 | Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). |
| Q88037105 | Sexual dysfunction and male infertility |
| Q37291138 | Sexual dysfunction and marital satisfaction among the chemically injured veterans |
| Q89471296 | Sexual dysfunction and mental health in patients with multiple sclerosis and epilepsy |
| Q40361931 | Sexual dysfunction and neuroendocrine correlates of posttraumatic stress disorder in combat veterans: Preliminary findings |
| Q44562253 | Sexual dysfunction and ocular timolol |
| Q56904746 | Sexual dysfunction and paraphilias in the DSM-5: Pathology, heterogeneity, and gender |
| Q37440866 | Sexual dysfunction and pelvic pain in men: a male sexual pain disorder? |
| Q91501615 | Sexual dysfunction and phobic anxiety in breast cancer survivors |
| Q51902782 | Sexual dysfunction and physicians' perception in medicated patients with major depression in Taiwan. |
| Q72530311 | Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients |
| Q33364297 | Sexual dysfunction and prostate cancer risk: one more piece of a complex puzzle |
| Q36628784 | Sexual dysfunction and prostatitis |
| Q52101959 | Sexual dysfunction and psychiatric morbidity in patients attending a clinic for sexually transmitted diseases. |
| Q72422744 | Sexual dysfunction and psycho-physiologic illness |
| Q67589958 | Sexual dysfunction and psychological distress in methadone maintenance |
| Q36548275 | Sexual dysfunction and psychotropic medications. |
| Q38086265 | Sexual dysfunction and quality of life in patients on maintenance dialysis |
| Q91660831 | Sexual dysfunction and related factors in pregnancy and postpartum: a systematic review and meta-analysis protocol |
| Q51778570 | Sexual dysfunction and related risk factors in a cohort of middle-aged Ecuadorian women. |
| Q88787131 | Sexual dysfunction and relationship stress: how does this association vary for men and women? |
| Q57158625 | Sexual dysfunction and reproductive concerns in young women with breast cancer: Type, prevalence, and predictors of problems |
| Q92523635 | Sexual dysfunction and satisfaction in obsessive compulsive disorder: protocol for a systematic review and meta-analysis |
| Q77355878 | Sexual dysfunction and selective serotonin reuptake inhibitors |
| Q47208738 | Sexual dysfunction and sex therapy: an historical perspective |
| Q35030411 | Sexual dysfunction and sexual quality of life among the physically challenged in the Kumasi metropolis, Ghana |
| Q67019415 | Sexual dysfunction and sexual satisfaction in 58 married Swedish men |
| Q37250994 | Sexual dysfunction and signs of gynecologic cancer |
| Q67016420 | Sexual dysfunction and somatic diseases in men |
| Q79358779 | Sexual dysfunction and sperm count--association? |
| Q35766182 | Sexual dysfunction and spousal communication in couples coping with prostate cancer |
| Q44311703 | Sexual dysfunction and sudden death in epileptic male EL mice: inheritance and prevention with the ketogenic diet |
| Q51747360 | Sexual dysfunction and sympathetic skin response recorded from the genital region in women with multiple sclerosis. |
| Q33817942 | Sexual dysfunction and symptom impact in men with long-standing type 1 diabetes in the DCCT/EDIC cohort |
| Q78871018 | Sexual dysfunction and tardiness in perineal wound healing after proctocolectomy for chronic ulcerative colitis |
| Q36766957 | Sexual dysfunction and the Mediterranean diet |
| Q37656616 | Sexual dysfunction and the ageing male |
| Q52918074 | Sexual dysfunction and the cardiac patient--no room for gender bias. |
| Q46216202 | Sexual dysfunction and the patient with burns. |
| Q70610306 | Sexual dysfunction and the patient with coronary heart disease |
| Q52618715 | Sexual dysfunction and the preservation of manhood: experiences of men with prostate cancer. |
| Q68031427 | Sexual dysfunction and the unemployed male professional |
| Q53922191 | Sexual dysfunction and topiramate: What does lie beneath the tip of the iceberg? |
| Q69935938 | Sexual dysfunction and treatment for early stage cervical cancer |
| Q40119213 | Sexual dysfunction and unprotected anal intercourse among men who have sex with men in two Chinese cities |
| Q78828670 | Sexual dysfunction as a complication of abdominoperineal resection of the rectum in the male: an anatomic and physiologic study |
| Q81934172 | Sexual dysfunction as a complication of treatment of gestational trophoblastic neoplasia |
| Q47572278 | Sexual dysfunction as a determinant of cardiovascular outcome in patients undergoing chronic hemodialysis |
| Q37193424 | Sexual dysfunction as a marker of cardiovascular disease in males with 50 or more years of type 1 diabetes |
| Q46942132 | Sexual dysfunction as a side effect of hyperprolactinemia in methadone maintenance therapy |
| Q72337361 | Sexual dysfunction as a suspected drug reaction reported to WHO Collaborating Centre for International Drug Monitoring |
| Q68328513 | Sexual dysfunction as a symptom of arteriosclerosis and a complication to reconstruction of the aorto-iliac segment |
| Q44637359 | Sexual dysfunction as an aftermath of sexual assault of men by women |
| Q41585559 | Sexual dysfunction as an obstacle to compliance with antihypertensive therapy. |
| Q51707201 | Sexual dysfunction as related to severity of fatigue in women with CFS. |
| Q84140404 | Sexual dysfunction as the last bastion of urological drug commercialisation within the pharmaceutical industry |
| Q48518294 | Sexual dysfunction assessment and hormonal correlations in patients with polycystic ovary syndrome |
| Q35873731 | Sexual dysfunction associated with antidepressant drugs |
| Q36993680 | Sexual dysfunction associated with antidepressant therapy |
| Q67378399 | Sexual dysfunction associated with chronic renal failure |
| Q39791300 | Sexual dysfunction associated with diabetes mellitus |
| Q42701341 | Sexual dysfunction associated with diazepam but not with clonazepam |
| Q71013701 | Sexual dysfunction associated with hyperprolactinemia in males and females undergoing hemodialysis |
| Q44250246 | Sexual dysfunction associated with infertility. A comparison of sexual function during the fertile and the non-fertile phase of the menstrual cycle |
| Q36731026 | Sexual dysfunction associated with intrathecal baclofen use: a report of two cases |
| Q30458935 | Sexual dysfunction associated with major depressive disorder and antidepressant treatment |
| Q69454792 | Sexual dysfunction associated with mesoridazine besylate (serentil) |
| Q74792550 | Sexual dysfunction associated with mirtazapine: a case report |
| Q45241996 | Sexual dysfunction associated with neuroleptic-induced hyperprolactinemia improves with reduction in prolactin levels |
| Q40343822 | Sexual dysfunction associated with oral antihypertensive medication: a critical survey of the literature |
| Q111623171 | Sexual dysfunction associated with outcrossing in Neurospora tetrasperma , a pseudohomothallic ascomycete |
| Q72793444 | Sexual dysfunction associated with physical disability: a treatment guide for the rehabilitation practitioner |
| Q39439384 | Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment |
| Q35066804 | Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis |
| Q61480070 | Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of olanzapine, risperidone, and quetiapine |
| Q72999582 | Sexual dysfunction associated with serotonin specific reuptake inhibitors |
| Q43892029 | Sexual dysfunction associated with the management of prostate cancer |
| Q28377591 | Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment |
| Q73646737 | Sexual dysfunction associated with treatment of cervical cancer |
| Q45126985 | Sexual dysfunction associated with urinary incontinence |
| Q48250943 | Sexual dysfunction at the onset of type 2 diabetes: the interplay of depression, hormonal and cardiovascular factors |
| Q73508047 | Sexual dysfunction before antidepressant therapy in major depression |
| Q43352554 | Sexual dysfunction caused by reboxetine |
| Q79896479 | Sexual dysfunction common among patients with refractory angina pectoris. Surprisingly many in this patient group are sexually active |
| Q46083065 | Sexual dysfunction common in long-term pain |
| Q87837363 | Sexual dysfunction common in people with coronary heart disease, but few cardiovascular changes actually occur during sexual activity |
| Q43816752 | Sexual dysfunction during antidepressant treatment. |
| Q45277209 | Sexual dysfunction during methadone maintenance treatment and its influence on patient's life and treatment: a qualitative study in South China |
| Q40292649 | Sexual dysfunction during primiparous and multiparous women following vaginal delivery |
| Q67660300 | Sexual dysfunction during rape |
| Q30384691 | Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial. |
| Q35755912 | Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR. |
| Q71449614 | Sexual dysfunction evaluated in sleep labs |
| Q90537273 | Sexual dysfunction factors in patients with schizophrenia treated with second generation antipsychotics: not only prolactin |
| Q71261202 | Sexual dysfunction following antidepressant drug therapy |
| Q52709621 | Sexual dysfunction following hysterectomy |
| Q71238341 | Sexual dysfunction following operation for carcinoma of the rectum |
| Q46673745 | Sexual dysfunction following proctocolectomy |
| Q71153286 | Sexual dysfunction following proctocolectomy and abdominoperineal resection |
| Q52503425 | Sexual dysfunction following proctocolectomy for benign disease of the colon and rectum. |
| Q68512496 | Sexual dysfunction following radical operation for cancer of the rectum and colon |
| Q38022556 | Sexual dysfunction following radical prostatectomy |
| Q72903556 | Sexual dysfunction following radical surgery for cancer of the rectum |
| Q41030828 | Sexual dysfunction following radiotherapy for cervical cancer |
| Q30234486 | Sexual dysfunction following rectal cancer surgery. |
| Q72875111 | Sexual dysfunction following rectal excision for ulcerative colitis |
| Q73873600 | Sexual dysfunction following stroke |
| Q37379861 | Sexual dysfunction following surgery for rectal cancer - a clinical and neurophysiological study |
| Q51186970 | Sexual dysfunction following traumatic hand injury. |
| Q54298432 | Sexual dysfunction following treatment for prostate cancer: nursing assessment and interventions. |
| Q53525524 | Sexual dysfunction following vulvectomy. |
| Q35092742 | Sexual dysfunction improved in heroin-dependent men after methadone maintenance treatment in Tianjin, China |
| Q34200663 | Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms |
| Q42677677 | Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors |
| Q37974503 | Sexual dysfunction in 2011: advances in epidemiology, pathophysiology and treatment |
| Q30398989 | Sexual dysfunction in 2013: Advances in epidemiology, diagnosis and treatment |
| Q38315945 | Sexual dysfunction in 2014: Men enjoy a year of significant progress |
| Q87054402 | Sexual dysfunction in 2015: Recovering sex drive in women - progress and opportunities |
| Q39434775 | Sexual dysfunction in African males in Nairobi, Kenya |
| Q73344437 | Sexual dysfunction in America |
| Q34282864 | Sexual dysfunction in Asian couples |
| Q70275491 | Sexual dysfunction in Asian couples |
| Q70279848 | Sexual dysfunction in Asian couples |
| Q70283369 | Sexual dysfunction in Asian couples |
| Q93721870 | Sexual dysfunction in Asian couples |
| Q34420481 | Sexual dysfunction in Assyrian/Syrian immigrants and Swedish-born persons with type 2 diabetes |
| Q90600142 | Sexual dysfunction in Behçet's syndrome |
| Q47195304 | Sexual dysfunction in China. |
| Q47746269 | Sexual dysfunction in Chinese patients with first-episode psychosis: prevalence, clinical correlates and functioning. |
| Q91835054 | Sexual dysfunction in Chinese rural patients with schizophrenia |
| Q96812324 | Sexual dysfunction in Egyptian females with systemic lupus erythematosus: a cross sectional study |
| Q61496460 | Sexual dysfunction in HIV infection |
| Q46895925 | Sexual dysfunction in HIV-infected men: role of antiretroviral therapy, hypogonadism and lipodystrophy. |
| Q44221269 | Sexual dysfunction in HIV-infected patients treated with highly active antiretroviral therapy |
| Q73011687 | Sexual dysfunction in HIV-positive individuals |
| Q36939372 | Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors. |
| Q91528812 | Sexual dysfunction in Huntington's Disease - a systematic review |
| Q98879711 | Sexual dysfunction in Huntington's Disease: what do we really know? |
| Q34058663 | Sexual dysfunction in India |
| Q98295097 | Sexual dysfunction in Indian men undergoing Double J ureteral stenting following ureteroscopy-A prospective analysis |
| Q43232816 | Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics |
| Q36807524 | Sexual dysfunction in Jordanian diabetic women |
| Q48789438 | Sexual dysfunction in Klinefelter's syndrome patients. |
| Q94490018 | Sexual dysfunction in Neuro-Behcet's disease |
| Q64905151 | Sexual dysfunction in Neurological disorders: do we see just the tip of the iceberg? |
| Q37299051 | Sexual dysfunction in Nigerian stroke survivors. |
| Q68649674 | Sexual dysfunction in Parkinson's disease |
| Q80810870 | Sexual dysfunction in Parkinson's disease |
| Q33901088 | Sexual dysfunction in Parkinson's disease. |
| Q71927175 | Sexual dysfunction in Peyronie's disease: an analysis of 222 patients without previous local plaque therapy |
| Q88074431 | Sexual dysfunction in Saudi depressed male patients |
| Q58782493 | Sexual dysfunction in Spanish women with breast cancer |
| Q79969468 | Sexual dysfunction in Thai women with early-stage cervical cancer after radical hysterectomy |
| Q48108730 | Sexual dysfunction in Turkish women with dyspareunia and its impact on the quality of life |
| Q69017756 | Sexual dysfunction in a patient treated with etretinate |
| Q51778771 | Sexual dysfunction in abusers of cocaine and alcohol. |
| Q39483085 | Sexual dysfunction in adolescents. |
| Q53669921 | Sexual dysfunction in advanced HIV disease. |
| Q53203088 | Sexual dysfunction in aging men with lower urinary tract symptoms. |
| Q42867316 | Sexual dysfunction in alcohol-dependent men on disulfiram or baclofen prophylaxis: A preliminary report |
| Q44219125 | Sexual dysfunction in alcoholic cirrhotic men. Copenhagen Study Group for Liver Diseases |
| Q34115879 | Sexual dysfunction in an Internet sample of U.S. men who have sex with men. |
| Q34201271 | Sexual dysfunction in an adult female with obsessive sexual thoughts: a case report |
| Q47704720 | Sexual dysfunction in arterial hypertension women: The role of depression and anxiety |
| Q81125357 | Sexual dysfunction in breast cancer survivors |
| Q35756848 | Sexual dysfunction in cancer patients |
| Q38171780 | Sexual dysfunction in cancer patients: a review |
| Q81936896 | Sexual dysfunction in cardiac rehabilitation patients is much more than simply an epiphenomenon and needs more study |
| Q61910624 | Sexual dysfunction in cardiovascular disease |
| Q59135455 | Sexual dysfunction in cervical dystonia and blepharospasm |
| Q45391194 | Sexual dysfunction in chronic hepatitis C virus patients treated with interferon alpha and ribavirin |
| Q37750452 | Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure? |
| Q44352294 | Sexual dysfunction in chronic painful radicular syndrome and the ways of its correction |
| Q38098400 | Sexual dysfunction in chronic prostatitis/chronic pelvic pain syndrome |
| Q44161023 | Sexual dysfunction in chronic renal failure |
| Q71525266 | Sexual dysfunction in chronic renal failure |
| Q45371080 | Sexual dysfunction in clinically stable patients with bipolar disorder receiving lithium |
| Q44656544 | Sexual dysfunction in college men and women |
| Q67417968 | Sexual dysfunction in college sexuality course attenders and course treatment benefits: a preliminary report |
| Q45333956 | Sexual dysfunction in combat veterans with post-traumatic stress disorder |
| Q88073785 | Sexual dysfunction in depressed patients undergoing treatment with antidepressants |
| Q34982497 | Sexual dysfunction in depression |
| Q37562068 | Sexual dysfunction in depression and anxiety: conceptualizing sexual dysfunction as part of an internalizing dimension. |
| Q74578627 | Sexual dysfunction in depression: disease- or drug-related? |
| Q37403752 | Sexual dysfunction in dermatological diseases |
| Q38269647 | Sexual dysfunction in diabetes |
| Q47669545 | Sexual dysfunction in diabetes - a taboo not limited to men. |
| Q71256642 | Sexual dysfunction in diabetes mellitus |
| Q70036203 | Sexual dysfunction in diabetes. A survey of physicians' responses to patients' problems |
| Q66946007 | Sexual dysfunction in diabetic men |
| Q67016422 | Sexual dysfunction in diabetic men |
| Q44102868 | Sexual dysfunction in diabetic women |
| Q37946041 | Sexual dysfunction in diabetic women. |
| Q35100884 | Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus |
| Q53206381 | Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: results from the DOPPS. |
| Q36511587 | Sexual dysfunction in dialysis patients: does vitamin D deficiency have a role? |
| Q38141133 | Sexual dysfunction in elderly men. |
| Q38141134 | Sexual dysfunction in elderly women. |
| Q37548898 | Sexual dysfunction in epilepsy |
| Q51080205 | Sexual dysfunction in epilepsy: identifying the psychological variables. |
| Q51900432 | Sexual dysfunction in epileptic men. |
| Q36440964 | Sexual dysfunction in essential hypertension: myth or reality? |
| Q67970276 | Sexual dysfunction in female adult children of alcoholics |
| Q38014216 | Sexual dysfunction in female cancer survivors |
| Q91577037 | Sexual dysfunction in female cancer survivors: A narrative review |
| Q43840630 | Sexual dysfunction in female hemodialysis patients: a multicenter study |
| Q43488664 | Sexual dysfunction in female hypertensives |
| Q51823023 | Sexual dysfunction in female partners of men who have undergone radical prostatectomy correlates with sexual dysfunction of the male partner. |
| Q73172820 | Sexual dysfunction in female patients with alcoholics |
| Q70668400 | Sexual dysfunction in female patients with multiple sclerosis |
| Q51825927 | Sexual dysfunction in female patients with panic disorder alone or with accompanying depression. |
| Q33810091 | Sexual dysfunction in female patients with relapsing-remitting multiple sclerosis |
| Q39101078 | Sexual dysfunction in female patients with type 2 diabetes mellitus: a cross-sectional single-centre study among Turkish patients |
| Q93270519 | Sexual dysfunction in female subjects with beta-thalassemia minor |
| Q53290474 | Sexual dysfunction in female subjects with fibromyalgia. |
| Q37804825 | Sexual dysfunction in females treated with peripheral blood progenitor cell transplantation: review of literature |
| Q47701362 | Sexual dysfunction in females with depression: a cross-sectional study |
| Q48275567 | Sexual dysfunction in females with multiple sclerosis: quantitative sensory testing |
| Q50776570 | Sexual dysfunction in fibromyalgia patients. |
| Q58257296 | Sexual dysfunction in gay and bisexual men with HIV infection: Evaluation, treatment and implications |
| Q44736144 | Sexual dysfunction in gay men requesting treatment |
| Q73570236 | Sexual dysfunction in genitourinary medicine clinics |
| Q38209723 | Sexual dysfunction in heart failure patients |
| Q39654453 | Sexual dysfunction in hypertensive men. A critical review of the literature |
| Q33947933 | Sexual dysfunction in hypertensive patients treated with losartan |
| Q51110057 | Sexual dysfunction in infertile Turkish females: prevalence and risk factors. |
| Q50708960 | Sexual dysfunction in infertile couples: evaluation and treatment of infertility. |
| Q36906929 | Sexual dysfunction in infertile women |
| Q38719096 | Sexual dysfunction in infertile women: A systematic review and meta-analysis |
| Q38287553 | Sexual dysfunction in inflammatory bowel disease |
| Q86958552 | Sexual dysfunction in inflammatory bowel disease: "don't ask, don't tell" doesn't work |
| Q69585260 | Sexual dysfunction in insulin-treated diabetics: a six-year follow-up study of 101 patients |
| Q36977968 | Sexual dysfunction in intensive care survivors |
| Q36548270 | Sexual dysfunction in major depression. |
| Q33844156 | Sexual dysfunction in male Iraq and Afghanistan war veterans: association with posttraumatic stress disorder and other combat-related mental health disorders: a population-based cohort study |
| Q51870033 | Sexual dysfunction in male Operation Enduring Freedom/Operation Iraqi Freedom patients with severe post-traumatic stress disorder. |
| Q69113195 | Sexual dysfunction in male alcohol addicts: prevalence and treatment |
| Q44107820 | Sexual dysfunction in male and female patients with epilepsy: a study of 86 outpatients |
| Q39510693 | Sexual dysfunction in male crystalline heroin dependents before and after MMT: a pilot study |
| Q92212777 | Sexual dysfunction in male individuals with spinal cord iniury: What do we know so far? |
| Q78695991 | Sexual dysfunction in male patients on hemodialysis: assessment with the International Index of Erectile Function (IIEF) |
| Q81559186 | Sexual dysfunction in male patients taking antipsychotics |
| Q46798483 | Sexual dysfunction in male patients undergoing hemodialysis in morocco. |
| Q90331076 | Sexual dysfunction in male patients with Parkinson's disease: related factors and impact on quality of life |
| Q36093267 | Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs |
| Q38161951 | Sexual dysfunction in male patients with multiple sclerosis: a need for counseling! |
| Q40739680 | Sexual dysfunction in male posttraumatic stress disorder patients |
| Q51966043 | Sexual dysfunction in male psychiatric outpatients: validity of the Massachusetts General Hospital Sexual Functioning Questionnaire. |
| Q50794596 | Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes. |
| Q54011918 | Sexual dysfunction in male schizophrenic patients. |
| Q53221198 | Sexual dysfunction in male stroke patients: correlation between brain lesions and sexual function. |
| Q36182687 | Sexual dysfunction in male subjects receiving trifluoperazine, risperidone, or olanzapine: rates vary with assessment questionnaire |
| Q70667502 | Sexual dysfunction in males following extensive colorectal surgery |
| Q40799455 | Sexual dysfunction in males following low anterior resection |
| Q46450326 | Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: interferon-induced functional androgen deficiency or depression? |
| Q35564336 | Sexual dysfunction in males with hepatitis C virus: relevance to histopathologic changes and peginterferon treatment |
| Q36296709 | Sexual dysfunction in males with systolic heart failure and associated factors |
| Q71673329 | Sexual dysfunction in males: significance of adverse childhood experiences |
| Q41811486 | Sexual dysfunction in married female patients with anorexia and bulimia nervosa |
| Q34587257 | Sexual dysfunction in married women with Systemic Sclerosis |
| Q38820470 | Sexual dysfunction in medical practice |
| Q92936407 | Sexual dysfunction in men after high energy pelvic fractures: Narrative review of targeted literature |
| Q35977572 | Sexual dysfunction in men after open or endovascular repair of abdominal aortic aneurysms |
| Q30703497 | Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial |
| Q48062099 | Sexual dysfunction in men and women on peritoneal dialysis: Differential link with metabolic factors and quality of life perception |
| Q35077668 | Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease |
| Q36738767 | Sexual dysfunction in men and women with endocrine disorders |
| Q39950157 | Sexual dysfunction in men diagnosed as substance use disorder |
| Q44651959 | Sexual dysfunction in men following surgical treatment for rectosigmoid carcinoma |
| Q89455831 | Sexual dysfunction in men on buprenorphine - naloxone-based substitution therapy |
| Q33595310 | Sexual dysfunction in men on chronic hemodialysis: a rehabilitation nursing concern |
| Q43587642 | Sexual dysfunction in men seeking treatment for opioid dependence: a study from India |
| Q48033137 | Sexual dysfunction in men suffering from genital warts |
| Q92580750 | Sexual dysfunction in men taking systemic dermatologic medication: A systematic review |
| Q46848936 | Sexual dysfunction in men treated with depot antipsychotic drugs: a pilot study |
| Q47910657 | Sexual dysfunction in men undergoing infertility evaluation: a cohort observational study |
| Q43809925 | Sexual dysfunction in men who abuse illicit drugs: a preliminary report |
| Q48421412 | Sexual dysfunction in men with COPD: impact on quality of life and survival |
| Q57389826 | Sexual dysfunction in men with alcoholic liver cirrhosis. A comparative study |
| Q46299516 | Sexual dysfunction in men with chronic liver disease |
| Q28261883 | Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training |
| Q41438011 | Sexual dysfunction in men with depressive disorders |
| Q44266612 | Sexual dysfunction in men with lower urinary tract symptoms |
| Q73465885 | Sexual dysfunction in men with lower urinary tract symptoms and benign prostatic hyperplasia: an emerging link |
| Q79293009 | Sexual dysfunction in men with lower urinary tract symptoms and benign prostatic hyperplasia: an emerging link |
| Q48774677 | Sexual dysfunction in men with multiple sclerosis--a comprehensive pilot-study into etiology |
| Q34023476 | Sexual dysfunction in men with paraparesis in lumbar burst fractures |
| Q79910883 | Sexual dysfunction in men with prostate cancer: psychosocial issues |
| Q44727231 | Sexual dysfunction in men with spinal cord injury: a case-control study. |
| Q37979188 | Sexual dysfunction in men with type 2 diabetes |
| Q98893502 | Sexual dysfunction in men with type II diabetes |
| Q50523410 | Sexual dysfunction in men. |
| Q78737323 | Sexual dysfunction in middle-aged couples: an andrological approach in relation to hormone replacement therapy of the partners |
| Q43691649 | Sexual dysfunction in middle-aged women: a multicenter Latin American study using the Female Sexual Function Index |
| Q84684676 | Sexual dysfunction in multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board |
| Q37409488 | Sexual dysfunction in multiple sclerosis |
| Q43692476 | Sexual dysfunction in multiple sclerosis |
| Q71289599 | Sexual dysfunction in multiple sclerosis |
| Q41347064 | Sexual dysfunction in multiple sclerosis: A 6-year follow-up study |
| Q51083797 | Sexual dysfunction in multiple sclerosis: II. Correlation analysis. |
| Q74147037 | Sexual dysfunction in multiple sclerosis: a 2-year follow-up study |
| Q48316334 | Sexual dysfunction in multiple sclerosis: a MRI, neurophysiological and urodynamic study |
| Q44721521 | Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups |
| Q48118674 | Sexual dysfunction in multiple sclerosis: still a neglected problem? |
| Q34649340 | Sexual dysfunction in neurologic disease |
| Q51688085 | Sexual dysfunction in newly diagnosed multiple sclerosis women. |
| Q41509880 | Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy |
| Q43059188 | Sexual dysfunction in obese and overweight women |
| Q38934115 | Sexual dysfunction in obese women is more affected by psychological domains than that of non-obese. |
| Q48196307 | Sexual dysfunction in obese women: does obstructive sleep apnea play a role? |
| Q51298163 | Sexual dysfunction in obsessive compulsive disorder and panic disorder. |
| Q41735958 | Sexual dysfunction in older adults. |
| Q35029078 | Sexual dysfunction in outpatients with schizophrenia in Turkey: a cross-sectional study |
| Q39406959 | Sexual dysfunction in partial epilepsy: a deficit in physiologic sexual arousal |
| Q53136667 | Sexual dysfunction in partners of men with premature ejaculation. |
| Q28207986 | Sexual dysfunction in patients taking conventional antipsychotic medication |
| Q46228053 | Sexual dysfunction in patients treated with atypical antipsychotics. |
| Q53254243 | Sexual dysfunction in patients under dialytic treatment. |
| Q50003110 | Sexual dysfunction in patients with IBD is not just a matter of quality of life. |
| Q34363679 | Sexual dysfunction in patients with alcohol and opioid dependence |
| Q46885471 | Sexual dysfunction in patients with allergic rhinoconjunctivitis |
| Q82211162 | Sexual dysfunction in patients with allergic rhinoconjunctivitis |
| Q33868455 | Sexual dysfunction in patients with benign prostatic hyperplasia |
| Q51757466 | Sexual dysfunction in patients with chronic hand eczema in the Turkish population. |
| Q38270957 | Sexual dysfunction in patients with chronic renal disease: does it improve with renal transplantation? |
| Q79199862 | Sexual dysfunction in patients with chronic renal failure |
| Q77157398 | Sexual dysfunction in patients with diabetes |
| Q38499763 | Sexual dysfunction in patients with epilepsy |
| Q88215155 | Sexual dysfunction in patients with epilepsy: Disentangling the pathogenic mechanisms! |
| Q36548280 | Sexual dysfunction in patients with epilepsy: communication strategies and assessment tools |
| Q37634657 | Sexual dysfunction in patients with fibromyalgia |
| Q51799870 | Sexual dysfunction in patients with gynecologic neoplasms: a retrospective pilot study. |
| Q35013788 | Sexual dysfunction in patients with hypertension: implications for therapy |
| Q40869578 | Sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia |
| Q87402286 | Sexual dysfunction in patients with lung disease |
| Q38499751 | Sexual dysfunction in patients with multiple sclerosis |
| Q41068173 | Sexual dysfunction in patients with multiple sclerosis |
| Q37386942 | Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management |
| Q91281734 | Sexual dysfunction in patients with neuromyelitis optica spectrum disorder |
| Q48461775 | Sexual dysfunction in patients with neuropsychiatric disorders: Challenges and opportunities. |
| Q44494313 | Sexual dysfunction in patients with painful bladder syndrome |
| Q44940542 | Sexual dysfunction in patients with painful bladder syndrome is age related and progressive. |
| Q38499701 | Sexual dysfunction in patients with peripheral nervous system lesions |
| Q34519491 | Sexual dysfunction in patients with polycystic ovary syndrome and its affected domains |
| Q83068187 | Sexual dysfunction in patients with polycystic ovary syndrome: clinical and hormonal correlations |
| Q38065947 | Sexual dysfunction in patients with psoriasis and psoriatic arthritis--a systematic review. |
| Q51778468 | Sexual dysfunction in patients with psoriasis. |
| Q92307185 | Sexual dysfunction in patients with schizophrenia and schizoaffective disorder and its association with adherence to antipsychotic medication |
| Q79895649 | Sexual dysfunction in patients with schizophrenia on antipsychotic medication |
| Q37224571 | Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone |
| Q34477605 | Sexual dysfunction in patients with spinal cord lesions |
| Q68454329 | Sexual dysfunction in patients with stomas, and their counseling |
| Q90430395 | Sexual dysfunction in patients with systemic sclerosis |
| Q90438813 | Sexual dysfunction in people with epilepsy |
| Q50730294 | Sexual dysfunction in people with long-term neurological conditions. |
| Q53371744 | Sexual dysfunction in people with prodromal or first-episode psychosis. |
| Q90675485 | Sexual dysfunction in perimenopausal women based on a national epidemiological survey in China |
| Q37582543 | Sexual dysfunction in perimenopause a review |
| Q51463552 | Sexual dysfunction in peritoneal dialysis patients. |
| Q68177418 | Sexual dysfunction in perspectives: an introduction |
| Q95937326 | Sexual dysfunction in polycystic ovary syndrome: a systematic review and meta-analysis |
| Q70221089 | Sexual dysfunction in postmenopausal women: the role of medical management |
| Q39418407 | Sexual dysfunction in pre-menopausal diabetic women: clinical, metabolic, psychological, cardiovascular, and neurophysiologic correlates. |
| Q47893044 | Sexual dysfunction in premenopausal women could be related to hormonal profile |
| Q44465334 | Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner |
| Q38271359 | Sexual dysfunction in psoriasis: a systematic review. |
| Q51742206 | Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication. |
| Q33921773 | Sexual dysfunction in relapsing-remitting multiple sclerosis: magnetic resonance imaging, clinical, and psychological correlates |
| Q67393038 | Sexual dysfunction in renal failure: a survey of chronic hemodialysis patients |
| Q44189689 | Sexual dysfunction in rheumatoid arthritis patients: arthritis and beyond. |
| Q82428522 | Sexual dysfunction in rheumatoid arthritis: a hot but sensitive issue |
| Q36728409 | Sexual dysfunction in schizophrenia |
| Q34761446 | Sexual dysfunction in schizophrenia: focus on recent evidence |
| Q46498342 | Sexual dysfunction in schizophrenics patients, the role of antipsychotics |
| Q35692500 | Sexual dysfunction in selected neurologic disorders: hypothalamopituitary disorders, epilepsy, myelopathies, polyneuropathies, and sacral nerve lesions |
| Q89329474 | Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review |
| Q47394433 | Sexual dysfunction in single males: A perspective from India |
| Q69993503 | Sexual dysfunction in stroke patients |
| Q77754300 | Sexual dysfunction in stroke patients |
| Q38814349 | Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis |
| Q43271388 | Sexual dysfunction in subjects with Klinefelter's syndrome |
| Q49998994 | Sexual dysfunction in systemic lupus erythematosus patients |
| Q48147284 | Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders |
| Q79337597 | Sexual dysfunction in the Australian population |
| Q69320582 | Sexual dysfunction in the COPD patient |
| Q54402143 | Sexual dysfunction in the United States. |
| Q33852255 | Sexual dysfunction in the United States: prevalence and predictors |
| Q39517041 | Sexual dysfunction in the diabetes female: a review |
| Q48808313 | Sexual dysfunction in the diabetic BB/WOR rat: a role of central neuropathy |
| Q77463107 | Sexual dysfunction in the diabetic patient |
| Q39646761 | Sexual dysfunction in the diabetic patient with hypertension |
| Q46120105 | Sexual dysfunction in the elderly male |
| Q68415676 | Sexual dysfunction in the elderly male |
| Q73187208 | Sexual dysfunction in the elderly patient |
| Q36359858 | Sexual dysfunction in the elderly: age or disease? |
| Q50537207 | Sexual dysfunction in the female ESRD patient. 1. (continuing education credit). |
| Q39828213 | Sexual dysfunction in the gynecologic oncology patient |
| Q37064897 | Sexual dysfunction in the highly active antiretroviral therapy era. |
| Q39744787 | Sexual dysfunction in the male dialysis patient: pathogenesis, evaluation, and therapy |
| Q50532730 | Sexual dysfunction in the male end stage renal disease patient |
| Q70769426 | Sexual dysfunction in the male patient with uremia: A reappraisal |
| Q40164501 | Sexual dysfunction in the medically ill |
| Q36830351 | Sexual dysfunction in the medically ill. |
| Q41220967 | Sexual dysfunction in the menopausal woman: hormonal causes and management issues |
| Q46942630 | Sexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects |
| Q35852777 | Sexual dysfunction in the older woman: an overview of the current understanding and management |
| Q81041447 | Sexual dysfunction in the older woman: complex medical, psychiatric illnesses should be considered in evaluation and management |
| Q36277102 | Sexual dysfunction in the patient with prostatitis |
| Q80162794 | Sexual dysfunction in the patient with prostatitis |
| Q36648186 | Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication. |
| Q97536166 | Sexual dysfunction in the postpartum period: Its relationship with postpartum depression and certain other factors |
| Q90369884 | Sexual dysfunction in tramadol hydrochloride use disorder male patients: a case-control study |
| Q50963410 | Sexual dysfunction in treated breast cancer patients. |
| Q77777505 | Sexual dysfunction in type II diabetic females: a comparative study |
| Q84641383 | Sexual dysfunction in type III chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) observed in Turkish patients |
| Q37760602 | Sexual dysfunction in uraemic patients undergoing haemodialysis: predisposing and related conditions. |
| Q67488574 | Sexual dysfunction in uremia |
| Q33653855 | Sexual dysfunction in uremia. |
| Q37925694 | Sexual dysfunction in uremia. Endocrine and neurological alterations |
| Q70474828 | Sexual dysfunction in uremic male: improvement following oral zinc supplementation |
| Q38349270 | Sexual dysfunction in veterans with post-traumatic stress disorder |
| Q69281203 | Sexual dysfunction in women |
| Q51261304 | Sexual dysfunction in women after low anterior resection. |
| Q45922064 | Sexual dysfunction in women during dialysis and after renal transplantation. |
| Q52520530 | Sexual dysfunction in women following pelvic fractures with sacro-iliac disruption. |
| Q61944699 | Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer |
| Q47777003 | Sexual dysfunction in women post stroke: The hidden morbidity |
| Q42265575 | Sexual dysfunction in women using major tranquilizers |
| Q43623772 | Sexual dysfunction in women who were molested as children: One response pattern and suggestions for treatment |
| Q42560770 | Sexual dysfunction in women with Crohn's disease |
| Q35995054 | Sexual dysfunction in women with ESRD requiring hemodialysis |
| Q42537571 | Sexual dysfunction in women with HIV. |
| Q39512578 | Sexual dysfunction in women with Parkinson's disease |
| Q92634626 | Sexual dysfunction in women with a history of childhood sexual abuse: The role of sexual shame |
| Q47674261 | Sexual dysfunction in women with alcohol dependence syndrome: A study from India |
| Q38134942 | Sexual dysfunction in women with cancer |
| Q38661411 | Sexual dysfunction in women with cancer: a systematic review with meta-analysis of studies using the Female Sexual Function Index. |
| Q37689465 | Sexual dysfunction in women with cardiovascular disease: what do we know? |
| Q43088935 | Sexual dysfunction in women with clinical hypothyroidism and subclinical hypothyroidism |
| Q36326495 | Sexual dysfunction in women with diabetes mellitus |
| Q83970162 | Sexual dysfunction in women with diabetes mellitus |
| Q34206413 | Sexual dysfunction in women with diabetic kidney |
| Q36216811 | Sexual dysfunction in women with epilepsy |
| Q80421958 | Sexual dysfunction in women with epilepsy |
| Q37301536 | Sexual dysfunction in women with epilepsy: role of antiepileptic drugs and psychotropic medications |
| Q92267388 | Sexual dysfunction in women with human papilloma virus infection in the Turkish population |
| Q46746083 | Sexual dysfunction in women with hyperprolactinemia: a pilot study report |
| Q100750704 | Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: A case-control study |
| Q48202808 | Sexual dysfunction in women with ketamine cystitis: a case-control study. |
| Q47997428 | Sexual dysfunction in women with migraine and tension-type headaches. |
| Q84198182 | Sexual dysfunction in women with migraine versus tension-type headaches: a comparative study |
| Q33771372 | Sexual dysfunction in women with multiple sclerosis: Dimensions and contributory factors |
| Q89835822 | Sexual dysfunction in women with multiple sclerosis: prevalence and impact on quality of life |
| Q44885079 | Sexual dysfunction in women with obstructive sleep apnea |
| Q42744988 | Sexual dysfunction in women with overactive bladder and their correction with m-cholinolytic spasmex |
| Q35948945 | Sexual dysfunction in women with premature menopause |
| Q46784436 | Sexual dysfunction in women with rheumatoid arthritis |
| Q81448701 | Sexual dysfunction in women with the metabolic syndrome |
| Q74508334 | Sexual dysfunction in women with type 1 diabetes: a controlled study |
| Q53444246 | Sexual dysfunction in women with type 1 diabetes: a controlled study. |
| Q37163654 | Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/ EDIC study cohort |
| Q82362309 | Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/EDIC study cohort: response to Enzlin et al |
| Q35604176 | Sexual dysfunction in women with type 2 diabetes mellitus |
| Q36520138 | Sexual dysfunction in women. |
| Q39322178 | Sexual dysfunction in women: Can we talk about it? |
| Q39114976 | Sexual dysfunction in women: population based epidemiological study |
| Q37306881 | Sexual dysfunction in women: what can urologists contribute? |
| Q45891828 | Sexual dysfunction in young women with breast cancer |
| Q93659521 | Sexual dysfunction in younger insulin-treated diabetic females. A comparative study |
| Q42866377 | Sexual dysfunction induced by antidepressants |
| Q39195939 | Sexual dysfunction induced by intrathecal baclofen administration: is this the price to pay for severe spasticity management? |
| Q87189649 | Sexual dysfunction induced by lacosamide: An underreported side effect? |
| Q42544336 | Sexual dysfunction induced by serotonin reuptake antidepressants |
| Q41547487 | Sexual dysfunction is associated with postural instability gait difficulty subtype of Parkinson's disease |
| Q45326095 | Sexual dysfunction is associated with suicidal ideation in female service members and veterans |
| Q77860305 | Sexual dysfunction is common and overlooked in female patients with hypertension |
| Q79077221 | Sexual dysfunction is common and overlooked in female patients with hypertension |
| Q44300685 | Sexual dysfunction is common in the morbidly obese male and improves after gastric bypass surgery |
| Q79920276 | Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study |
| Q43788711 | Sexual dysfunction is correlated with tenderness in female fibromyalgia patients |
| Q43661783 | Sexual dysfunction is frequent in premenopausal women with diabetes, obesity, and hypothyroidism, and correlates with markers of increased cardiovascular risk. A preliminary report |
| Q45415714 | Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life |
| Q48166511 | Sexual dysfunction is more than twice as frequent in Danish female predialysis patients compared to age- and gender-matched healthy controls |
| Q101166490 | Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress |
| Q38914384 | Sexual dysfunction levels in iranian women suffering from multiple sclerosis |
| Q86831761 | Sexual dysfunction of male, after pelvic fracture |
| Q48234927 | Sexual dysfunction of persons after traumatic brain injury: perceptions of professionals |
| Q70492153 | Sexual dysfunction of the male with diabetes mellitus |
| Q73495143 | Sexual dysfunction on fluvoxamine therapy |
| Q81039295 | Sexual dysfunction or pain disorder?: dyspareunia from the perspective of the harmful dysfunction analysis |
| Q45923636 | Sexual dysfunction predicts depression among women on hemodialysis. |
| Q50066994 | Sexual dysfunction predicts depressive symptoms during the first 2 years postpartum |
| Q55124366 | Sexual dysfunction prevalence in a group of pre- and postmenopausal Mexican women. |
| Q53125945 | Sexual dysfunction prevalence rates: marketing or real? |
| Q52291563 | Sexual dysfunction prior to first drug use among former drug addicts and its possible causal meaning on drug addiction: preliminary results. |
| Q47629702 | Sexual dysfunction prior to high-dose chemotherapy and bone marrow transplantation. |
| Q42661334 | Sexual dysfunction related to alprazolam treatment of social phobia |
| Q38631074 | Sexual dysfunction related to antiepileptic drugs in patients with epilepsy. |
| Q28377397 | Sexual dysfunction related to antihypertensive agents: results from the animal model |
| Q35432458 | Sexual dysfunction related to drugs: a critical review. Part IV: cardiovascular drugs. |
| Q38112069 | Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics |
| Q38112070 | Sexual dysfunction related to psychotropic drugs: a critical review--part I: antidepressants. |
| Q35039846 | Sexual dysfunction related to psychotropic drugs: a critical review. Part III: mood stabilizers and anxiolytic drugs |
| Q82103891 | Sexual dysfunction related to the treatment of young women with breast cancer |
| Q70058595 | Sexual dysfunction resulting from drug side effects |
| Q47307397 | Sexual dysfunction risk and associated factors in young Peruvian university women. |
| Q39650601 | Sexual dysfunction risk and quality of life among women with a history of sexual abuse |
| Q52140347 | Sexual dysfunction secondary to Mellaril. |
| Q36848953 | Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients |
| Q51807073 | Sexual dysfunction secondary to cocaine abuse in two patients. |
| Q34185660 | Sexual dysfunction secondary to depressive disorders. |
| Q43856637 | Sexual dysfunction secondary to gemfibrozil |
| Q70114982 | Sexual dysfunction secondary to topical ophthalmic timolol |
| Q50646196 | Sexual dysfunction service provision in UK genitourinary medicine clinics in 2007. |
| Q40144728 | Sexual dysfunction symptoms in men age 40 or older: prevalence and associated factors. |
| Q82966028 | Sexual dysfunction treatment in a patient with müllerian agenesy submitted to neovaginoplasty: a case report |
| Q69047381 | Sexual dysfunction vaginal exercises and clitoral adhesions |
| Q73865957 | Sexual dysfunction with PIs |
| Q39646752 | Sexual dysfunction with aging and systemic hypertension |
| Q33178569 | Sexual dysfunction with antidepressive agents. Effect of the change to amineptine in patients with sexual dysfunction secondary to SSRI |
| Q34558857 | Sexual dysfunction with antihypertensive and antipsychotic agents |
| Q40735206 | Sexual dysfunction with antihypertensive drugs |
| Q77810672 | Sexual dysfunction with protease inhibitors |
| Q78165592 | Sexual dysfunction with protease inhibitors |
| Q35593993 | Sexual dysfunction with psychotropic drugs |
| Q35079833 | Sexual dysfunction with the use of antidepressants in a tertiary care mental health setting - a retrospective case series |
| Q52262969 | Sexual dysfunction within an adult developmental perspective. |
| Q46126397 | Sexual dysfunction ın multiple sclerosis: gender differences |
| Q35006836 | Sexual dysfunction, HIV, and AIDS in men who have sex with men |
| Q35993671 | Sexual dysfunction, Part I: Classification, etiology, and pathogenesis |
| Q34555760 | Sexual dysfunction, Part II: Diagnosis, management, and prognosis |
| Q50690625 | Sexual dysfunction, cardiovascular risk and effects of pharmacotherapy. |
| Q50949227 | Sexual dysfunction, cardiovascular risk factors, and inflammatory biomarkers in women undergoing coronary angiography. |
| Q41000412 | Sexual dysfunction, depression, and anxiety in young women according to relationship status: an online survey |
| Q34985834 | Sexual dysfunction, depression, and the impact of antidepressants. |
| Q33956355 | Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. |
| Q36603943 | Sexual dysfunction, mood, anxiety, and personality disorders in female patients with fibromyalgia |
| Q34410093 | Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs |
| Q45228999 | Sexual dysfunction, social maladjustment, and psychiatric disorders in women seeking treatment in a premenstrual syndrome clinic |
| Q38572402 | Sexual dysfunction: A systematic review of South African research |
| Q50215693 | Sexual dysfunction: Blue light, not blue pills, for erectile dysfunction |
| Q84235084 | Sexual dysfunction: C. histolyticum collagenase effective against Peyronie |
| Q87183038 | Sexual dysfunction: First EAU priapism treatment guidelines published |
| Q82084203 | Sexual dysfunction: MCID provides new perspective on erectile function research |
| Q86704946 | Sexual dysfunction: Magnetic control of stem cells: feasible for ED |
| Q87457530 | Sexual dysfunction: Microtissue injection enhances erectile function |
| Q44730739 | Sexual dysfunction: Multiple (types of) female orgasm |
| Q85586954 | Sexual dysfunction: PDE5i and melanoma-correlation is not causation |
| Q86449726 | Sexual dysfunction: Paternal dapoxetine is detrimental to reproductive outcomes |
| Q83960684 | Sexual dysfunction: Psychological inputs to sexual dysfunction |
| Q82618911 | Sexual dysfunction: Shock therapy can improve erectile function |
| Q88444107 | Sexual dysfunction: Shortened CCH treatment for Peyronie's disease |
| Q39517384 | Sexual dysfunction: The potential of stem cell therapy for Peyronie disease |
| Q84447463 | Sexual dysfunction: The unspoken side effect of antipsychotics |
| Q88177127 | Sexual dysfunction: Young at heart? ED linked to CVD |
| Q74168961 | Sexual dysfunction: a neglected complication of panic disorder and social phobia |
| Q83629731 | Sexual dysfunction: a new tool for early identification of penile endothelial dysfunction |
| Q90969441 | Sexual dysfunction: an often overlooked concern for people with inflammatory arthritis |
| Q43281703 | Sexual dysfunction: anesthetic spray improves premature ejaculation |
| Q84039285 | Sexual dysfunction: immediate penile prosthesis for acute ischemic priapism |
| Q71934761 | Sexual dysfunction: interview with a couple who have experienced sexual dysfunction secondary to diabetes mellitus |
| Q59813933 | Sexual dysfunction: is acupuncture a therapeutic option for premature ejaculation? |
| Q44609483 | Sexual dysfunction: looking beyond the obvious |
| Q34568181 | Sexual dysfunction: male and female issues. |
| Q35022476 | Sexual dysfunction: overview of prevalence, etiological factors, and treatments |
| Q84911442 | Sexual dysfunction: penile revascularization has good long-term success rates |
| Q51140789 | Sexual dysfunction: premature ejaculation and female sexual satisfaction. |
| Q90012090 | Sexual dysfunction: prevalence and associated factors in patients with mental illness receiving psychotropic medication in Nigeria |
| Q85316728 | Sexual dysfunction: serotonin SNPs in PVD |
| Q71934758 | Sexual dysfunction: taking a sexual history |
| Q37293801 | Sexual dysfunction: the 'prima ballerina' of hypertension-related quality-of-life complications |
| Q34019041 | Sexual dysfunction: the unspoken side effect of antipsychotics |
| Q36274722 | Sexual dysfunction: treat or refer |
| Q83472315 | Sexual function: diagnosis and management of sexual dysfunction |
| Q84296478 | Sexual function: diagnosis and management of sexual dysfunction |
| Q84461787 | Sexual function: diagnosis and management of sexual dysfunction |
| Q84595859 | Sexual function: diagnosis and management of sexual dysfunction |
| Q94921768 | Sexual function: diagnosis and management of sexual dysfunction |
| Q49680347 | Sexual functioning and sexual dysfunction in women with infertility |
| Q84597472 | Sexual health and sexual dysfunction |
| Q42140899 | Sexual medicine disparities between Asia and North America: commentary on male sexual dysfunction in Asia |
| Q51318174 | Sexual medicine: Experts debate--should DSM-V raise the bar for female sexual dysfunction diagnosis? |
| Q34648001 | Sexual rehabilitation and cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate cancer survivors |
| Q34619354 | Sexual self-schemas, sexual dysfunction, and the sexual responses of women with a history of childhood sexual abuse |
| Q53398191 | Sexuality and sexual dysfunction in gynecological psychooncology. |
| Q41284305 | Sexuality and sexual dysfunction in spinal cord-injured men in Turkey. |
| Q38712313 | Sexuality in eating disorders patients: etiological factors, sexual dysfunction and identity issues. A systematic review |
| Q33824573 | Short- and long-term effects of Ginkgo biloba extract on sexual dysfunction in women. |
| Q40084079 | Short-term treatment in sexual dysfunction: A review |
| Q34403864 | Should dyspareunia be retained as a sexual dysfunction in DSM-V? A painful classification decision |
| Q38004301 | Should questionnaires of female sexual dysfunction be used in routine clinical practice? |
| Q56918205 | Side effects and complications. Italian study explores reasons for sexual dysfunction in men |
| Q56937390 | Side effects. Male sexual dysfunction and HAART--the confusion continues |
| Q56937384 | Side effects. Sexual dysfunction in men: a report from Boston |
| Q56937378 | Side effects. Sexual dysfunction in men: a report from France |
| Q100749611 | Significant Increase of Sexual Dysfunction in Patients With Renal Failure Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis |
| Q34279788 | Significant resolution of female sexual dysfunction after bariatric surgery |
| Q33764715 | Sildenafil and sexual dysfunction associated with antidepressants |
| Q82726025 | Sildenafil as treatment for antidepressant-induced sexual dysfunction |
| Q73206129 | Sildenafil citrate (Viagra) treatment of sexual dysfunction in a schizophrenic patient |
| Q39419836 | Sildenafil citrate effectively reverses sexual dysfunction induced by three-dimensional conformal radiation therapy |
| Q44000904 | Sildenafil citrate for the sexual dysfunction in antidepressant-treated male patients with posttraumatic stress disorder. A preliminary pilot open-label study |
| Q50899044 | Sildenafil citrate in the treatment of sexual dysfunction and its effect on quality of life in alcohol dependent men: preliminary findings. |
| Q73136870 | Sildenafil for St. John Wort-induced sexual dysfunction |
| Q74601014 | Sildenafil for iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patients |
| Q73714704 | Sildenafil for psychotropic-induced sexual dysfunction in 31 women and 61 men |
| Q73075513 | Sildenafil for sexual dysfunction in women taking antidepressants |
| Q34504583 | Sildenafil for women patients with antidepressant-induced sexual dysfunction |
| Q95810009 | Sildenafil in postmenopausal women with sexual dysfunction |
| Q35664705 | Sildenafil in the Treatment of SSRI-Induced Sexual Dysfunction: A Pilot Study |
| Q28368342 | Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors |
| Q53334959 | Sildenafil in the treatment of sexual dysfunction in spinal cord-injured male patients. |
| Q44572280 | Sildenafil reduced antidepressant-associated sexual dysfunction in men with remitted major depressive disorder |
| Q73425867 | Sildenafil treatment of antidepressant-induced sexual dysfunction |
| Q77228791 | Sildenafil treatment of serotonin reuptake inhibitor-induced sexual dysfunction |
| Q34594639 | Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial |
| Q37704628 | Six Out of Ten Women with Recurrent Urinary Tract Infections Complain of Distressful Sexual Dysfunction - A Case-Control Study |
| Q47763546 | Sleep disturbance and sexual dysfunction in postmenopausal women |
| Q91414383 | Sleep, Sleep Disorders, and Sexual Dysfunction |
| Q81628055 | Smoking and sexual dysfunction in Chinese males: findings from men's health survey |
| Q36967113 | Snoring as a risk factor for sexual dysfunction in community men. |
| Q50109604 | Social Support for Female Sexual Dysfunction in Fibromyalgia |
| Q90175317 | Social Support in Patients With Sexual Dysfunction After Non-Nerve-Sparing Radical Prostatectomy: A Qualitative Study |
| Q70501604 | Social influence, Ericksonian strategies and hypnotic phenomena in the treatment of sexual dysfunction |
| Q92237204 | Social media addiction and sexual dysfunction among Iranian women: The mediating role of intimacy and social support |
| Q39218026 | Sociodemographic and clinical correlates of sexual dysfunction among psychiatric outpatients receiving common psychotropic medications in a Neuropsychiatric Hospital in Northern Nigeria |
| Q40895081 | Sociodemographic factors associated with sexual dysfunction in Mexican women with spinal cord injury |
| Q48026793 | Sox3 and sexual dysfunction: it's in the head |
| Q91862814 | Soy Isoflavone Improved Female Sexual Dysfunction of Mice Via Endothelial Nitric Oxide Synthase Pathway |
| Q90811279 | Spectatoring Mediates the Association Between Penis Appearance Concerns and Sexual Dysfunction |
| Q66912318 | Spinal cord injury patients and sexual dysfunction |
| Q45025457 | Ssri-induced sexual dysfunction in adolescents |
| Q74149971 | St John's wort-induced sexual dysfunction |
| Q38098218 | Standard operating procedures for neurophysiologic assessment of male sexual dysfunction |
| Q93641263 | Standard surgery for urinary symptoms leaves men with less sexual dysfunction |
| Q47861813 | Standards for Clinical Trials in Male and Female Sexual Dysfunction: I. Phase I to Phase IV Clinical Trial Design |
| Q39133731 | Standards for Clinical Trials in Male and Female Sexual Dysfunction: II. Patient-Reported Outcome Measures |
| Q47896537 | Standards for Clinical Trials in Male and Female Sexual Dysfunction: III. Unique Aspects of Clinical Trials in Male Sexual Dysfunction. |
| Q47896546 | Standards for Clinical Trials in Male and Female Sexual Dysfunction: IV. Unique Aspects of Clinical Trials in Female Sexual Dysfunction. |
| Q30449979 | Standards for clinical trials in sexual dysfunction in women: research designs and outcomes assessment |
| Q36237220 | Stem Cells in Male Sexual Dysfunction: Are We Getting Somewhere? |
| Q64249327 | Stepped approach to improving sexual function after gynaecological cancer: the SAFFRON feasibility RCT |
| Q73610983 | Strategic planning in research and development is needed in female sexual dysfunction |
| Q36649071 | Strategies for managing antidepressant-induced sexual dysfunction: a review |
| Q36257325 | Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials |
| Q24202675 | Strategies for managing sexual dysfunction induced by antidepressant medication |
| Q24245847 | Strategies for managing sexual dysfunction induced by antidepressant medication |
| Q32067902 | Strategies for the treatment of antidepressant-related sexual dysfunction |
| Q38005470 | Strategies for the treatment of antipsychotic-induced sexual dysfunction and/or hyperprolactinemia among patients of the schizophrenia spectrum: a review |
| Q43920036 | Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice |
| Q46333448 | Strategy for the management of antipsychotic-induced sexual dysfunction: a case report description |
| Q55333230 | Stress, anxiety, depression, and sexual dysfunction among postmenopausal women in Shiraz, Iran, 2015. |
| Q38355850 | Stroke and sexual dysfunction - a narrative review |
| Q98784735 | Study of Sexual Dysfunction in People Living with Epilepsy at a Tertiary Care Center of South India |
| Q47409114 | Study of the prevalence of female sexual dysfunction in sexually active women 18 to 40 years of age in Medellín, Colombia. |
| Q51298939 | Study on female sexual dysfunction in type 2 diabetic Chinese women. |
| Q97557911 | Study protocol for the Fex-Can Childhood project: An observational study and a randomized controlled trial focusing on sexual dysfunction and fertility-related distress in young adult survivors of childhood cancer |
| Q41642739 | Subclinical Hypothyroidism is not a Risk Factor for Female Sexual Dysfunction in Korean Middle-Aged Women |
| Q47549032 | Subclinical hypothyroidism would not lead to female sexual dysfunction in Chinese women. |
| Q42272941 | Subjective assessment of sexual dysfunction of patients on long-term administration of digoxin |
| Q44290931 | Subjective quality of life and sexual dysfunction in outpatients with schizophrenia or schizoaffective disorder |
| Q79076597 | Substance-induced sexual dysfunction |
| Q51748885 | Success of sildenafil treatment in neurogenic female sexual dysfunction caused by L5-S1 intervertebral disk rupture: a case report. |
| Q45026441 | Successful treatment of sexual dysfunction with dronabinol: a case report |
| Q38579685 | Summary of findings from the FDA regulatory science forum on measuring sexual dysfunction in depression trials |
| Q91640518 | Surgical Complications after Open Abdominal Aortic Aneurysm Repair: Intestinal Ischemia, Buttock Claudication and Sexual Dysfunction |
| Q47549011 | Surgical Factors Associated With Male and Female Sexual Dysfunction After Radical Cystectomy: What Do We Know and How Can We Improve Outcomes? |
| Q60619776 | Surgical management is associated with sexual dysfunction in gynecologic cancer |
| Q67745234 | Surrogate therapy for sexual dysfunction |
| Q80350051 | Survey of sexual dysfunction services in Bristol, UK |
| Q46521593 | Survey of treatment practices for sexual dysfunction(s) associated with anti-depressants |
| Q35735025 | Survivorship: sexual dysfunction (female), version 1.2013. |
| Q35735012 | Survivorship: sexual dysfunction (male), version 1.2013 |
| Q33944826 | Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study |
| Q35093754 | Sweet Bee Venom Pharmacopuncture May be Effective for Treating Sexual Dysfunction |
| Q28369643 | Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression. |
| Q70281841 | Symposium on sexual dysfunction. The behavioural treatment of sexual dysfunction |
| Q70281833 | Symposium on sexual dysfunction. The therapy of sexual dysfunction |
| Q92038867 | Symptoms of sexual dysfunction among men from infertile couples: prevalence and association with testosterone deficiency |
| Q67901193 | Symptoms of sexual dysfunction and depression in diabetic women |
| Q30445299 | Symptoms of sexual dysfunction in patients treated for major depressive disorder: a meta-analysis comparing selegiline transdermal system and placebo using a patient-rated scale |
| Q57199831 | Synergy Between Sexual Abuse and Cervical Cancer in Causing Sexual Dysfunction |
| Q92197314 | Systematic Review and Meta-Analysis for Sexual Dysfunction in Women With Hypertension |
| Q38991728 | Systematic Review of Sexual Dysfunction Among Veterans with Post-Traumatic Stress Disorder |
| Q91439896 | Systematic review of the prevalence, symptomatology and management options of sexual dysfunction in women with multiple sclerosis |
| Q102202976 | Systemic lupus erythematosus and risk of sexual dysfunction: A systematic review and Meta-Analysis |
| Q48059991 | Systemic sclerosis: Sexual dysfunction and lower urinary tract symptoms in 73 patients |
| Q46761321 | Tadalafil reversal of sexual dysfunction caused by serotonin enhancing medications in women |
| Q74809736 | Tamoxifen-induced sexual dysfunction in a breast cancer patient: a case report |
| Q28271756 | Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction |
| Q37389609 | Targeting vascular structure for the treatment of sexual dysfunction |
| Q51297909 | Temporary sexual dysfunction in reversible health limitations |
| Q67967383 | Test with vasoactive drugs: its predictive value in the diagnosis of erectile sexual dysfunction of venous origin |
| Q38471477 | Testosterone deficiency in the aging male and its relationship with sexual dysfunction and cardiovascular diseases |
| Q57988384 | Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen: A Phase III Research Study of Female Sexual Dysfunction in Women on Testosterone Patch Without Estrogen (APHRODITE) |
| Q83428585 | Testosterone patches for female sexual dysfunction |
| Q94397591 | Testosterone supplementation in men with sexual dysfunction |
| Q90606429 | Testosterone therapy and other treatment modalities for female sexual dysfunction |
| Q47420570 | Testosterone therapy for sexual dysfunction in men with Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials |
| Q37196403 | Testosterone therapy for sexual dysfunction in postmenopausal women |
| Q36730427 | Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials |
| Q74376424 | Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism |
| Q68091499 | Thalassemia, zinc deficiency, and sexual dysfunction in women |
| Q44033212 | Thalidomide and sexual dysfunction in men. |
| Q73611013 | The "consensus" conference on female sexual dysfunction: conflicts of interest and hidden agendas |
| Q91905351 | The ABC of Sexual Dysfunction conference |
| Q90950320 | The Assessment of Sexual Dysfunction in Male Patients with Multiple Sclerosis |
| Q104280622 | The Association Between Female Sexual Dysfunction and Sexual Dysfunction in the Male Partner: A Systematic Review and Meta-Analysis |
| Q101569778 | The Correlation between Severity of Overactive Bladder Symptoms with Female Sexual Dysfunction and Sexual Satisfaction of Partners |
| Q34768784 | The DSM criteria of sexual dysfunction: need for a change |
| Q55967021 | The DSM-5’s Proposed New Categories of Sexual Disorder: The Problem of False Positives in Sexual Diagnosis |
| Q49544114 | The Discussion of Sexual Dysfunction Before and After Kidney Transplantation From the Perspective of the Renal Transplant Surgeon |
| Q44436237 | The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France |
| Q102074586 | The Effect of Exposure to Sexual Violence on Sexual Dysfunction and Sexual Distress in Pregnant Women |
| Q60708182 | The Effect of Fatigue and Fibromyalgia on Sexual Dysfunction in Women With Chronic Fatigue Syndrome |
| Q29036544 | The Effect of Gepirone‐ER in the Treatment of Sexual Dysfunction in Depressed Men |
| Q95642358 | The Effect of a Midwife-Based Group Discussion Education on Sexual Dysfunction Beliefs in Rural Postmenopausal Women |
| Q96834266 | The Effectiveness of Psycho-Educational and Cognitive-Behavioral Counseling on Female Sexual Dysfunction |
| Q100735777 | The Effects of Herbal Medicines on Women Sexual Dysfunction: A Systematic Review |
| Q47114475 | The Evaluation of Relationship between Sexual Self-concept and Sexual Dysfunction in Individuals Undergoing Methadone Maintenance Treatment |
| Q27311513 | The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research. |
| Q69538194 | The GRISS: a psychometric instrument for the assessment of sexual dysfunction |
| Q48791642 | The Global Online Sexuality Survey (GOSS): female sexual dysfunction among Internet users in the reproductive age group in the Middle East |
| Q64113971 | The Impact of Metabolic Syndrome and Its Components on Female Sexual Dysfunction: A Narrative Mini-Review |
| Q55263536 | The Impact of Migration on Attitudes to Female Genital Cutting and Experiences of Sexual Dysfunction Among Migrant Women with FGC. |
| Q90642721 | The Impact of Sacral Neuromodulation on Sexual Dysfunction |
| Q90596987 | The Impact of Thyroid Disease on Sexual Dysfunction in Men and Women |
| Q90661221 | The Incidence of Sexual Dysfunction in Patients With Irritable Bowel Syndrome |
| Q97421364 | The Overactive Pelvic Floor (OPF) and Sexual Dysfunction. Part 2: Evaluation and Treatment of Sexual Dysfunction in OPF Patients |
| Q38817658 | The Physiology of Female Sexual Function and the Pathophysiology of Female Sexual Dysfunction (Committee 13A). |
| Q57575755 | The Prevalence and Associated Factors of Female Sexual Dysfunction in Korean Premenopausal Women: A Community-Based Study |
| Q46013325 | The Prevalence of Sexual Dysfunction among the Patients with End Stage Renal Disease in Jamaica. |
| Q99569926 | The Prevalence of Sexual Dysfunction in Patients With Multiple Sclerosis in Cyprus: A Cross-sectional Study |
| Q60922327 | The Prostate Cancer Rehabilitation Clinic: a biopsychosocial clinic for sexual dysfunction after radical prostatectomy |
| Q114597061 | The Relationship Between Sexual Addiction and Sexual Dysfunction |
| Q114596768 | The Relationship between Sexual Addiction and Sexual Dysfunction |
| Q52608381 | The Relevance of Sexual Dysfunction Related to Groin Pain After Inguinal Hernia Repair - The SexIHQ Short Form Questionnaire Assessment. |
| Q92981997 | The Risk of Sexual Dysfunction and Effectiveness of Treatment of Benign Prostatic Hyperplasia With Severe Lower Urinary Tract Dysfunction With Combination of Dutasteride and Solifenacin |
| Q52648856 | The Risks of Using Herbal Supplements for Sexual Dysfunction Associated With Psychotropic Medications: A Case Report of ExtenZe Use and Priapism. |
| Q39015977 | The Role of Pelvic Floor Muscles in Male Sexual Dysfunction and Pelvic Pain |
| Q58189450 | The Role of Sexual Assault and Sexual Dysfunction in Alcohol/Other Drug Use Disorders |
| Q37325896 | The SAD-MEN questionnaire: a new and reliable questionnaire for assessing sexual dysfunction in Asians with diabetes |
| Q48473166 | The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients |
| Q72897503 | The Sexual Interaction System Scale: a new inventory for assessing sexual dysfunction and sexual distress |
| Q36898927 | The Study of Gonadal Hormonal Abnormalities and Sexual Dysfunction in HIV Positive Females: An Exploratory Study |
| Q89365237 | The Use of Stromal Vascular Fraction in the Treatment of Male Sexual Dysfunction: A Review of Preclinical and Clinical Studies |
| Q35619368 | The assessment of sexual dysfunction in Egyptian women with lower urinary tract symptoms |
| Q93359778 | The association between fibromyalgia and female sexual dysfunction: a systematic review and meta-analysis of observational studies |
| Q35977243 | The association between lower urinary tract symptoms and sexual dysfunction: fact or fiction? |
| Q36257011 | The association between physical activity and sexual dysfunction in patients with diabetes mellitus of European and South Asian origin: The Oxford Sexual Dysfunction Study. |
| Q35624474 | The association between psychosocial and medical factors with long-term sexual dysfunction after treatment for colorectal cancer |
| Q92483827 | The association between sexual dysfunction and metabolic syndrome among Turkish postmenopausal women |
| Q48730753 | The association between symptoms of sexual dysfunction and age at onset in Parkinson's disease |
| Q44187134 | The association of higher depressive symptoms and sexual dysfunction in male haemodialysis patients. |
| Q43565009 | The association of sexual dysfunction and substance use among a community epidemiological sample |
| Q90964262 | The association of sexual dysfunction with race in women with gynecologic malignancies |
| Q53245548 | The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation. |
| Q38559489 | The clinical relevance of sexual dysfunction in systemic sclerosis |
| Q44000029 | The comparison of the relationship between sociocultural-economic features and sexual dysfunction frequency in sexually active premenopausal female patients on renal replacement therapy |
| Q47823176 | The concomitant use of fesoterodine and topical vaginal estrogen in the management of overactive bladder and sexual dysfunction in postmenopausal women. |
| Q73611007 | The consensus-based classification of female sexual dysfunction: barriers to universal acceptance |
| Q42147577 | The correlation between emotional distress and aging males' symptoms at a psychiatric outpatient clinic: sexual dysfunction as a distinguishing characteristic between andropause and anxiety/depression in aging men. |
| Q99415383 | The correlation between sexual dysfunction and intimate partner violence in young women during pregnancy |
| Q24564068 | The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression |
| Q35651558 | The effect of amantadine on clomipramine induced sexual dysfunction in male rats |
| Q49030520 | The effect of anti-tumor necrosis factor agents on sexual dysfunction in male patients with ankylosing spondylitis: a pilot study |
| Q92087964 | The effect of ginseng on sexual dysfunction in menopausal women: A double-blind, randomized, controlled trial |
| Q49582615 | The effect of intravesical instillations with Hyaluronic Acid on sexual dysfunction in women with recurrent urinary tract infections (RUTI). |
| Q51137459 | The effect of pelvic floor muscle training alone or in combination with electrostimulation in the treatment of sexual dysfunction in women with multiple sclerosis. |
| Q51183747 | The effects of Femore™ cream on sexual dysfunction in Turkish women. |
| Q90904372 | The effects of buprenorphine/naloxone maintenance treatment on sexual dysfunction, sleep and weight in opioid use disorder patients |
| Q36757400 | The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease |
| Q34659636 | The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study. |
| Q42642161 | The etiological relationship between anxiety sensitivity, sexual distress, and female sexual dysfunction is partly genetically moderated. |
| Q41456612 | The evaluation of sexual dysfunction in male patients with migraine and tension type headache. |
| Q39157869 | The evolution of sexual dysfunction in young men aged 18-25 years |
| Q47653280 | The fear of female power--a cause of sexual dysfunction |
| Q51743950 | The female sexual dysfunction (FSD) revolution reverts to evolution. |
| Q37368433 | The genetics and epidemiology of female sexual dysfunction: a review. |
| Q35582317 | The hidden impact of diabetes on male sexual dysfunction and fertility |
| Q33650768 | The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia |
| Q36372433 | The impact of aging on sexual function and sexual dysfunction in women: a review of population-based studies |
| Q33809752 | The impact of body awareness on sexual arousal in women with sexual dysfunction |
| Q45210542 | The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study |
| Q73610949 | The impact of female sexual dysfunction in the evaluation and management of the impotent patient |
| Q51244876 | The impact of frequently encountered cardiovascular risk factors on sexual dysfunction in rheumatic disorders. |
| Q37114780 | The impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument |
| Q30445909 | The impact of physical illness on sexual dysfunction |
| Q48177132 | The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis |
| Q44548448 | The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis |
| Q48685313 | The inter-relational effect of metabolic syndrome and sexual dysfunction on hypogonadism in type II diabetic men. |
| Q46580441 | The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial |
| Q50794462 | The low frequency of reported sexual dysfunction in Asian patients with schizophrenia (2001-2009): low occurrence or ignored side effect? |
| Q99638486 | The majority of Danish breast cancer survivors on adjuvant endocrine therapy have clinically relevant sexual dysfunction: a cross-sectional study |
| Q33813396 | The making of a disease: female sexual dysfunction |
| Q79257382 | The making of a disease: female sexual dysfunction |
| Q34503184 | The management of neurogenic bladder and sexual dysfunction after spinal cord injury |
| Q103822390 | The management of sexual dysfunction resulting from radiotherapy and androgen deprivation therapy to treat prostate cancer: A comparison of uro-oncology practice according to disease stage |
| Q24557503 | The marketing of a disease: female sexual dysfunction |
| Q71293169 | The measurement of sexual dysfunction in cancer patients |
| Q51807280 | The mechanistic basis for sexual dysfunction in male transforming growth factor beta1 null mutant mice. |
| Q44142390 | The medicalization of female sexual dysfunction: the need for caution |
| Q45270377 | The metabolic syndrome: a cause of sexual dysfunction in women |
| Q95805337 | The metabolic syndrome: a cause of sexual dysfunction in women |
| Q48340215 | The morbidity of sexual dysfunction of 125 Chinese women following different types of radical hysterectomy for gynaecological malignancies |
| Q66944746 | The myth of symptomatic versus asymptomatic partners in the conjoint treatment of sexual dysfunction |
| Q70023928 | The natural history of sexual dysfunction in diabetic women. A 6-year follow-up study |
| Q68068361 | The need for cooperative professional relationships in diagnosing and treating male sexual dysfunction |
| Q70036195 | The need to address sexual dysfunction in diabetes |
| Q48429798 | The neurology of male sexual dysfunction and its investigation by clinical neurophysiological methods |
| Q71434971 | The older patient with a sexual dysfunction |
| Q44062810 | The place of female sexual dysfunction in the urological practice: results of a Dutch survey. |
| Q48085287 | The potential role of sleep in sexual dysfunction in patients with schizophrenia |
| Q54758858 | The pre-treatment prevalence and types of sexual dysfunction among patients diagnosed with prostate cancer. |
| Q45987400 | The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure. |
| Q51705886 | The prevalence and risk factors of female sexual dysfunction in young korean women: an internet-based survey. |
| Q35399494 | The prevalence of female sexual dysfunction among migraine patients |
| Q75286807 | The prevalence of female sexual dysfunction and potential risk factors that may impair sexual function in Turkish women |
| Q81909855 | The prevalence of male sexual dysfunction and potential risk factors in Turkish men: a Web-based survey |
| Q34118956 | The prevalence of phimosis of the clitoris in women presenting to the sexual dysfunction clinic: lack of correlation to disorders of desire, arousal and orgasm |
| Q37473133 | The prevalence of sexual activity, and sexual dysfunction and behaviours in postmenopausal woman in Poland. |
| Q38171837 | The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a meta-analysis study |
| Q104472156 | The prevalence of sexual dysfunction among postpartum women on the East Coast of Malaysia |
| Q51804768 | The prevalence of sexual dysfunction and associated risk factors in women with chronic pelvic pain: a cross-sectional study. |
| Q39027313 | The prevalence of sexual dysfunction and its association with quality of life in adults with congenital heart disease |
| Q40279202 | The prevalence of sexual dysfunction and potential risk factors that may impair sexual function in Malaysian women |
| Q43898247 | The prevalence of sexual dysfunction before myocardial infarction in population of Polish men: a retrospective pilot study |
| Q34983815 | The prevalence of sexual dysfunction in the female health care providers in Jeddah, Saudi Arabia |
| Q73917759 | The provision of sexual dysfunction services by genitourinary medicine physicians in the UK, 1999 |
| Q104751853 | The quality, suitability, content and Readability of online health-related Information regarding sexual Dysfunction after rectal cancer surgery |
| Q36100562 | The quest for a little pink pill: female sexual dysfunction finally attracting attention. |
| Q47790386 | The relation of sexual dysfunction to depression and anxiety in patients with Parkinson's disease |
| Q36607272 | The relationship between beliefs about men's and women's roles in society and views on male sexual dysfunction in 135 women |
| Q35009516 | The relationship between childhood sexual abuse and sexual dysfunction in Jamaican adults |
| Q40797966 | The relationship between childhood sexual/physical abuse and sexual dysfunction in patients with social anxiety disorder |
| Q28068847 | The relationship between epilepsy and sexual dysfunction: a review of the literature |
| Q52348559 | The relationship between hydration status, male sexual dysfunction and depression in hemodialysis patients. |
| Q90929772 | The relationship between injury mechanism and sexual dysfunction in surgically treated pelvic fractures |
| Q67903319 | The relationship between sexual addiction and sexual dysfunction |
| Q33796284 | The relationship between sexual dysfunction and quality of marital relationship in genital and breast cancers women |
| Q39280821 | The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD). |
| Q39477318 | The relationship of serum and salivary cortisol levels to male sexual dysfunction as measured by the International Index of Erectile Function |
| Q36037386 | The rhetoric of female sexual dysfunction: faux feminism and the FDA. |
| Q30992584 | The risk of bladder, bowel, and sexual dysfunction after radiation therapy: what the data tell us and how we can use it to counsel our patients |
| Q57576027 | The role of functional MRI in neural assessment of female sexual dysfunction |
| Q34728040 | The role of mechanical devices in treating female sexual dysfunction and enhancing the female sexual response |
| Q37096223 | The role of pelvic floor physical therapy in the treatment of pelvic and genital pain-related sexual dysfunction (CME). |
| Q58641428 | The role of performance anxiety in the development and maintenance of sexual dysfunction in men and women |
| Q28334792 | The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction |
| Q37252334 | The role of sexual self-schema in a diathesis-stress model of sexual dysfunction |
| Q43869137 | The role of trait-affect, depression, and anxiety in women with sexual dysfunction: a pilot study |
| Q36366950 | The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine |
| Q82442789 | The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines, new challenges |
| Q73335183 | The serotonin antagonist mianserin for treatment of serotonin reuptake inhibitor-induced sexual dysfunction in women: an open-label add-on study |
| Q48460129 | The sexual dysfunction of Louis XVI: a consequence of international politics, anatomy, or naïveté? |
| Q34210002 | The sexual interaction inventory: a new instrument for assessment of sexual dysfunction |
| Q90460096 | The short-term outcome of laser in the management of female pelvic floor disorders: Focus on stress urine incontinence and sexual dysfunction |
| Q51347561 | The somatic and autonomic innervation of the clitoris; preliminary evidence of sexual dysfunction after minimally invasive slings. |
| Q71211335 | The study of sexual dysfunction in uremic males: problems for patients and investigators |
| Q67778625 | The symptomatology of sexual dysfunction |
| Q64980919 | The treatment of sexual dysfunction in a university health service setting. |
| Q67017149 | The treatment of sexual dysfunction in gay male couples |
| Q41190083 | The treatment of sexual dysfunction: a review |
| Q43472631 | The unconsummated marriage: its frequency and clinical characteristics in a sexual dysfunction clinic |
| Q39252780 | The use of a self-report questionnaire to assess the frequency of sexual dysfunction in family practice clinics |
| Q44274363 | The use of fluoxetine (Prozac) in premenstrual syndrome: is the incidence of sexual dysfunction and anorgasmia acceptable? |
| Q78195320 | The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction |
| Q37832779 | The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature |
| Q74505964 | The use of the Female Intervention Efficacy Index (FIEI) as an immediate outcome measure of medical intervention to treat female sexual dysfunction |
| Q53234029 | The utility of sildenafil citrate for infertile men with sexual dysfunction: a pilot study. |
| Q47970633 | The vagina dialogues: genital self-image and communication with physicians about sexual dysfunction and dissatisfaction among Jewish patients in a women's health clinic in southern Israel |
| Q70106080 | Therapeutic Rounds. Sexual dysfunction |
| Q34657234 | Therapeutic options in female sexual dysfunction |
| Q36772353 | Therapy Insight: sexual dysfunction in patients with chronic kidney disease |
| Q67570224 | Therapy of sexual dysfunction in alcohol abusers: a Pandora's box |
| Q28341797 | Thioridazine and sexual dysfunction |
| Q68668154 | Thyroid response to dexamethasone: a study on normal controls and patients with psychogenic sexual dysfunction |
| Q46730624 | Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial |
| Q96343394 | Title: Female Sexual Dysfunction - Awareness and Education Among Resident Physicians |
| Q86422512 | Topiramate and sexual dysfunction: myth or reality? |
| Q39367067 | Topiramate-associated sexual dysfunction: A systematic review |
| Q48586018 | Toward optimal health: Sandra R. Leiblum, PH.D. discusses sexual dysfunction in women. [Interview by Jodi R. Godfrey]. |
| Q47711425 | Traditional Chinese Medicine for Sexual Dysfunction: Review of the Evidence |
| Q38230464 | Traditional plant aphrodisiacs and male sexual dysfunction |
| Q54084342 | Training non-psychologists in the treatment of sexual dysfunction with special reference to the training of marriage guidance counsellors. |
| Q108906570 | Transcripts of Unfulfillment: A Study of Sexual Dysfunction and Dissatisfaction among Malay-Muslim Women in Malaysia |
| Q91684370 | Transcutaneous Electrical Nerve Stimulation to Improve Female Sexual Dysfunction Symptoms: A Pilot Study |
| Q36316683 | Transdermal and topical pharmacotherapy for male sexual dysfunction |
| Q42563424 | Transient sexual dysfunction observed during antiarrhythmic therapy by long-acting disopyramide in a male Wolff-Parkinson-White patient |
| Q101044419 | Translating Sexual Dysfunction: Does Language Impact Clinical Discussion of Painful Sex? |
| Q46268930 | Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label study |
| Q38887944 | Treating male sexual dysfunction after traumatic brain injury: Two case reports |
| Q51171508 | Treating sexual dysfunction associated with prior sexual trauma. |
| Q67493644 | Treating sexual dysfunction in dialysis and transplant patients |
| Q36304675 | Treating sexual dysfunction in general practice |
| Q80216508 | Treating sexual dysfunction in sex offenders: a case example |
| Q43966105 | Treating sexual dysfunction: psychiatry's role in the age of sildenafil. |
| Q34449471 | Treatment of 26 cases of male sexual dysfunction by behaviour modification techniques. |
| Q39602451 | Treatment of Male Sexual Dysfunction: An Interdisciplinary Undertaking in a Military Hospital |
| Q34530073 | Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial |
| Q79257371 | Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial |
| Q77947074 | Treatment of antidepressant-induced sexual dysfunction |
| Q34013919 | Treatment of endocrinologic male sexual dysfunction |
| Q35092955 | Treatment of female sexual dysfunction |
| Q51281662 | Treatment of female sexual dysfunction through symbolic modeling |
| Q42282313 | Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report |
| Q70675891 | Treatment of homosexual and heterosexual sexual dysfunction in male-only groups of mixed sexual orientation |
| Q71267162 | Treatment of hypertension in diabetic men: problems with sexual dysfunction |
| Q34187768 | Treatment of male sexual dysfunction |
| Q44919108 | Treatment of male sexual dysfunction: sex therapy compared with systematic desensitization and rational emotive therapy |
| Q51805888 | Treatment of paraphilic sexual disorder: the use of topiramate in fetishism. |
| Q67538901 | Treatment of psychogenic sexual dysfunction II. Some types of therapy |
| Q52075952 | Treatment of sexual disorder: a prophylaxis for major pathology? |
| Q58280404 | Treatment of sexual dysfunction |
| Q69492565 | Treatment of sexual dysfunction |
| Q67377001 | Treatment of sexual dysfunction |
| Q71940193 | Treatment of sexual dysfunction by behavioural psychotherapy |
| Q72579122 | Treatment of sexual dysfunction in a patient with systemic sclerosis |
| Q74646732 | Treatment of sexual dysfunction induced by selective serotonin-reuptake inhibitors |
| Q36626779 | Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido). |
| Q41031589 | Treatment of sexual dysfunction: a review of outcome studies |
| Q52735132 | Treatment of single-partner sexual dysfunction by systematic desensitization. |
| Q70636580 | Treatment of vasculogenic sexual dysfunction with pentoxifylline |
| Q64043229 | Treatment of verrucous carcinoma in penis with topical aminolevulinic acid photodynamic therapy: An effective and safe treatment method |
| Q99708154 | Treatment of women's sexual dysfunction using Apium graveolens L. Fruit (celery seed): A Double-blind, Randomized, Placebo-controlled Clinical Trial |
| Q41888296 | Treatment options for men with sexual dysfunction |
| Q33888333 | Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials |
| Q30278078 | Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis |
| Q34017507 | Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis |
| Q34236311 | Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period |
| Q36175426 | Treatments of Female Sexual Dysfunction Symptoms during Pregnancy: A Systematic Review of the Literature. |
| Q96952589 | Trends in reported male sexual dysfunction over the past decade: an evolving landscape |
| Q98182554 | Tribulus Terrestris for Female Sexual Dysfunction: A Systematic Review |
| Q33712768 | Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study |
| Q50992207 | Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. |
| Q37137897 | Two challenges for the classification of sexual dysfunction |
| Q51314182 | Two unconventional risk factors for major adverse cardiovascular events in subjects with sexual dysfunction: low education and reported partner's hypoactive sexual desire in comparison with conventional risk factors. |
| Q104757800 | Uncommon Case of Oral Vancomycin Neurotoxicity With Sexual Dysfunction |
| Q40457413 | Understanding and diagnosing sexual dysfunction: Recent progress through psychophysiological and psychophysical methods |
| Q73610927 | Understanding female sexual dysfunction and the consensus conference: this is progress? |
| Q64243826 | Understanding the Mechanism of Antidepressant-Related Sexual Dysfunction: Inhibition of Tyrosine Hydroxylase in Dopaminergic Neurons after Treatment with Paroxetine but Not with Agomelatine in Male Rats |
| Q91340216 | Understanding the relationship between BMI and sexual dysfunction: Can DSM-5 shed light into this topic? |
| Q83323883 | Unexpected improvement of sexual dysfunction during atazanavir therapy |
| Q46653163 | Unexpected improvement of sexual dysfunction during atazanavir therapy. |
| Q87535487 | Unusual masturbatory practice as an etiological factor in the diagnosis and treatment of sexual dysfunction in young men |
| Q36356625 | Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia |
| Q93573523 | Updated evidence-based treatment of male sexual dysfunction among spinal cord injury patients |
| Q95718300 | Urinary and Sexual Dysfunctions Evaluation After Rectal Resection |
| Q44250127 | Urinary and sexual dysfunction after rectal cancer operation |
| Q37816947 | Urinary and sexual dysfunction after rectal cancer treatment |
| Q68044721 | Urinary and sexual dysfunction after rectosigmoid surgery |
| Q51118055 | Urinary and sexual dysfunction in women after resection with and without preoperative radiotherapy for rectal cancer: a population-based cross-sectional study. |
| Q48961541 | Urinary and sexual dysfunction rates and risk factors following rectal cancer surgery |
| Q40522539 | Urinary incontinence and sexual dysfunction after treatment of localized prostate cancer: Results from a population aged less than 65years old |
| Q93335639 | Urinary incontinence as a cause of depression and sexual dysfunction: Questionnaire-based study |
| Q38839947 | Urinary symptoms and sexual dysfunction among Italian men: The results of the #Controllati survey |
| Q28142428 | Urinary, faecal and sexual dysfunction in patients with multiple sclerosis |
| Q37729348 | Urogenital complaints and female sexual dysfunction (part 1). |
| Q93581366 | Urological Management of Complications of Penile Constriction Devices: |
| Q34018388 | Urological aspects of female sexual dysfunction |
| Q36355624 | Use of an operant paradigm for the study of antidepressant-induced sexual dysfunction |
| Q33630536 | Use of bupropion in the treatment of sexual dysfunction: patent highlight |
| Q41830618 | Use of medical gymnastics in the overall treatment of inflammatory diseases of the female genital area complicated by sexual dysfunction |
| Q36452473 | Use of sildenafil for female sexual dysfunction |
| Q92195742 | Uterine Leiomyoma Is Associated with Female Sexual Dysfunction in Postmenopausal Women |
| Q47549085 | Vaginal Laxity, Sexual Distress, and Sexual Dysfunction: A Cross-Sectional Study in a Plastic Surgery Practice. |
| Q38715886 | Vaginal Testosterone for Management of Aromatase Inhibitor-Related Sexual Dysfunction: An Integrative Review |
| Q43007949 | Vaginal atrophy and sexual dysfunction in current users of systemic postmenopausal hormone therapy. |
| Q37323310 | Validated questionnaires for assessing sexual dysfunction and BPH/LUTS: solidifying the common pathophysiologic link |
| Q47391708 | Validation and cross-cultural adaptation of sexual dysfunction modified scale in multiple sclerosis for Brazilian population |
| Q50591071 | Valsartan, an angiotensin receptor blocker treats sexual dysfunction in a female hypertensive: a case report. |
| Q34064577 | Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. |
| Q74733761 | Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes |
| Q99411637 | Vasectomy and male sexual dysfunction risk: A systematic review and meta-analysis |
| Q69785873 | Videotape feedback in the treatment of couples with sexual dysfunction |
| Q105790870 | Visceral Sensitivity in Women With BS and Sexual Dysfunction |
| Q67987049 | Vitamin A treatment of sexual dysfunction in male alcoholics |
| Q40622935 | Vitamin D3 deficiency is associated with female sexual dysfunction in premenopausal women |
| Q58570997 | Vitexin alleviates streptozotocin-induced sexual dysfunction and fertility impairments in male mice via modulating the hypothalamus-pituitary-gonadal axis |
| Q34140070 | Voiding and sexual dysfunction after cerebrovascular accidents |
| Q81677194 | Voiding and sexual dysfunction after deep rectal resection and total mesorectal excision: prospective study on 52 patients |
| Q51689212 | Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. |
| Q46783036 | Weight gain, sexual dysfunction, and bupropion |
| Q64072552 | What Patients and Partners Want in Interventions That Support Sexual Recovery After Prostate Cancer Treatment: An Exploratory Convergent Mixed Methods Study |
| Q56515606 | What are the factors that contribute to the development of sexual dysfunction in breastfeeding women? A systematic scoping review protocol |
| Q64087815 | What are the prevalence and factors associated with sexual dysfunction in breastfeeding women? A Brazilian cross-sectional analytical study |
| Q33770690 | What every urologist should know about female sexual dysfunction |
| Q43409619 | What is frigidity? Comments on the terminology of sexual dysfunction in women |
| Q39182231 | What kind of sexual dysfunction is most common among overweight and obese women in reproductive age? |
| Q64114225 | When sex meets age: Family physicians' perspectives about sexual dysfunction among older men and women: A qualitative study from Israel |
| Q50876770 | Which are the male factors associated with female sexual dysfunction (FSD)? |
| Q37030456 | Which patients with sexual dysfunction are suitable for testosterone replacement therapy? |
| Q90485871 | Why Odds Ratios Can Be Tricky Statistics: The Case of Finasteride, Dutasteride, and Sexual Dysfunction |
| Q35155026 | Why is impaired sexual function distressing to women? The primacy of pleasure in female sexual dysfunction |
| Q39897667 | Women with chronic fatigue syndrome and sexual dysfunction: past, present, and future |
| Q69606781 | Women's role in male sexual dysfunction |
| Q88343770 | Women's sexual dysfunction associated with psychiatric disorders and their treatment |
| Q35772611 | Women's sexual dysfunction: a pathophysiological review |
| Q36464953 | Women's sexual dysfunction: a review of the "surgical landscape". |
| Q24555658 | Women's sexual dysfunction: revised and expanded definitions |
| Q57560933 | Written information material and availability of sexual health care for men experiencing sexual dysfunction after prostate cancer treatment: An evaluation of Dutch urology and radiotherapy departments |
| Q72883224 | Yohimbine for male sexual dysfunction |
| Q44317366 | Zaprinast, a phosphodiesterase 5 inhibitor, overcomes sexual dysfunction produced by fluoxetine, a selective serotonin reuptake inhibitor in hamsters |
| Q70338436 | Zinc and sexual dysfunction |
| Q72435761 | Zinc and sexual dysfunction |
| Q69268438 | Zinc deficiency and hyperprolactinaemia are not reversible causes of sexual dysfunction in uraemia |
| Q83151239 | [25 years of progress in urology: breakthrough for sexual dysfunction, testicular cancer and incontinence] |
| Q73936576 | [A study on sexual dysfunction in female patients with alcoholics] |
| Q78648607 | [Aetiology of female sexual dysfunction] |
| Q81094275 | [Age and psychologic disorders. Variables associated to post-infarction sexual dysfunction] |
| Q64965416 | [Alcohol and sexual dysfunction] |
| Q84514699 | [An investigation on female sexual dysfunction among urban Chinese women in Nanjing] |
| Q78820201 | [Analysis of 50 cases of sexual dysfunction] |
| Q80857775 | [Animal models in sexual dysfunction] |
| Q73475488 | [Antidepressants and sexual dysfunction] |
| Q90679461 | [Application of MRI in the studies of female sexual dysfunction] |
| Q75226017 | [Application of the preparation "vitamax" in the complex treatment of chronic prostatitis complicated by sexual dysfunction] |
| Q95529315 | [Aripiprazole for drug-induced sexual dysfunction in schizophrenic males] |
| Q84671359 | [Aspects of psychosomatic medicine and current treatment options in male sexual dysfunction] |
| Q71902646 | [Assistance: experience in the treatment of sexual dysfunction in women] |
| Q70879576 | [Behavioral approach to sexual dysfunction] |
| Q79089321 | [Behavioral treatment for female sexual dysfunction (56 case reports)] |
| Q82110176 | [Benign prostatic hyperplasia and sexual dysfunction] |
| Q83829779 | [Bladder, bowel and sexual dysfunction in patient with mulitple sclerosis] |
| Q71640415 | [Blood prolactin in 845 cases of clinically idiopathic sexual dysfunction] |
| Q90439861 | [Changes in classification of sexual dysfunction: from DSM-IV-TR to DSM-5] |
| Q69400880 | [Chronic disease and sexuality. An interview study on sexual dysfunction in patients with multiple sclerosis] |
| Q81319648 | [Chronic prostatitis related sexual dysfunction and its psychologic treatment] |
| Q83098260 | [Clinical observation of the treatment of male sexual dysfunction by yangjingjiaonang] |
| Q70435823 | [Comparative evaluation of the endocrine function of the testes and the gonadotropic and lactotropic functions of the adenohypophysis in various forms of interoceptive sexual dysfunction] |
| Q85641224 | [Comparison of quality of life in women with sexual dysfunction] |
| Q81459636 | [Complications after treatment of colorectal cancer, with special focus on stomas, urological conditions and sexual dysfunction] |
| Q57211923 | [Construction of an explanatory model of female sexual dysfunction] |
| Q82489064 | [Contribution of psychosexual approach to assessment and treatment of sexual dysfunction: a working model] |
| Q90724543 | [Correlation between the phenotypic domains of the UPOINT system and sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome] |
| Q104563704 | [Correlation of oxytocin with male sexual dysfunction: An update] |
| Q81042351 | [Depression and sexual dysfunction: aspects of a multi-faceted relationship] |
| Q84437030 | [Depression, antidepressants and male sexual dysfunction] |
| Q84644330 | [Detection of sexual dysfunction in primary care] |
| Q73342746 | [Dextromethorphan-induced sexual dysfunction] |
| Q71242151 | [Diagnosis of androgenic insufficiency in interoreceptive forms of sexual dysfunction] |
| Q73259269 | [Drug induced sexual dysfunction] |
| Q74584915 | [Drug-induced sexual dysfunction] |
| Q86885916 | [Drug-induced sexual dysfunction] |
| Q71253585 | [Dynamics of endocrine disorders in interoceptive sexual dysfunction] |
| Q72093965 | [Dynamics of the sympathetic-adrenal changes in the electrostimulation of patients with interoceptive-autonomic sexual dysfunction] |
| Q77467714 | [Effect of 2/100 Hz transcutaneous electrical nerve stimulation on sexual dysfunction and serum sex hormone of heroin addicts] |
| Q96113436 | [Effect of Wubi Shanyao Pills on sexual dysfunction in rats with adenine-induced kidney-Yang deficiency] |
| Q85002015 | [Efficacy of compound xuanju capsule on type-III prostatitis-related sexual dysfunction] |
| Q91044954 | [Efficacy of physical therapy for female sexual dysfunction] |
| Q70839022 | [Endocrine testing of sexual dysfunction in chronic alcoholic males] |
| Q79757496 | [Epilepsy and male sexual dysfunction: etiology, diagnosis and therapy] |
| Q54220420 | [Evaluation of sexual dysfunction in prostate cancer management]. |
| Q73799723 | [Exploratory study of factors related sexual dysfunction among cancer patients] |
| Q80539558 | [Exploratory study on related factors of sexual dysfunction among breast cancer patients] |
| Q84970181 | [Factors related to sexual dysfunction in patients with cervical cancer] |
| Q80955463 | [Female sexual dysfunction (FSD)] |
| Q90745876 | [Female sexual dysfunction and multiple sclerosis: A case-control study] |
| Q80782611 | [Female sexual dysfunction and postmenopausal androgen therapy] |
| Q89113343 | [Female sexual dysfunction: Drug treatment options] |
| Q81155521 | [Female sexual dysfunction: classification, epidemiology, diagnosis and treatment] |
| Q73156454 | [Female sexual dysfunction] |
| Q73183229 | [Female sexual dysfunction] |
| Q80526441 | [Female sexual dysfunction] |
| Q81458131 | [Female sexual dysfunction] |
| Q82412825 | [Female sexual dysfunction] |
| Q82489071 | [Female sexual dysfunction] |
| Q83197913 | [Female sexual dysfunction] |
| Q83151071 | [Frequency of subjectively assessed symptoms of sexual dysfunction and sexual disorders] |
| Q50933526 | [Hormonal control of sexual behavior in males and endocrinologic causes of sexual dysfunction] |
| Q81112879 | [II-Relationship care. 8/10 Persons with sexual dysfunction disorders] |
| Q80367041 | [Investigation and analysis of chronic prostatitis and sexual dysfunction] |
| Q57102333 | [Investigation of sexual dysfunction among chronic prostatitis patients in high altitude area] |
| Q70972876 | [Italian centers that deliver treatment for male sexual dysfunction] |
| Q79813601 | [Levitra in the treatment of patients with chronic prostatitis associated with sexual dysfunction] |
| Q80575485 | [Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)] |
| Q95382735 | [Male sexual dysfunction and Parkinson's disease: a preliminary investigation] |
| Q80592223 | [Male sexual dysfunction and its treatment in neurourology] |
| Q85915934 | [Male sexual dysfunction and obesity] |
| Q79831047 | [Male sexual dysfunction involving penile erection, emission and ejaculation] |
| Q78648532 | [Male sexual dysfunction with spinal cord injury and other neurologic diseases] |
| Q74585056 | [Male sexual dysfunction: introduction] |
| Q71129038 | [Male sexual dysfunction: neuroanatomy, neurophysiology and semiology] |
| Q72255350 | [Male sexual dysfunction] |
| Q70972879 | [Management of sexual dysfunction in spinal cord injury] |
| Q70149988 | [Mechanisms of sexual dysfunction in alloxan diabetic rats] |
| Q82681059 | [Medical and social implications of sexual dysfunction and safety of antihypertensive therapy in hypertensive patients] |
| Q71811913 | [Medication causing sexual dysfunction] |
| Q81319690 | [Outline of diagnosis and treatment on male sexual dysfunction] |
| Q83329888 | [Overactive bladder as a cause of sexual dysfunction] |
| Q85946727 | [Patient with late-start hypogonadism and sexual dysfunction] |
| Q79452254 | [Peripheral nerve injury and male sexual dysfunction] |
| Q74839239 | [Pharmacology of male sexual dysfunction] |
| Q71937122 | [Postoperative sexual dysfunction in patients with cancer of the large intestine--the conditions and its management] |
| Q93177781 | [Prevalence and characteristics of sexual dysfunction among Moroccan patients consulting for a first depressive episode] |
| Q83400158 | [Prevalence of female sexual dysfunction in Rostov on Don] |
| Q84329435 | [Prevalence of sexual dysfunction in two women groups of different socioeconomic status] |
| Q54687603 | [Problems in the gastrointestinal and urinary tract system and sexual dysfunction in patients suffering from multiple sclerosis]. |
| Q95583703 | [Progress in the treatment of female sexual dysfunction] |
| Q70409358 | [Prolactin and male sexual dysfunction] |
| Q74584919 | [Psychoactive substance-induced sexual dysfunction in men] |
| Q56967954 | [Psychological treatment of female sexual dysfunction: a critical review of the literature] |
| Q82762466 | [Psychosocial aspects of patients with sexual dysfunction] |
| Q85758168 | [Questionnaires on male sexual dysfunction and their clinical application] |
| Q91034890 | [Relation between sexual dysfunction and metabolic syndrome] |
| Q52710680 | [Results of a multicenter non-interventional study on the efficacy and safety of NeyroDoz complex for sexual dysfunction in men]. |
| Q71236873 | [Role of hypothalamic monoamines in the pathogenesis of sexual dysfunction caused by hyperandrogenization] |
| Q68113639 | [Sex hormone metabolism and sexual dysfunction in chronic kidney failure with maintenance hemodialysis therapy] |
| Q79840191 | [Sex therapy for male sexual dysfunction] |
| Q90946739 | [Sexual Dysfunction in Primary Health Care] |
| Q82489098 | [Sexual disorder from an evolutionary perspective] |
| Q50919685 | [Sexual disorder in men]. |
| Q69584194 | [Sexual dysfunction after aortoiliac surgery] |
| Q57141377 | [Sexual dysfunction after curietherapy and external radiotherapy of the prostate for localized prostate cancer] |
| Q82740491 | [Sexual dysfunction after localized prostate cancer treatment] |
| Q82740503 | [Sexual dysfunction after radical prostatectomy] |
| Q78451091 | [Sexual dysfunction after rape] |
| Q90828714 | [Sexual dysfunction among oncological patients: The importance of a specialized approach] |
| Q78451081 | [Sexual dysfunction among patients with epilepsy] |
| Q70672009 | [Sexual dysfunction among young female alcoholics. An interview study of 30 women, aged 25-39 years, receiving Antabuse therapy] |
| Q84327652 | [Sexual dysfunction and antidepressants] |
| Q91862126 | [Sexual dysfunction and antihypertensive treatment: Involvement of the different therapeutic classes and what to do about the treatment of hypertension] |
| Q82489082 | [Sexual dysfunction and coronary artery disease in adult women] |
| Q45955706 | [Sexual dysfunction and depression: Validity of a French version of the ASEX scale]. |
| Q71466985 | [Sexual dysfunction and diabetes mellitus] |
| Q70826428 | [Sexual dysfunction and disordered carbohydrate metabolism (author's transl)] |
| Q53923078 | [Sexual dysfunction and its consequences in patients with cardiovascular diseases]. |
| Q70177522 | [Sexual dysfunction and zinc in renal insufficiency] |
| Q68699223 | [Sexual dysfunction as a cause of infertile marriage] |
| Q73468888 | [Sexual dysfunction as a drug side effect] |
| Q91414434 | [Sexual dysfunction as a side effect of medication] |
| Q77822913 | [Sexual dysfunction associated to the use of psychodrugs. Present importance and therapeutic possibilities] |
| Q85887728 | [Sexual dysfunction associated with antidepressant agents] |
| Q54107168 | [Sexual dysfunction associated with psychotropic drugs and treatment options]. |
| Q80643898 | [Sexual dysfunction at urinary incontinence] |
| Q73069152 | [Sexual dysfunction due to antihypertensive drugs] |
| Q72521148 | [Sexual dysfunction due to captopril and amlodipine] |
| Q73277135 | [Sexual dysfunction during treatment of depression] |
| Q71230378 | [Sexual dysfunction following operation for cancer of the uterine cervix stages Ib and IIa] |
| Q54373419 | [Sexual dysfunction following pelvic surgery]. |
| Q72205544 | [Sexual dysfunction following rectal surgery] |
| Q80334242 | [Sexual dysfunction in ESRD patients] |
| Q64977218 | [Sexual dysfunction in Parkinson's disease] |
| Q83158313 | [Sexual dysfunction in Russia: risk factors for women] |
| Q54316893 | [Sexual dysfunction in a general practice. Study of 40 women and 40 men in the age-group 26-45 years] |
| Q73172817 | [Sexual dysfunction in alcoholic men] |
| Q73936553 | [Sexual dysfunction in diabetes mellitus] |
| Q78451076 | [Sexual dysfunction in diabetes mellitus] |
| Q83838665 | [Sexual dysfunction in diabetic women] |
| Q81000893 | [Sexual dysfunction in female patients with chronic renal insufficiency] |
| Q70645341 | [Sexual dysfunction in infarct patients and their partner: repercussions on the couple's relations] |
| Q45978690 | [Sexual dysfunction in male: a matter of old age or a warning signal?] |
| Q70519334 | [Sexual dysfunction in male] |
| Q69606790 | [Sexual dysfunction in males in long-term hemodialysis] |
| Q90651795 | [Sexual dysfunction in males with chronic kidney disease] |
| Q81061218 | [Sexual dysfunction in males with concomitant urological diseases] |
| Q84317426 | [Sexual dysfunction in men after surgery of colorectal carcinoma. New developments in prevention and therapy] |
| Q71295592 | [Sexual dysfunction in men and epilepsy] |
| Q54267522 | [Sexual dysfunction in men in the first 9 months after myocardial infarction]. |
| Q80195937 | [Sexual dysfunction in men treated for testicular cancer] |
| Q80700491 | [Sexual dysfunction in men with spinal injuries] |
| Q80700487 | [Sexual dysfunction in men] |
| Q73156470 | [Sexual dysfunction in mental disorders] |
| Q53658053 | [Sexual dysfunction in migraine patients who receive preventive treatment: identification by means of two screening tests]. |
| Q73156466 | [Sexual dysfunction in neurological disorders] |
| Q78621984 | [Sexual dysfunction in patients with cardiovascular diseases] |
| Q90453630 | [Sexual dysfunction in patients with chronic prostatitis and its treatment] |
| Q81122394 | [Sexual dysfunction in patients with myocardial infarction] |
| Q84467046 | [Sexual dysfunction in remittent depressive women] |
| Q73936556 | [Sexual dysfunction in the male patients on hemodialysis] |
| Q78451058 | [Sexual dysfunction in torture victims] |
| Q78330962 | [Sexual dysfunction in treated hypertensive patients. Results of a national survey] |
| Q70256728 | [Sexual dysfunction in various gynecologic diseases] |
| Q78451071 | [Sexual dysfunction in women after certain surgical interventions] |
| Q80955466 | [Sexual dysfunction in women] |
| Q85641704 | [Sexual dysfunction induced by antidepressants and antipsychotics] |
| Q74811564 | [Sexual dysfunction is common during treatment with antidepressive agents] |
| Q95623645 | [Sexual dysfunction is frequent in patients with anal fistulas and anal fissures] |
| Q80306193 | [Sexual dysfunction management in multiple sclerosis] |
| Q95527809 | [Sexual dysfunction secondary to urethral stricture and urethroplasty] |
| Q81246124 | [Sexual dysfunction, depression and quality of life in male implantable cardioverter defibrillator (ICD) recipients--with and without shock delivery] |
| Q95602538 | [Sexual dysfunction, gender identity disorders, paraphilic disorders] |
| Q52562739 | [Sexual dysfunction: Changing conceptions and criteria of classification]. |
| Q86235749 | [Sexual function and factors associated with sexual dysfunction in climacteric women.] |
| Q85722065 | [Shugan Jieyu Capsules combined with conventional therapy for type III B prostatitis complicated by sexual dysfunction] |
| Q79778869 | [Strategies for talking to the patient with sexual dysfunction in the doctor's office] |
| Q91189970 | [Stress Urinary Incontinence and Female Sexual Dysfunction: The Role of Pelvic Floor Rehabilitation] |
| Q79310676 | [Studies on sexual dysfunction in male patients with chronic renal insufficiency] |
| Q81466951 | [Study on the knowledge of and attitude to sexual dysfunction in aged men] |
| Q78451067 | [Surgical aspects of sexual dysfunction in men] |
| Q69567849 | [Surgical treatment with prosthesis implantation in 100 patients with erectile sexual dysfunction] |
| Q92829705 | [Systematic review of personality disorders and sexual dysfunction] |
| Q73363174 | [The adolescent and sexual dysfunction: real or imagined] |
| Q83183578 | [The assessment and management of female sexual dysfunction] |
| Q73110268 | [The endocrine basis of sexual dysfunction in the elderly] |
| Q51960446 | [The physiopathology and management of sexual dysfunction in epileptic patients] |
| Q71699259 | [The preventive effect of indeloxazine hydrochloride to the sexual dysfunction caused by anti-androgenergic agent (allylestrenol)] |
| Q90176141 | [The role of herbal therapy, vitamins and micronutrients formanagement of male sexual dysfunction and male infertility] |
| Q82489076 | [The role of physical therapy in the treatment of female sexual dysfunction] |
| Q71341794 | [The significance of some selected factors for sexological advice and therapy. A review of 397 persons referred on account of sexual dysfunction during the period 1974-1979] |
| Q71462913 | [Theoretical and animal experimental bases of anterior hypothalamotomy in the treatment of severe sexual disorder and the accuracy of the method] |
| Q79805776 | [Therapeutic aspects in coronary cardiac patients who suffer from sexual dysfunction in a cardiac rehabilitation program] |
| Q67872321 | [Treatment of male sexual dysfunction] |
| Q83645179 | [Treatment specificity of age-related sexual dysfunction] |
| Q70879582 | [Trial concerning 100 male alcoholics with sexual dysfunction] |
| Q90724608 | [Updated application of penile electrophysiological examination in the diagnosis and treatment of male sexual dysfunction] |
| Q93550441 | [Urinary stoma care. On sexual dysfunction] |
| Q70214269 | [Urological contingencies in the management of sexual dysfunction in men] |
| Q69873095 | [Use of diadynamic currents in sexual dysfunction] |
| Q70650994 | [Venous return blood in sexual dysfunction in the male (author's transl)] |
| Q90754299 | [Yun's optimized pelvic floor training therapy for idiopathic moderate overactive bladder with sexual dysfunction in young and middle-aged women] |
| Q93218134 | miR-137 Affects Vaginal Lubrication in Female Sexual Dysfunction by Targeting Aquaporin-2 |
| Q89455273 | Yacov Reisman | field of work | P101 |
| Q102730727 | Mammalian disorder of sexual development | medical condition | P1050 |